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Abstract 
 
UNIVERSITY OF SUSSEX 
Ann-Sofie Schreurs 
A thesis submitted for the degree of Doctor of Philosophy 
 
“In vivo structure-mediated regulation of Ribonucleotide Reductase in S. 
pombe” 
 
 Sufficient and balanced pools of deoxyribonucleotide triphophates (dNTPs) is 
crucial for high-fidelity DNA replication as well as correct DNA repair. The enzyme 
RiboNucleotide Reductase (RNR) catalyses NDP to dNDP and is therefore an 
essential enzyme by providing the “building blocks” to the cells. dNTPs production 
needs to be tightly regulated in order to minimize mutation frequencies and prevent 
genome instability.  
 RNR in S. pombe is composed of two proteins, Cdc22R1 and Suc22R2, and has 
been described as a heterotetramer with a dimer of each subunit: the big subunit 
Cdc22R1 and the small subunit Suc22R2. S. pombe also posseses an RNR inhibitor: 
Spd1, as well as a second RNR regulator Spd2 which has been newly discovered. 
Spd1 has been demonstrated to inhibit RNR and to regulate its activity throughout the 
cell cycle. The detailed mechanism of the RNR regulation during the cell cycle or after 
DNA damage is not entirely clear, as are the means of inhibition by Spd1. In order to 
shed some light on the RNR complex and its regulation, we used various microscopy-
based methods to study RNR in vivo as well as in vitro.  
 The data of this thesis suggest there are different forms of active RNR 
heterocomplexes, found throughout the cell cycle in the cytoplasm as well as in the 
nucleus. We propose that the precise stoichiometry of subunits in the complexes may 
vary, or that the complex conformation may be modified in an Spd1-dependent 
manner. In addition, treatment of the cells with a UV mimetic agent, 4NQO, seems to 
promote RNR regulation in an Spd1-dependent manner. On the contrary, inhibition of 
RNR by HydroxyUrea  (HU) affects the RNR in a possible structure-related manner, 
independently of Spd1 or Spd2. The in vivo observations correlate with structural 
and/or oligomerization modifications of the RNR, representing a novel RNR regulation 
in S. pombe. 
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Δ / -d Gene deletion 
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CHAPTER I INTRODUCTION 
Accurate genome duplication is dependent on several factors in order to 
achieve high fidelity replication of hereditary information. This information is 
supported in the genome of the organism, based in Deoxyribo Nucleic Acid 
(DNA). DNA is therefore an indispensable component of cells, and its 
maintenance is important. Different events in the cell can be source of instability 
to the genome during DNA replication in synthesis phase (S-phase), or after 
DNA damage from endogenous or exogenous sources. The aim of this project 
is to understand the role of an essential enzyme, Ribonucleotide Reductase 
(RNR) in genome maintenance and stability, due to its role of providing dNTPs 
to the cell. As dNTPs are the substrate for genome replication, RNR has an 
important role in genome stability. 
I will introduce various important areas relevant to this work: genome 
stability during DNA replication and DNA repair, an overview of the 
Ribonucleotide Reductase (RNR) enzyme, followed by a summary of the 
advanced fluorescent microscopy methods used. 
I.  Genome Stability: Interplay between cell cycle 
checkpoints, DNA replication and DNA repair 
1.  Genome maintenance during cell division  
A cell is duplicated in an orderly and sequential manner, in which the genetic 
material as well as the cell mass are copied and divided into two. This 
duplication step is part of the cell cycle, known as the S-phase or synthesis 
phase. Cells cycle through different phases that are fundamental for organism 
reproduction. Although the cell cycle varies from organism to organism, most 
mechanisms and components have been conserved throughout evolution. 
I will focus on Eukaryotes, although the non-nucleated prokaryotes have a 
similar cell cycle mechanism. 
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1.1 Schizosaccharomyces pombe as a model organism: 
Schizosaccharomyces pombe (S. pombe) (Figure I.1), also called fission 
yeast, was isolated from East African beer in 1893 by P. Lindner, who used the 
Swahili translation for beer: “pombe” to identify this yeast. It was further 
described by several more scientists (C. Eijkman in 1894 and M.W Beijerinck in 
1897) but finally used as a model in the 1950’s by Urs Leupold to study genetics 
(Leupold, 1949) and Murdoch Mitchison who worked on the cell cycle 
(Mitchison, 1957). Afterwards, Paul Nurse (1970’s) used S. pombe extensively 
and helped towards S. pombe being accepted as a very good model for cell 
cycle analysis, DNA replication as well as DNA damage and repair (Nurse P, 
1976 ). 
This small unicellular eukaryote, 3-4 µm in diameter and 7-14 µm in 
length, is an ascomycete fungus with a unique rod-shaped cell growing in length 
and dividing by fission. In addition to the advantage of the cell shape and 
growth, S. pombe cells are usually haploid, and reside mostly in G2-phase. 
Finally, its genome consists of 3 chromosomes, making S. pombe a good 
eukaryotic model to study cell cycle, checkpoints and genetics (Nurse, 1992). 
Also worth mentioning is the fact that S. pombe was the sixth model organism 
to be fully sequenced (Wood et al, 2002) making it more approachable and 
interesting as a model organism. It is the organism used throughout this project. 
 
Figure I. 1 Schizosaccharomyces pombe, its origins and usages 
Representative pictures of the origins and research evolution of the model yeast S. pombe.  
 a. “Making Pombe in the hollowed-out stump of a tree” is from Swahili and other native tribes, 
Globusz publishing. Figure b. represents drawings from the first description and publication of 
S. pombe, Lindner P. 1893. Schizosaccharomyces pombe, ein neuer Gärungserreger, 
Wochenschrift für Brauerei Third image c. is a scanning electron microscope image of dividing 
S. pombe cells from Jurgen Berger, Max Plank Institute. The image in d. is a soft X-ray 
tomography of rapidly frozen S. pombe from the National Centre for X-ray Tomography, Carolyn 
Larabelle. The key cell components are: nucleus in blue; nucleolus in orange; mitochondria in 
gray; vacuoles in white; and lipid-rich vesicles in green. 
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1.2 Cell cycle and Checkpoints at a glance: 
As mentioned above, the cell cycle is required for the division of one cell 
into two daughter cells, and the cell cannot divide unless its entire genome has 
been fully replicated. To achieve this, the cells undergo DNA synthesis followed 
by mitosis. The cell cycle happens in a chronological and sequential order of 
different phases (see Figure I.2), where the later phases are dependent on the 
completion of the earlier phases. The G1 phase stands for “GAP-1” and is 
required for cell growth and preparation of DNA synthesis. The S-phase stands 
for “synthesis” of DNA and replication of the entire genome. The G2 phase is 
“GAP-2” and is essential for cell growth and preparation for mitosis (Nurse P, 
1976 ). Finally, the M phase stands for “Mitosis” and represents the 
chromosomes division generally segregating the newly duplicated DNA. In 
order to verify the correct progress of these, the cell has checkpoints at different 
stages of the cell cycle with various roles, but mainly to verify cell mass and 
assess DNA damage, as well as the correct chromosome alignment (Norbury & 
Nurse, 1992). These are detected by a sensor-signal-effector mechanism.  
One checkpoint is at the start of S-phase, after completion of the G1 
phase, and is called the G1, G1/S or Restriction checkpoint (Start Checkpoint in 
yeast) (Nurse & Thuriaux, 1980; Sveiczer et al, 1996). The G1-phase is 
characterized by an accumulation of proteins, which are required for 
progression through the cell cycle. At the end of the G1-phase, the decision is 
made whether the cell will continue to divide, arrest, or enter the G0 (quiescent) 
phase. The determination of entering S-phase is made on assessment of 
growth factors, cell mass, and undamaged DNA. Using a network of cyclin 
proteins (Hunt, 1991) (Evans et al, 1983), cyclin-dependent kinases (CDK) 
(Nurse & Thuriaux, 1980) and CDK inhibitors (Morgan, 1995); the cell will 
progress into S-phase  (Langerak & Russell, 2011). 
The next checkpoint is the intra-S phase checkpoint (Carr, 1998), as 
DNA replication is a complex process, with multiple and unsynchronized DNA 
origins firing, there are many possibilities for replication fork stalling and thus 
damage to the DNA. DNA replication and its inspection before cell cycle 
development will be explained more thoroughly later. 
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Before the start of Mitosis, the G2/M checkpoint, also called DNA 
damage checkpoint (Nurse, 1992) (Carr, 1998), ensures the cell size and 
morphogenesis are correct, but especially that the DNA replication happened 
faithfully thus establishing the absence of DNA damage (O'Connell et al, 2000). 
The Maturation/Mitosis Promoting Factor (MPF) will be activated, as it is 
necessary for entering mitosis. MPF will be activated by the phosphatase 
Cdc25, which removes the inhibiting phosphorylation on the MPF. However, 
when DNA damage occurred, the cell cycle will be arrested through the 
degradation of Cdc25 (Sveiczer et al, 1999) upon phosphorylation by the ATM 
kinase (Furuya & Carr, 2003) (Enoch et al, 1992).  
The spindle checkpoint, also called metaphase or mitotic checkpoint 
ensures the correct alignment of the chromosomes on the spindle and will be 
the major decisive factor to proceed through the cell cycle in order to obtain an 
equal distribution of the genetic material (Norbury & Nurse, 1992). 
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Figure I. 2 Simplified schematic of the general Eukaryotic cell cycle and the associated 
checkpoints 
A cell progresses through a sequential cycle of phases: G1 (GAP-1), S (synthesis), G2 (GAP-2) 
and M (Mitosis).  There are 4 checkpoints, the G1/S  (Restriction or Start checkpoint) allowing 
the entry into S-phase, the intra-S phase in order to verify the correct DNA replication, followed 
by the G2/M checkpoint ensuring a correct cell mass and DNA duplication, and the spindle 
checkpoint in order to avoid missegregation of genomic material. 
1.3 Cell cycle and checkpoints in S. pombe: 
As mentioned before, the model yeast S. pombe has proven to be very 
useful, especially in the case of cell division studies to identify the implicated 
genes in the cell cycle: cell-division-control genes, or cdc genes (Nurse & 
Thuriaux, 1980) .  
The cell cycle is mainly dependent on cyclin-dependent kinases (Cdk), resulting 
in cyclical phosphorylation of target proteins. In S. pombe, Cdc2 (Durkacz B, 
1986) is the only Cdk, and in S. cerevisae Cdc28Sc is the Cdk, while 
mammalians have more than one (Langerak & Russell, 2011; Uranbileg et al, 
2012). 
During every cell cycle phase, specific Cdk-cyclin complexes are present 
in order to tightly regulate the Cdk proteins activity. The cyclin proteins will be 
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synthesized or degraded by the ubiquitin pathway in order to have them at 
precise levels at a specific cell cycle phase. In addition, another group of 
proteins are important for the regulation of the cell cycle progression: CKI (Cdk 
Inhibitor Proteins). They are small proteins that bind to Cdk. The CKI in S. 
pombe is Rum1 (Carr, 1994) (SigSc), and inhibits Cdc2, ensuring a control of the 
Cdc2-cyclin complexes (Furuya & Carr, 2003).  
The different steps of the cell cycle progression with the associated cell 
cycle “engines” (Nurse & Thuriaux, 1980) (Hunt, 1991) (Nurse, 1992) are as 
follow (see Figure I.3): 
- The effector complex in G1 phase is Cdc2-Cig1 (Cdk-cyclin) 
which inhibits Rum1 (CKI) by phosphorylation. This process 
allows increased levels of the complex Cdc2-Cig2 in G1-S 
phase, triggering entry into S-phase (Labib et al, 1995) (Carr, 
1994) 
- Progressing through the cell cycle, the levels of the cyclin 
Cdc13 rise, resulting in an association with Cdc2 in S-phase. At 
this point, Cdc2-Cdc13 is regulated through inhibitory 
phosphorylation on Y15 of Cdc2: inhibited by the kinases 
Wee1Sp (Wee1Hs SweeSc) and Mik1 (Myt1Hs) or activated by the 
phosphatase Cdc25 (Cdc25Hs Mih1Sc) (Sveiczer et al, 1999) 
(Langerak & Russell, 2011) 
- Ultimately, Cdc25 will fully regulate Cdc2, activating the Cdk 
and allowing the complex Cdc2-Cdc13 to reach its 
concentration peak required for entry in mitosis (Sveiczer et al, 
1999) 
One of many other mechanisms to regulate cell cycle progression is for 
example by control of gene transcription with DSC1. The DSC1 system 
regulates the transcription of genes containing a MCB sequence and are 
important for entry into S-phase. One target gene of DSC1 is cdc22+ encoding 
the big subunit of the Ribonucleotide Reductase Cdc22 (Fantes, 1986 ) 
(Fernandez Sarabia MJ, 1993 ) (Maqbool et al, 2003). 
I will now focus a bit more on the intra-S phase checkpoint (DNA 
replication checkpoint) as well as the G2/M checkpoint (DNA damage 
checkpoint).
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Figure I. 3 Cell cycle of S. pombe 
Schematic of the cell cycle progression and checkpoints in S. pombe. The cell cycle is composed of 
sequential phases: G1, S  G2  and Mitosis, but the length of the phases for S. pombe are different i.e. for 
the majority of the time, the fission yeast cell will be in G2. There are also 4 checkpoints, the G1/S  (Start 
checkpoint), the intra-S phase followed by the G2/M checkpoint and the spindle checkpoint. Cdc2-Cig1 is 
the Cdk-cyclin complex present in G1 Phase, and by inhibition of Rum1, will allow the next complex to 
form: Cdc2-Cig2, thus promoting entry into S-phase. Cdc2-Cdc13 will increase during S-phase 
(regulated by balanced levels of kinases -Wee1 and Mik1- and phosphatase -Cdc25-) and at its peak will 
allow entry into mitosis. Also represented on the diagram are the distinctive cell shapes and nucleus 
formation drawn in accordance to the cell cycle phase stage. 
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1.4 DNA replication: 
DNA replication is an essential process, and has complex assembly 
mechanisms as well as interplay with the cell cycle. As DNA replication needs 
dNTPs, RiboNucleotide Reductase (RNR) can therefore indirectly modulate the 
DNA replication, thus the cell cycle. I will give some insight into the DNA 
replication process. 
a. Initiation of DNA replication 
Although the replication of the genome happens during S-phase, it is a 
stepwise assembly requiring preparations completed beforehand: in G2-M the 
Origin Replicative Complex (ORC) binds to the DNA at sites of replications 
origins throughout the genome (Diffley, 1996). Subsequently, in G1 phase, the 
pre-Replicative Complex (pre-RC) is loaded on DNA, and is needed for the 
unwinding of the DNA strands during replication (Diffley, 2011) (Figure I.4): 
- The pre-RC complex is composed of Cdc18Sp (Cdc6Sc and Hs), Cdt1 and 
MCM (Mini Chromosome Maintenance). Cdc18 (with the help of Sap1) 
and Cdt1 are recruited to the site, allowing the loading of the MCM 
complex onto the DNA as part of the fully licensed pre-RC complex 
- Next, the pre-RC complex has to be activated; therefore the pre-IC (pre-
Initiation Complex) is formed in G1-S phase. The essential transition 
from the pre-RC (assembled complex) to pre-IC (active helicase) will 
involve two kinases: the Cdk Cdc2Sp, and DDK which is composed of 
Hsk1Sp (Cdc7Sc and Hs) and Dfp1Sp (Dbf4Sc and Hs)   
- Cdc2 and Hsk1 phosphorylate the heterohexamer MCM, followed by 
Cdc18 displacement whilst additional proteins are recruited: Cdc45Sp, 
Sld3Sp and the GINS complex (Psf1-3, Sld5).  
- The essential checkpoint and replication factor Rad4Sp/Cut5Sp (Dbp11Sc 
TopB1hs) is recruited. Subsequently, Cdc23Sp (MCM10Sc) is loaded onto 
the origin and could be needed for loading of the polymerase. 
Polymerase ε (Pol ε) is loaded on the pre-RC, and in S phase the 
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replication can finally start, with the replisome complex complete upon 
recruitment of the replicative DNA polymerase Pol α. 
 
Figure I. 4  Simplified schematic of the initiation of DNA replication 
Diagram of the stepwise complex assembly for the initation of DNA replication. Pre-RC: pre-
Replication Complex; pre-IC: pre-initation Complex; RPC: Replisome Progression Complex. In 
first instance, ORC and Sap1 bind to the DNA replication origins during the cell cycle, then Cdt1 
is loaded to the origin by ORC alone, but ORC and Sap1 are both required for loading of Cdc18 
to the origins. Afterwards, Cdc18 and Cdt1 recruit MCM, and the pre-RC is assembled. 
Activation of the replication origins is partially accomplished by recruitment of Hsk1/Dfp1 
followed by loading of Cdc45, Sld3, the GINS complex, Rad4, Cdc23 and polymerase ε (Pre-
IC). Finally, polymerase α is recruited and the RPC is ready. 
b. Fork Replication  
The replication fork is an ingenious structure permitting the faithful and 
fast duplication of the double stranded DNA. Because of the particular anti-
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parallel nature of the double helix, in addition to the fact that DNA polymerase 
does synthesize DNA in a 5’ to 3’ manner, the fork will have a leading strand 
and a lagging strand. The 3’ to 5’ DNA strand is used as template by Pol ε (to 
produce the nascent 5’ to 3’ leading strand), while the lagging strand uses a 
system of DNA primase and Okazaki fragments operated by Pol α to produce 
the 3’ to 5’ DNA. The DNA fork replication is composed of different sub-
components with various roles (Stillman, 2008) as shown in figure I.5:  
- Helicase proteins: MCM complex (with some of the above mentioned 
proteins i.e. Cdc45 and GINS). Other helicases have been described to 
play a role in replication i.e. Dna2Sp, Rqh1Sp  
- Topoisomerases to relax the super-coiling of the DNA induced by the 
helicases 
-  DNA polymerases: Pol α and its associated primase to initiate the DNA 
replication, followed by Pol δ on the lagging strand and Pol ε on the 
leading strand. The clamp loader Replication Factor-C (RFC) and PCNA 
are important to load Pol δ and Pol ε while PCNA is also essential for the 
processivity of those DNA polymerases. 
- Ligase is essential to ligate the Okazaki fragments 
- The single-strand binding protein, RPA, is important to protect the single 
stranded DNA (ssDNA). RPA is essential for the recognition of ssDNA in 
order to signal the presence of ssDNA and therefore the necessity for 
DNA replication and especially DNA repair. 
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Figure I. 5  Simplified model of the Replisome Complex (RC) 
Schematic of the proposed model based on the trombone model in Prokaryotes. The helicase 
will unwind the DNA, while the topoisomerase will allow the DNA to relax. Pol α, in association 
with the primase, initiaties the replication, and Pol δ and Pol ε will proceed on the lagging strand 
and the leading strand respectively. RFC and PCNA are present for the loading and processivity 
of the DNA polymerases. On the lagging strand, the replication is operated by Okazaki 
fragments, which will then be ligated. The single strand binding protein RPA is protecting the yet 
unreplicated single stranded DNA. 
c. Fork stalling: stabilization and checkpoint activation 
The replication fork is a multi-component complex (Fig I.5), with 
additional proteins associated with the replisome in order to maintain and 
stabilize it.  DNA replication is tightly regulated, as each origin has to fire only 
once per cell cycle, and the replication has to be fully completed without any 
errors. In addition, different obstacles will destabilize the fork, a lack of dNTPS 
for the DNA polymerases, DNA damage, fork replication barriers or aberrant 
DNA structure. 
If a fork stalls, in order to restart the fork once the obstacle is overcome, 
the cell cycle has to be paused, thus the checkpoint is activated. But the fork 
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will collapse if it is not maintained in a stable structure, leading to the loss of the 
fully functional replisome, which can lead to a broken fork. 
The DNA replication checkpoint, or also called intra S-phase checkpoint, will 
come into play to arrest the cell cycle to permit the fork restart or recovery 
(Figure I.6) (Caspari, 1999) (Furuya & Carr, 2003): 
- The Rad3-Rad26 kinase complex (ATR-ATRIPHs Mec1-Dcd2Sc) is 
recruited to the stalled fork, together with the RFC-like (Rad17 and 
RFC2-5) and PCNA-like (Rad1-Hus1-Rad9 i.e. 9-1-1) complexes 
(Caspari et al, 2000) (Paciotti et al, 2001) 
- Next, the essential step in the checkpoint activation is the 
phosphorylation of Cds1 (Chk2Hs Rad53Sc) by Rad3 (Lindsay et al, 1998) 
- Mrc1 (ClaspinHs Mrc1Sc) is the mediator protein in the Cds1-dependent 
checkpoint activation 
- This activation results in an accumulation of Mik1 (Myt1Hs Swee1Sc) 
leading to an inhibition of Cdc2 by phosphorylation of its residue Y15, 
therefore preventing entry in mitosis (Christensen et al, 2000) 
- In addition, the Cds1-Mrc1 complex inhibits the firing of new origins of 
replication (through inhibition of Hsk1 which is part of the DDK essential 
to pass from pre-RC to pre-IC) and slowing down the progression of 
replication throughout the genome 
- Finally, the Cds1-Mrc1 complex regulates the Mus81-Eme1 
endonuclease complex required for fork restart 
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Figure I. 6  Simplified fork replication stabilization and checkpoint activation 
When there is limited supply of dNTPS or DNA damage, the replication fork will stall, and after 
being stabilized will activate the checkpoint to arrest the cell in order to give time to overcome 
the obstacle. At the Replisome Complex (RC), the kinase complex Rad3-Rad26 is loaded, and 
the RFC-like complex as well as PCNA-like complex 9-1-1 might be linked for the recruitment of 
the mediator protein Mrc1. Mrc1 in turn, recruits the effector protein Cds1 which will inhibit entry 
in Mitosis (by accumulation of Mik1 which will increase the inactive Cdc2). At the same time, 
Cds1-Mrc1 will inhibit Hsk1, which is essential for origins firing; and the effector/mediator Cds1-
Mrc1 module will also regulate Mus81-Eme1 and their role in fork restart.  
 
In absence of this DNA replication checkpoint, the fork will collapse and 
ultimately create DNA strand breaks, possibility creating genomic instability 
(Lambert & Carr, 2005). Therefore the stabilization of the fork, as well as the 
preservation of the replisome, is important. After removal of the DNA lesion or 
increased supply of dNTPs, the replication will resume. Hydroxyurea (HU) is 
used to provoke fork stalling. HU is a Ribonucleotide Reductase inhibitor thus 
limits the dNTPS supply to the cell.  
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1.5 G2/M DNA damage checkpoint and comparison of the checkpoints 
a. DNA Damage checkpoint 
Damage to the DNA in cells occurs regularly, and can be due to different 
sources, resulting in various DNA damages. Corresponding DNA repair 
pathways repairs these DNA damages, once the DNA damage checkpoint is 
activated.  
The G2/M checkpoint, also called the DNA damage checkpoint, and has the 
same cascade reaction as the previous checkpoint i.e. sensors, mediators and 
effectors. In S. pombe, considering that the longest phase is G2, this checkpoint 
is important (fig I.7) (Furuya & Carr, 2003; O'Connell et al, 2000) (Langerak & 
Russell, 2011). 
- In first instance, the heterotrimer RPA binds to the single strand DNA, 
resulting from the DNA damage and is followed by recruitment of the 
kinase complex Rad3-Rad26 
- It is thought that the PCNA-like complex 9-1-1 and Rad17 are recruited 
onto the damaged DNA enabling closer proximity between Rad3-Rad26 
and the mediator proteins 
- Rad4 is recruited by Rad9 (from the 9-1-1 complex) 
- The mediator protein Crb2 (53BP1Hs Rad9Sc) is loaded and activated by 
a Rad3-dependent phosphorylation, thus regulating the Chk1 effector 
protein 
- Upon activation of Chk1, Mik1 and Wee1 accumulate (therefore inhibiting 
Cdc2) leading to non-entry into mitosis. It is thought that Chk1 may 
inactivate Cdc25 through the 14-3-3 complex, also resulting in a 
checkpoint inhibition. 
- In addition, Rad3 phosphorylates H2A, hallmark of an active checkpoint 
and thus DNA damage nearby.                               
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Figure I. 7 Simplified G2/M checkpoint activation 
When DNA damage occurs, RPA will be the first present to protect single stranded DNA. Next 
the essential Rad3-Rad26 is recruited, followed by the loading of the 9-1-1 complex and Rad17. 
Rad4 is recruited and which in turn will bring the mediator protein Crb2 to the site, and the 
effector Chk1. Once activated, Chk1 will be able to prevent entry in mitosis through 
accumulation of the Cdc2 inhibitors Mik1 and Wee1.  It might also inhibit the Cdc2 activator 
Cdc25 through the complex 14-3-3. In addition, Rad3 will phosphorylate H2A in order to flag 
DNA damage where an active checkpoint is already on site.  
 
More recently, it has been described that Tel1Sp (ATMHs Tel1Sc) is also recruited 
to the DNA damage sites and interacts with Nbs1 from the MRN complex: 
Rad32 (Mre11Hs) Rad50, and Nbs1 (Xrs2Sc) (Langerak & Russell, 2011) 
(Mantiero et al, 2007). 
b. Checkpoint signalling comparison  
Below is a summary (Figure I.8) of the checkpoints (Furuya & Carr, 
2003) , as well as the signaling cascade system in the cell to arrest the cell 
cycle in order to give time to restart a stalled/collapsed fork and repair DNA 
damage. Comparison is done with humans, Homo sapiens, and budding yeast, 
S. cerevisae (Longhese et al, 2003; Longhese, 1998) involving similar 
mechanisms although different denominations.  
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Figure I. 8 Simplified overview of the DNA checkpoints in Eukaryotes 
When a replication fork is stalled, or when DNA damage occurs, cells use their DNA 
maintenance checkpoints to arrest the cell cycle and facilitate fork restart or DNA repair 
pathways. The signaling cascade is composed of sensors recruited to the damage, and whilst 
activating many proteins, they will mainly activate mediators needed to trigger the effectors. 
Those effectors will indirectly regulate the cell cycle arrest as well as assisting in the replication 
fork stabilization and/or the repair mechanisms.  
Annotated are the proteins in each species: Sp.: Shizosaccaromyces pombe, Hs.: Homo 
sapiens, Sc. Saccharomyces cerevisae. 
 In vivo structure-mediated regulation of Ribonucleotide Reductase in S. pombe – PhD thesis by Ann-Sofie Schreurs 
 
31 
 
Now that we have an understandable view of the cell cycle and its 
checkpoints as well as the interplay of the proteins in DNA replication, I want to 
address how the enzyme Ribonucleotide Reductase (RNR) is involved in those 
pathways. 
1.6 RNR involvement in the cell cycle and checkpoints 
Cells are provided with a large supply of ribonucleotides, which serve as 
substrate for various important cellular functions including RNA synthesis, 
energy generation (ATP), as well as regulation of enzyme activities (GDP/GTP), 
post-translational modification of proteins (ATP), cell signaling (cAMP and 
cGMP) and others. Ribonucleotides also serve as precursor for 
deoxyribonucleotide tri-phosphates (dNTPs), which are essential for DNA 
synthesis (Nordlund & Reichard, 2006). The enzyme, which converts 
NucleoDiPhosphates (NDPs) to deoxyNucleoDiPhosphates (dNDPs) is 
Ribonucleotide Reductase (RNR). Therefore, as RNR is the main enzyme 
regulating the rate-limiting reaction of dNTPs supply to the cell, it has a key role 
in S-phase.  RNR is tightly regulated to avoid an unbalanced or limited supply of 
dNTPs to the cell (Fernandez-Sarabia & Fantes, 1990). A limited amount of 
dNTPs can lead to fork stalling and collapse, possibly leading to 
rearrangements; and an unbalanced dNTPs pool can conduct to dNTPs 
misincorporations resulting in mutations and genomic instability (Chabes et al, 
2003a; Chabes & Stillman, 2007). 
I will describe the RNR complex and its regulation in more detail in Chapter I.2, 
but the following paragraph is to emphasize the interplay of RNR with the cell 
cycle. 
In S. pombe, Cdc22 (R1Hs RNR1/RNR3Sc) is the big subunit of the RNR 
complex, while Suc22 (R2Hs RNR2/RNR4Sc) is the small RNR subunit. Both are 
targets of the DSC1-MCB system, thus transcriptionally induced during S-phase 
and after DNA damage (Fernandez Sarabia MJ, 1993 ). The RNR also has 
allosteric regulation, in addition to spatial regulation. Suc22R2 and Cdc22R1 are 
in different compartments during most of the cell cycle i.e. Suc22R2 is nuclear 
while Cdc22R1 is pan-cellular. There are also known inhibitors, or rather 
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regulators of the RNR: Spd1 and, the newly discovered, Spd2. In S. cerevisae 
the regulators are Sml1, Hug1, Dif1; and none so far have been found in 
humans (Lee et al, 2008) . 
Spd1’s degradation is induced upon activation of Chk1 (Liu et al, 2003) in 
G2 phase, and Spd1 is degraded in a ubiquitin-dependent manner. The COP9 
SigNalosome (CSN) forms a complex with cullin4 and the E3 ubiquitin ligase to 
perform the ubiquitylation (Liu et al, 2003), which triggers the degradation of 
Spd1. This degradation is necessary to allow the relocalization of Suc22R2 to 
the cytoplasm in S-phase to form complexes with Cdc22R1, in order to have 
active RNR complexes to provide new dNTPs for the cell. If the signalsome is 
non-functional (for example in a Csn1 deletion) and Rad3 is deleted as well, it 
will result in lethality as Spd1 is not degraded anymore. If Spd1 is not degraded, 
it will constantly be present and inhibit the RNR therefore no dNTPs will be 
available for the cells (Liu et al, 2003). Over-expression of the small subunit 
Suc22R2 or deletion of Spd1 will restore viability in the Csn1-deletion Rad3-
deletion strain. I will go through more details later about that rescue, which can 
be used as an assay to measure the activity of RNR (Nestoras et al, 2010).  
Despite the essential need for dNTPs during DNA replication and DNA 
repair, it must be remembered that the replication of mitochondrial genomes 
occurs independently of the cell cycle, through the process of D-loop replication. 
Therefore, dNTPs will be needed at those sites and at unsynchronized times 
with the genomic DNA replication cycle (Sazer & Sherwood, 1990) . 
Also, some recent investigations suggest that the RNR is associated and 
involved with the replication machinery, providing the dNTPs locally. Through 
this, it could also co-ordinates initiation, elongation and termination of the DNA 
replication (Poli et al, 2012). It also has been proposed that the RNR is recruited 
to the sites of DNA damage (Niida et al, 2010a), therefore I will give an 
overview of the DNA damages occurring in cells and the repair mechanisms 
associated, in order to stress the importance and role of RNR in genome 
stability (Niida et al, 2010b). 
 In vivo structure-mediated regulation of Ribonucleotide Reductase in S. pombe – PhD thesis by Ann-Sofie Schreurs 
 
33 
2.  DNA damage and repair: DNA repair pathways in Eukaryotes 
DNA damages can arise from different sources, exogenous: UV 
(components of the sunlight) as well as other radiations (ionizing radiation: X-
ray, γ), as well as numerous genotoxic chemicals can cause lesions. Also 
endogenous sources can damage DNA: DNA lesions, errors or gaps might 
occur during DNA replication, reactive oxidative species (ROS) resulting from 
cell processes, as well as spontaneous base losses. During DNA replication, 
translesion synthesis (TLS) will bypass such damages due to its DNA damage 
tolerance function. This happens by ubiquitylation of the PCNA, which then will 
recruit specialized DNA polymerases to get around the lesion or mismatch 
(Ulrich, 2011). 
 All these damages can result in gene mutations and general genomic 
instability leading to a variety of disorders. Fortunately, the cell has numerous 
mechanisms to repair them throughout the cell cycle (Nouspikel, 2009; 
Robertson et al, 2009). 
I will describe those DNA repair mechanisms, which are grouped into 
categories with regards to the nature of the DNA damage.  
2.1 Single Strand repair: Base Excision Repair (BER), Nucleotide Excision 
Repair (NER) and Mismatch repair (MMR) 
There are several sources for damage to a single strand of the double 
helix: reactive oxygen species (ROS), radiations, and genotoxic chemicals, as 
well as topoisomerases that create single strand breaks to relax the DNA 
structure.  
There are 3 main pathways to repair a defect on a single strand: BER, NER, 
MMR. In humans there is another single-strand repair pathway (Single-Strand 
Break Repair: SSBR (Caldecott, 2008) involving PARP, XRCC1 and DNA ligase 
III but homologous proteins or pathway has not been described in yeast yet. 
 In vivo structure-mediated regulation of Ribonucleotide Reductase in S. pombe – PhD thesis by Ann-Sofie Schreurs 
 
34 
a. Base Excision Repair (BER) 
BER is used when bases have been affected by deamination, oxidation, 
and alkylation (Nouspikel, 2009; Robertson et al, 2009). It follows a classic DNA 
excision by endonuclease cut and filling of the gap by a polymerase system (fig. 
I.9). 
DNA glycosylase recognizes the lesion and an AP (Apurinic/Apyrimidinic) 
endonuclease incises the single strand yielding a 3’ OH (Hydroxyl) site as well 
as a 5’dRP (Deoxyribosephosphate). This reaction is followed by either the 
short patch way or the long patch repair pathway. 
 In the short patch, the 5’dRP gap is lysed by an AP lyase (Nth1Sp with 
Apn1Sp and Apn2Sp) followed by filling with Pol4Sp (Pol βHs) and ligation with a 
DNA ligase (DNA ligase III Hs and XRCC1Hs).  
The long patch can use Pol βHs, as well as Pol λHs and Pol εHs, and the 
polymerases will displace the 5’ flap while filling the gap, thus creating a longer 
5’ flap, which can be processed by the flap endonuclease FEN1Hs (Rad2Sp 
Rad27Sc). Finally the newly synthesized DNA is ligated by a DNA ligase.  
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Figure I. 9 Diagram of the model for Base Excision Repair (BER) 
A damaged base is repaired in different steps: first recognition of the damage by a glycosylase, 
followed by an AP endonuclease, which will provide a 5’dRP. The long patch will use displacing 
polymerases, ending the repair by a flap endonuclease and ligation. Whereas in the short patch, 
a lyase will remove the 5’dRP, followed by a single nucleotide filling by a polymerase, and  
ligation. 
 
b. Nucleotide Excision Repair (NER) 
NER is required to repair bulky DNA adducts that distort the double helix 
(Nouspikel, 2009). NER is divided in two groups, the Global Genome Repair 
(GGR or GC-NER) and the Transcription Coupled Repair (TCR or TC-NER) 
(Figure I.10).  TC-NER occurs when the DNA is being transcribed, and the 
transcription machinery encounters the damage (Lehmann, 2011). 
First, the damage is recognized by XPEHs, HR23BHs (Rhp23Sp) and 
XPCHs (Rhp41 Sp), in GC-NER. In TC-NER, it is recognized by CSAHs (Ckn1?Sp) 
and CSBHs (Rhp26Sp) where the RNA polymerase II is  transcribing. 
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 Next the transcription factor (TFIIH), along with XPBHs (Ercc3Sp) and XPDHs 
(Rad15Sp) unwinds the DNA, while XPGHs (Rad13Sp) is recruited for its 
endonuclease activity. Subsequently, ERCC1Hs (Rad16Sp) (bound with XPFHs) 
will cut the damaged strand on the 5’ end, completing the incision and the 
removal of the damage. 
Finally, DNA polymerase Pol δ or Pol ε fill the gap with the help of RFC and 
PCNA, while a DNA ligase will complete the work. 
NER is a good example of the importance of correct genome 
maintenance and efficient repair, as deficiency in NER is translated in various 
disorders: for example Xenoderma Pigmentosum (XP) and Cockayne syndrome 
(CS) (Lehmann, 2003). 
 
Figure I. 10 Diagram of generalized model for Nucleotide Excision Repair (NER) 
Nucleotide excision repair is initiated by helical distortion. In first instance, DNA lesion is 
recognized by different proteins depending on the pathway: Global NER or Transcription 
coupled NER (RNA pol II collision). Helicase-proficient protein complexes unwind the DNA, 
allowing RPA to bind to the single stranded DNA. The damaged strand will be incised on both 5’ 
and 3’ in order to be removed. The gap will be filled by a DNA polymerase, and finally ligated. 
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c. MisMatch Repair (MMR) 
Mismatch repair is very conserved from Prokaryotes to Eukaryotes, 
probably in part because MMR is actively involved in the fidelity of the DNA 
replication, thus limiting genome instability (Marti et al, 2002) (Jun et al, 2006). 
Many reasons can result in wrong nucleotide incorporation, but the most 
common is an unbalanced pool of dNTPs. 
This repair mechanism has again a similar pathway as the above described 
system: recognition and removal of the damage followed by filling of the gap 
(Figure I.11).  
 
The lesion recognition is done by:  
- MutS: MutSα (Msh2Hs/Msh6Hs Msh2Sp/Msh6Sp) or MutSβ (Msh2Hs/Msh3Hs 
Msh2Sp/Swi4Sp)  
- Together with MutL: MutLα (Mlh1Hs/Pms3Hs Mlh1Sp) or MutLγ (Mlh1 
Hs/Mlh3Hs) 
The next step for the assembly of the repair complex involves PCNA and 
RFC, although their roles are not entirely clear yet. An exonuclease, Exo1Hs Sp, 
digests the DNA strand resulting in ssDNA, which is protected by RPA. Pol δ 
fulfill the role of synthesizing new error-free DNA strand, ligated by DNA ligase 
I. 
MMR is another example of the direct impact of a malfunction DNA repair 
system on human health, as there are disorders associated with MMR 
deficiency: mutation in the Mut genes will lead to microsatellites instability 
resulting in cancers, for example HNPCC (Hereditary Non-Polyposis Colorectal 
Cancer) (Hamelin et al, 2008). 
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Figure I. 11 Diagram of a simplified model for MisMatch Repair (MMR) 
The MutS and MutL clamps will be recruited to the mismatch, as well as PCNA and RFC. The 
clamps will diffuse to the PCNA complex, followed by excision of the damaged strand. Next, 
RPA will protect the single stranded DNA while the DNA polymerase resynthesises the DNA 
strand which is ligated by DNA ligase I. 
2.2 Double Strand Breaks Repair:  Homologous Recombination (HR), Non-
Homologous End-Joining (NHEJ) and Single Strand Annealing (SSA) 
When both strands of the DNA are broken, it is defined as a Double 
Strand Break (DSB) and can lead to cell death or worst: serious chromosomal 
aberrations. DSBs can occur in a programmed manner during meiosis (sexual 
replication), at replication forks (by topoisomerases) or for immunoglobins V (D) 
J variety, but can also arise from radiations (UV, X-ray, Gamma), genotoxic 
chemicals, free radicals and others. 
 
There are mainly two mechanisms used by the cell to repair those damages: 
HR and NHEJ (Kass & Jasin, 2010; Langerak & Russell, 2011; Martín et al). 
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a.  Homologous Recombination (HR) 
HR is error-free as it uses the sister chromatid (available in G2, the 
prominent phase for S. pombe) or homologous chromosome as a template for 
DNA repair (Aylon & Kupiec, 2004). The steps of the early stages of DSB repair 
are (Figure I. 12): 
- Recruitment and binding on either side of the MRN (Rad32Sp /Mre11Hs, Sc 
-Rad50Sp, Hs, Sc - Nbs1Sp, Hs/Xrs2Sc) complex (Williams et al, 2010)  
- The MRN complex recruits and activates ATM (Rad3Sp/Tel1Sp) (Williams 
et al, 2010) 
- ATM phosphorylates H2AX, p53Hs, 53BP1Hs as part of the checkpoint 
activation and allows DSB flagging (Martín et al, 2012)  
- The MRN complex (Rad32Sp-Rad50Sp-Nbs1Sp) resects both DNA ends in 
5’ to 3’ with the help of other nucleases: the exonuclease Ctp1Sp and 
Exo1Sp (SaeSc) (Baroni et al, 2004; Clerici et al, 2006; Williams et al, 
2010) 
- RPA protects the ssDNA by binding to the 3’ overhangs  
- Recruitment of Rad51Hs (Rhp51Sp) replace the RPA to form the Rad51 
filament, facilitated by Rad52Hs (Rad22Sp) (Caspari et al, 2002) 
- Recruitment of BRCA2Hs (Holloman, 2011), BRCA1Hs  (Ohta et al, 2011) 
by interaction to Rad51  
- Rad54Hs (Rhp54Sp) is recruited and has been shown to be important for 
pairing to the donor strand as well as the strand invasion (Krogh & 
Symington, 2004) 
 
After the initial recognition and 5’ to 3’ resection, the Rad51 
nucleoprotein will invade the template homologous DNA using its 3’ overhang, 
thus forming a Displacement loop (D-loop). DNA synthesis by DNA 
polymerases will then occur, allowing strand extension. 
 
Following the classical Szostak model (Szostak et al, 1983), the DNA 
strands will form a cross-shaped structure: the Holliday Junction (HJ). The 
Holliday Junction is a recombination intermediate with possibilities for two 
resolving methods, resulting in recombination with crossover or with non-
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crossing over. Two RecQ helicases BLMHs and WRNHs (Rqh1Sp / Sgs1Sc) are 
necessary for resolving the HJ, together with the endonuclease proteins 
Mus81Sp and Eme1Sp (Ho et al, 2010). Depending on the cutting sites, the 
resolving of the HJ will provide some genetic material exchange (cross-over) or 
keep the integrity of the genome (non crossing-over) (Wu & Hickson, 2006) 
(Longhese et al, 2006). 
 
There are variants models for mechanism of homologous recombination 
as well as implication of HR in diverse pathways:  
- Single-Displacement Strand annealing/ Synthesis-dependent Strand 
annealing (SDSA): this pathway involves strand displacement and 
branch migration without forming any HJ (Helleday et al, 2007)  
- Single strand annealing (SSA): it occurs between repeated sequences, 
but is an error-prone mechanism (Raji & Hartsuiker, 2006) 
-  Break Induced Replication (BIR): although the mechanisms remains 
unclear, it seems to involve HR components at telomeres for example 
(McEachern et al, 2000)  
- In addition, some components of HR are involved in the repair of 
Interstrand Cross Link (ICL) damage (Dronkert et al, 2000) (Hinz, 2010)  
- Finally, HR also occurs during meiosis to provide meiotic chromosome 
crossover, and although the pathways are different, most mechanistic 
details remain (Youds & Boulton, 2011) (Phadnis et al, 2011)  
 
Defects in the HR pathway can cause major genome instability (Gene 
conversion, Loss of Heterozygoty…) and disorders (for example Bloom and 
Werner syndrome, as well as breast cancer).  
On a side note, HR has proven to be a great system for genetics and is 
used routinely for gene targeting in basic research but is also a hope for gene 
therapy. 
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Figure I. 12 Simplified model of Homologous Recombination (HR) 
Homologous recombination allows damaged DNA sequence to be repaired using an identical or 
nearly identical template (sister chromatid in G2 or homologous chromosome). The damage is 
first identified and signaled, ensuring the recruitment of the DSB repair machinery. Following 
resection of the DNA, a nucleoprotein filament will be formed and used to invade the 
homologous sequence in a D-loop formation. DNA synthesis and ligation will create a Holliday 
junction, which can be resolved in two manners, non-crossover or cross over. 
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b. Non-Homologous End-Joining (NHEJ) 
  The second main DSB repair pathway used in yeast is NHEJ, although in 
humans it is the most common pathway (Daley et al, 2005) (Lieber, 2010) 
(Langerak & Russell, 2011). NHEJ is error-prone due to the direct ligation of 
DNA strands. NHEJ can lead to chromosome translocation, rearrangements 
and telomere fusion if not controlled properly. It can be advantageous, for 
example in the case for the V (D) J system where new variants of antibodies 
can be made to help the immune system.  The NHEJ mechanism is mainly 
prominent in humans, although some orthologues have been found in yeast. 
- The heterodimer Ku70Hs and Ku80Hs (Ku70Sp and Ku80Sp Yku70Sc and 
Yku80Sc) are recruited to the DSB, and in Humans, DNA PKcs seem to 
be important for the tethering of the ends (Clerici et al, 2008; Hammel et 
al, 2010)   
- The MRN complex is loaded and may act at the resection of the DNA 
ends, while DNA Pol λHs and Pol µHs will process the ends (Lieber et al, 
2003) 
-  Finally, the DNA ligase IVHs /XRCC4Hs complex will rejoin the ends 
(Wilson et al, 1997)  
 
In S. pombe, Ctp1Sp has been described in the resections of the DNA ends 
along with Exo1Sp, while Pol4Sp is the polymerase involved (Langerak & 
Russell, 2011).  
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Figure I. 13 Simplified model of Non-Homologous End Joining (NHEJ) 
Ku70/Ku80 will be recruited to the DSB allowing DNA PKCs recruitment and activation, followed 
by MRN complex loading. After resection, the DNA ends will be processed and then joined by 
XRCC4/ligase. 
 
Defects in the NHEJ in humans can lead to various disorders ranging 
from radiosensivity to microcephaly-linked diseases. 
c. RNR involvement in DNA damage and Meiosis 
 So far I have introduced the cell cycle and the implication of RNR in the 
cell cycle as well as the different DNA repair mechanisms in the cell, which 
involve DNA synthesis thus RNR. This sub-chapter will emphasize on the links 
between DNA repair and RNR in order to allow the appreciation of RNR’s 
importance in genome stability. 
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Figure I. 14 Basic current model for involvement of RNR in genome stability 
Schematic of the implication of RNR in genome stability after DNA damage or DNA replication 
stalling. After activation of the checkpoint, there will be the degradation of the RNR regulator 
(Spd1Sp), while the RNR subunits will be actively transcribed. This will lead to an active RNR 
enzyme providing dNTPs to the cell in order to allow DNA synthesis during repair. 
 
Upon DNA damage, the RNR is actively transcribed and the RNR 
inhibitor Spd1 is degraded, leading to an increase in the pool of dNTPs. RNR 
has been demonstrated to be necessary for efficient HR (Moss et al, 2010) 
involving Rad3-dependent RNR activation as well as degradation of Spd1 by 
Ddb1Sp (Holmberg et al, 2005) (Liu et al, 2005).  Although providing more 
dNTPs to the cell will help to improve the pace and efficiency of the DNA repair, 
this could also lead to an increase in the mutation rate.  
A recent study (Niida et al, 2010b) also allowed to link RNR activity and 
DNA repair, as the recruitment of RNR to the sites of damage in form of foci 
(colocalization with H2AX) was observed. In addition, they described R1 and R2 
bound to the chromatin in a Tip60Hs dependent manner, albeit in a small 
fraction. 
This allows us to modify our view with regard to the localization of RNR, active 
RNR complexes and functions of RNR.  
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In humans there is an alternative small subunit R2: p53R2, which is 
induced after damage (Tanaka et al, 2000) (Guittet et al, 2001).This is also 
observed in S. cerevisae with RNR4 (Zhou & Elledge, 1992) (Huang & Elledge, 
1997). I will later describe those subunits and their comparisons more 
thoroughly, as well as the RNR regulators. 
 
Finally, meiosis is a specialized process to produce spores in yeast (i.e. 
“sexual reproduction”). During meiosis, DSB will be formed in a Rec12Sp 
dependent manner (Spo11Sc) followed by DSB repair essential for chromosome 
cross-over with the aim of genetic material exchange (Youds & Boulton, 2011). 
Therefore, DSB repair is very important during meiosis, and indirectly so is RNR 
(Holmberg et al, 2005). 
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II.  Ribonucleotide reductase 
Ingenious in vivo experiments in the fifties (Reichard & Estborn, 1951) 
showed that ribonucleotides are the precursors of deoxyribonucleotides, and 
interestingly already observed a difference between different ribonucleotides 
precursors and their turnovers. 
Very early on, it was understood how deoxyribonucleotides are formed 
by direct reduction i.e. oxygen removed from the compound (Reichard et al, 
1961) (Brown et al, 1968). This is one of the first catalytic steps to provide the 
cells with those “building blocks” in order to supply the cell with a sufficient and 
balanced source of dNTPs. Another important observation made was that the 
Ribonucleotide Reductase subunits B1 and B2 (E. coli) were inactive on their 
own, but active when in complex and with iron as co-factor. Although a few 
important aspects of the function, regulation and structure were understood 
early on (Thelander & Reichard, 1979) (Reichard, 1987), until today we have 
not grasped the entire picture of the enzyme Ribonucleotide Reductase (RNR). 
 Since then, Ribonucleotide Reductase (or Ribonucleotide Diphosphate 
Reductase) has been described in many organisms, ranging from viruses, 
bacteria, sea urchin, yeasts, worms, mouse, mammalian etc… (Hofer et al, 
2012). 
 
In the next paragraph, I will review the RNR and the different classes, 
followed by some detailed description of both RNR subunits. Their regulation by 
many features as well as the structure will be finally depicted.  
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1.  RNR classification and common characteristics 
1.1 Variety of RNR enzymes  
The RNRs have been classified in 3 classes, based on the nature of the 
thiyl radical, their essential metal cofactor and their interaction with oxygen as 
recently reviewed in (Cotruvo & Stubbe, 2011) (Hofer et al, 2012):  
- Class I are aerobic heterocomplexes requiring oxygen in the iron 
centre. The subclass Ia has a diferric centre and a tyrosyl radical 
(FeIII-O-FeIII/Y•) while Ib uses manganese (MnIII-O-MnIII) instead of 
iron to provide and stabilize the tyrosyl radial Y•; and Ic lacks the 
tyrosyl radical whilst having an MnIV-O-FeIII centre. 
- Class II are oxygen independent homocomplexes (only one subunit of 
the complex) using adenosylcobalamin (AdoCbl) to generate the 
radical  
- Class III are also homocomplexes using glycyl radical as cofactor 
 
The RNRs from class I are found mostly in Eukaryotes but also in some 
bacteria, archea and viruses (Nordlund & Reichard, 2006), whereas class II and 
class III are found predominantly in bacteria, archea, viruses and a few 
Eukaryotes. Some species have multiple RNR enzymes from different classes, 
providing evolutionary advantage. The classes differ also in their structural 
composition, as class I has 2 subunits α and β, both essential for enzyme 
activity; whereas class II and II only have one subunit α. In addition, the RNR 
classes are different with regards to the substrates they use for producing de 
novo dNTPs: Class I using NDPs while class II and III use NTPs (Cotruvo & 
Stubbe, 2011). 
Although the different RNR enzymes classes (and sub-classes) vary on 
oxygen dependency, free radical chemistry, subunit composition, substrates 
usage, as well as allosteric regulation; they do have a very striking common 
feature: the tertiary structure of the α subunit with a 10-stranded α/β barrel 
(Hofer et al, 2011). 
 In vivo structure-mediated regulation of Ribonucleotide Reductase in S. pombe – PhD thesis by Ann-Sofie Schreurs 
 
48 
I will now use mainly the RNR from class Ia as example, as it regroups 
bacteria, yeast and humans, allowing me to unravel in more detail the RNR 
whilst comparing through those few species. 
1.2 Ribonucleotide Reduction mechanism 
The RNR enzyme with its metallocofactor will catalyze the reduction of the 
–OH in position 2’ of the ribose into –H through direct substitution, thus 
converting ribonucleosides diphosphate (NDP) into their deoxy forms (dNDP) 
(Figure I.15) (Reichard et al, 1961) (Stubbe, 1998) (Nordlund & Reichard, 
2006). 
 
Figure I. 15 Representation of dNTPs in the DNA and the reduction done by RNR 
DNA is composed of deoxyNucleotides TriPhosphates (dNTP), and in order to build the double 
helix necessary for the genome, a large and balanced supply of dNTPs are needed. 
RibNucleotide Reductase (RNR) catalyses the rate limiting step in the production of dNTPs. It 
will reduce Nucleotides DiPhosphates (NDP) into their deoxy form: deoxyNucleotides 
DiPhosphates. 
 
The reduction reaction by RNR is a multicomponent oxidation-reduction 
reaction cascade (Figure I.16). Two different pathways are known for the E. coli 
RNR: the first one uses thioredoxin, and the second one glutathione and 
glutaredoxin are used. In both cases, NAPDH is the ultimate reductant (Eklund, 
1994). 
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Figure I. 16 Reduction cascades of the E. coli RNR via Thioredoxin and glutaredoxin  
Involvement of oxidation-reduction active disulfides in NDP reduction in E. Coli as part of a 
hydrogen transport system. NADPH+/NADP+ will use either a thioredoxin reductase/thioredoxin 
mode or a glutathione reductase + glutathione and glutaredoxin mode to allow NDP reduction 
by RNR. 
1.3 General structure of RNR 
Taking the E. coli RNR as example (but most RNR class Ia have 
similarities), RNRs were first described as heterotetramer. R1 is the big sub-
unit, and is functional at least as a homodimer, as is the smaller sub-unit R2. 
The enzyme is in a α2β2 conformation with R1: α and R2: β (Thelander & 
Reichard, 1979) (Nordlund & Reichard, 2006) (Hofer et al, 2011) (Figure I.17). 
R2 can be considered as the radical generator, while R1 as a reductant will 
need the radical. The stoichiometry of each subunit is modified depending on 
the state of the enzyme, and although the crystal structures of RNR subunits 
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have been resolved, some doubts remain about the quaternary structure 
configuration, especially in vivo. It has been modeled that the R1 dimer will fit 
on top of the R2 dimer (fig. I.17) (Eklund, 1994) (Hofer et al, 2011) (Cotruvo & 
Stubbe, 2011). 
RNR is an allosteric enzyme, using the allosteric feedback by binding 
dNTPs in order to regulate the further production of dNTPs. The activity site on 
the big subunit R1 will bind activating-ATP and inhibitory-dATP. The specificity 
site at the dimer interface will bind ATP, dATP, dTTP and dGTP allowing a 
correct and balanced production of dNTPs. This allosteric feedback is part of a 
complex dNTPs regulatory production, which will be explained in the following 
sub-chapter. At the interface of the R1 dimer and R2 dimer, between the iron-
generated tyrosyl radical of R2 and the active cysteines of R1, is the active site 
where the reduction of the NDPs will occur.  
This model is mostly accepted for class Ia RNR although some 
differences between species are present as well as some unanswered 
questions, especially with regards to the stoichiometry and the mechanisms 
behind activation/inactivation of the RNR complex. 
 
 
Figure I. 17 Schematic structure of E. coli RNR α2β2 
Diagram representing the RNR α2β2 active form model in E. coli, R1 (α) corresponding to the big 
sub-unit and R2 (β) the small one. R1 has the 2 allosteric sites: activity site binding ATP and 
dATP, as well as the specificity site. R2 has the diferric centre and the tyrosyl radical, while the 
interface between the homodimers is the active site where the reduction reaction of NDPs will 
take place, using the free radical of R2 and the cysteines of R1. 
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2.  The big subunit R1: gene, protein, structure and function 
2.1 General 
Each R1 subunit by itself is inactive, and needs to be dimerized in at 
least a one-to-one stoichiometry to be active. The binding is weak (easily 
dissociated during purification) and requires magnesium (Mg2+). R1 has two 
allosteric binding sites (figure I.19) (Thelander & Reichard, 1979) (Stubbe, 
1998) (Cotruvo & Stubbe, 2011): 
- The overall activity site is also called “h-site” for high binding of dATP, 
also mentioned as the ATP-cone domain. The overall activity site 
binds Adenosine TriPhosphate (ATP) which will act as an activator, 
as well as deoxyAdenosine TriPhosphate (dATP) which by acting as 
an inhibitor will inform of the general levels of the dNTP pools thus 
inhibiting the RNR activity 
- The specificity site is also called “l-site” for low binding of dATP. The 
specificity site binds ATP, dATP, as well as dTTP and dGTP. This will 
allow a balance of the 4 different dNTPs in the cell through a 
multifaceted feedback regulation. With ATP bound, the RNR will 
reduce CDP and UDP, while with dTTP bound it will reduce GDP, 
whereas with dGDP bound, ADP will be reduced 
 
R1 also contains the catalytic site (Figure I.18) with the active dithiols (-
SH), which are essential for the reduction process: 
NDP + RNR-(SH2)  deoxyNDP + RNR-(S-S) + H20 
 
An intricate network of amino acids has been depicted as the active site 
using a radical-mediated reduction process: Cys439 is the initial thiyl radical 
carrier in the reaction (oxidized by the tyrosyl radical of R2), while two cysteins 
Cys225 and Cys462 are providing reducing equivalents, and are directly involved 
in the reaction (Cotruvo & Stubbe, 2011). Glu441 and Asn437 of R1 are also 
implicated in the catalytic mechanism, although to a lesser extent.  
This multistep substrate turnover cycle will ultimately result in the 2’ 
ribose oxygen leaving as a water molecule using the two hydrogen molecules 
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from the cysteine pair, whom will subsequently form a disulfide bridge (see 
Figure I.18) (Cotruvo & Stubbe, 2011). 
 
Figure I. 18 Schematic of the proposed mechanism of nucleotide reduction by RNR in E. coli 
Simplified diagram representing the reaction mechanism of class I RNR. The network of amino 
acids given in E. coli numbering. The NDP substrate localizes in the active/catalytic site of 
reduced R1, followed by a reaction of substrates radical intermediates as well as R1 protein 
radical intermediate, dNDP will be produced. 
 
R1 crystal’s structure in E. coli  (Figure I.19) has revealed a core domain 
of 10-stranded α/β-barrel conserved between species (Eklund et al, 2001). 
More precisely, R1 has an helical N-terminal domain of 220 residues; one ten-
stranded α/β-barrel domain of 480 residues; and a small stretch of 70 residues 
with α helices and β strands domain. The α/β barrel is composed of two halves, 
where each half contains five parallel strands and four regularly arranged 
connecting helices (see I.19). The two halves are connected in an antiparallel 
fashion between strands. R1 has an approximate size of 11 nm long and 7.5 nm 
wide. 
 
When in dimer, the two R1 have an “S” shaped structure. The important 
sites have been described in the crystal structure of R1 (Eriksson, 1997) 
(Eklund et al, 2001): 
- The essential radical-carrier cysteine is on the central β-hairpin 
finger, and the other cysteines are localized on nearby β-strands (in 
the C-terminus); together this forms the active site, localized between 
the N-terminus and the barrel domains. This active site has been 
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shown to be flexible and by conformational change of the subunit 
make the active site more or less accessible as it is buried 2 nm 
deep (in E. coli) 
- The specificity-binding site is found at the dimer interface, not far 
from the active site above-mentioned, linked by a loop (loop 2). The 
loop 2 (Figure I.19) is a major determinant for specificity regulation, 
as this loop will be induced into a distinct conformation depending on 
each effectors-substrate pair by direct bridging between the 
specificity site and the active site. 
- The activity site (overall activity site, ATP cone) is positioned at the 
N-terminus in the form of a small α-helical bundle. Different 
experiments showed that the effectors on the ATP cone would 
stabilize R1 into an oligomer, and also steady the R1/R2 complexes 
(Xu et al, 2006).  
 
 
Figure I. 19 Schematic structure of R1 in E. coli along with tertiary structure model (Eriksson, 
1997) 
Schematic of the structure of the R1 dimer and the associated sites. The global activity is ruled 
by inhibitory dATP or activating ATP binding at the ATP cone domain situated at the N-terminal. 
The balanced production of dNTPs is governed by dNTPs binding to the specificity site. The 
reduction reaction will occur in the depth of the catalytic site, localized close to the dimer 
interface and to the just mentioned specificity site. The loop 2 is located nearby the catalytic site 
and will allow flexibility to the catalytic site necessary for the reduction of NDPs.  
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The second image is a tertiary structure borrowed from Eriksson et al., as it allows us to 
observe the important sites of R1 in relation to the secondary structure (α α-helices and β 
strands) as well as the model for the tertiary structure. (N-terminal: magenta; ten-stranded α/β-
barrel domain: green; loop 2: yellow) 
 
R1 has evolved into a sophisticated protein that properly supplies dNTPs 
by monitoring the ATP/dATP ratio thus modulating the overall activity. In 
addition, by means of the complex allosteric regulation, R1 will manage the right 
balance of dNTPs through the specificity site. Finally the catalytic site has a 
main role in the reduction of the NDP riboses 2’ –OH. Also, an interesting 
observation is the flexibility of the C-terminus, and it has been proposed that the 
C-terminus of R1 can “swing out” of the surface to act as a reduction shuttle 
(Hofer et al, 2011).  
S. cerevisae has a different version of R1, called R3 and seems to be 
induced after DNA damage (Zhou & Elledge, 1992) , and even though the null 
mutant has no phenotype, over-expression of this different version of the big 
subunit can rescue RNR1 null mutants.  
2.2 R1 in S. pombe 
S. pombe RNR is a class Ia, the same as E. coli described previously i.e. a 
heterocomplex with a big and small subunit in a α2β2 complex.  
 The big subunit Cdc22R1 (β) was first discovered in a collection of temperature-
sensitive lethal mutants with a cell division cycle (cdc) phenotype of cell cycle 
arrest (Nurse P, 1976 ). Cdc22R1 is required early in the cell cycle, and its 
transcripts fluctuate afterwards. In fact, transcription induction after DNA 
damage and during the cell cycle was really striking that it sparked some 
interest and was studied. Cdc22 was finally assigned as the big subunit of the 
RNR (69% amino acid identity with the mouse R1) (Fantes, 1986 ). 
Cdc22R1 achieves its expression peak during Mitosis - G1/ S-phase and 
is at its lowest during G2 phase. Indeed, Cdc22R1 is needed for active RNR 
complexes during S-phase as well as after DNA damage (when it is also 
induced) and after HU treatment. 
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Figure I. 20 Cdc22R1 expression during the cell cycle in S. pombe (Bahler’s laboratory data) 
This represents the fluctuating levels of Cdc22R1 expression during the cell cycle after elutriation 
of the cells or after block-release with Cdc25 mutant. It clearly has a peak of protein expression 
during M/G1/S phase and is at lowest during G2 phase. This data is just indicative and has 
been borrowed from the Bahler’s extensive online data. Same results were observed in the 
”CycleBase” data. 
 
Cdc22R1 gene (SPAC1F7.05) is found on chromosome 1 (position 
4226982-4229733) and is one of the targets DSC1-MCB system which acts on 
specific sequences upstream the coding sequence, in the gene’s promoter 
(Fernandez Sarabia MJ, 1993 ). 
Cdc22R1 has the relative unusual characteristic (in S. pombe) of having an 
intron in its 2752 bp sequence. The 811 amino acids protein (Figure I.21) 
shares the cystein network with E. coli described earlier. Thus the active site is 
present, and seems to be described as the amino acids at position 427 (proton 
acceptor), 218 and 444 (which will form the disulfide bond) as well as the 
cystein 429 (radical intermediate), 431 (proton acceptor) and others are still 
being investigated and assigned. While the previous amino acids described are 
situated at the C-terminus, the sites at positions 806 and 809 are suggested to 
interact with thioredoxin and glutaredoxin (Eriksson, 1997). 
The allosteric activity site has also been situated by similarity at the 
position 11-17 in the ATP cone domain (1-92); and the sites 202 and 247 are for 
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binding of the NDP substrate, while the specificity site is composed of the sites 
285-288. 
This 2.7 kb gene results in a 91.6 kDa protein with a isoelectric point of 
6.4, and slightly negatively charged (-0.5). Cdc22R1 proteins are localized 
throughout the cell and are regulated by various methods, which I will portray 
later in more detail.  
 
 
 
 
 
Figure I. 21 Cdc22R1 protein domains and organization  
This diagram represents schematically the cdc22R1+ gene product at the protein level, with the 
different domains associated as well as the sites for Cdc22R1 function. Data obtained from 
Uniprot with in silico similarity searches. The ATP cone domain is at the N-terminus (where the 
allosteric site is situated) followed by an all alpha α-helices  domain and a all beta barrels 
domain where the specificity site can be found, as well as the amino acids necessary to 
constitute the active site. 
3.  The small subunit R2: gene, protein, structure and function 
3.1 General 
The small subunit R2 is also only active as a dimer, and each monomer 
contains a binuclear ferric (FeIII) iron center. These metal cofactor are essential 
for activity as the apoprotein R2 (loss of iron center) is not functional.  
This is due to the fact that the iron center generates and maintains the tyrosyl 
radical (Y•), via a process of oxidation through surrounding amino acids (Asp84, 
Glu115, His118, Glu204, Glu238 His241) represented in figure I.22 (Eklund et 
al, 2001) (Hofer et al, 2011). 
R2 was one of the first proteins described to have a polypeptide serving 
as free radical (Reichard, 1987), and the tyrosine at position 122 of R2 was 
 In vivo structure-mediated regulation of Ribonucleotide Reductase in S. pombe – PhD thesis by Ann-Sofie Schreurs 
 
57 
described as the organic radical (in E. coli, (Larsson et al, 1988) ). The Tyr122 is 
buried some 10 Å (1nm) inside a hydrophobic pocket in the structure and 
therefore cannot interact directly with R1, thus the cysteines network explained 
before (I.18). This free radical is essential for the activity of RNR, but its stability 
varies from species to species (4 days in E. coli vs. 25 min in humans) leading 
to speculate the in vivo stabilization and/or regeneration mechanisms (Hofer et 
al, 2011). 
The loss of the free radical transforms the protein in a metR2, but still 
has the iron center intact (contrary to apoR2, where both the iron centre and 
free radical are lost). ApoR2 proteins can be obtained by iron-chelating agents, 
while metR2 occurs when radical scavengers are present such as hydroxyurea 
(HU) or ageing R2. HU is a small radical scavenger used in cancer treatments, 
but in our interest especially, it has been used since a long time (Elford, 1968) 
and extensively in vivo and in vitro to reduce the RNR’s tyrosyl radical.  
Structure analysis has shown that the iron center of each R2 monomer are 2.5 
nm apart but in an metR2 it seems to have shifted further apart although it is not 
entirely clear how the metR2 is modified (Ormo et al, 1995) (Eklund et al, 2001).  
It seems that metR2 and apoR2 have a slightly different conformation as well as 
some denaturation leading to an array of results: unusual cluster of carboxyl-
side chains instead of the iron center (Aberg et al, 1993) , differential allosteric 
binding, and upon iron intake R2 will have a conformational change which has 
been significantly studied by radical chemist (Logan DT, 1996) (Han & 
Noodleman, 2011) . 
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Figure I. 22 ApoR2 iron center and active R2 iron center organization (Logan DT, 1996)  
This picture (Logan et al. 1996) shows a diagram of the iron center organization of R2 in apoR2 
protein (without iron and without radical) to an active R2 Iron center. There are side chain shifts 
and deprotonation as part of the conformational changes in the formation of the active iron 
centre. Hydrogen bonds are in dashed lines and the interatomic distances are given in 
angstroms. NB: later studies have proven those specific distances to be different.  
 
The E. coli R2 structure revealed a stable dimer of 2x43 kDa with the 
dimensions of 8x6x5 nm, composed mainly by α-helices, although with two β-
sheet strands at the tip of the dimer (Figure I.23). The proteins are folded in 3 
layers of α-helices, but with extensive dimer interaction. As mentioned just 
earlier, the iron centre and the free radical are located in the interior of the 
protein. The N-terminal of R2 is a random coil structure, with a lot of flexibility 
but does not seem important for enzyme activity (Eklund et al, 2001). Whereas 
the C-terminus tail of R2 is highly mobile and corresponds to the interaction 
domain with the C-terminus of R1. 
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Figure I. 23  R2 protein structure and RNR model for α2β2  
These structures have been borrowed from (Ando et al, 2011). The first is the homodimer of R2 
in order to represent the structure of the small subunit, mainly compose oh α-helices , and with 
a disorder C-terminal necessary for binding with R1. The free radical on Tyr122 is embedded 
inside the protein. The second picture represents the model for the docking between the 2 
homodimers of R1 and R2, to form the complex α2β2. 
 
An important point to note is the distance between the tyrosyl radical (Y•) 
site of R2 and the thiyl radical site of R1 (~35 Å or 3.5 nm) as modeled by 
Eklund and Uhlin (Eklund, 1994) (Eklund et al, 2001). The detailed mechanism 
is not entirely clear, but the large distance between the proton coupled electron-
transfer (PCET) sites implies some relatively large conformational 
rearrangements (Ando et al, 2011; Cotruvo & Stubbe, 2011). It seems that the 
PCET control is important to regulate the enzyme’s activity as the PCET can be 
disrupted if the distances are too large (Reece et al, 2006) (Stubbe & Cotruvo 
Jr, 2011) (Ando et al, 2011). It has been proposed that the conversion between 
active RNR and inactive RNR through modification of the structure is the 
mechanism by which activity is controlled. 
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Figure I. 24 Radical transfer (Nordlund & Eklund, 1993) 
This picture from Nordlund and Ekhlund 1993, shows the distance of the PCET and the relative 
position of the amino acids implicated as well as the position of the substrate and the loop 2. 
This is interesting as such a distance is quite remarkable and even with the network of amino 
acids for the transfer, the RNR complex must require flexibility to induce an optimal 
conformation.  
 
Mammalian cells have another version of R2: p53R2 (Tanaka et al, 
2000) (Smith et al, 2009) that has been showed to be involved in DNA repair, 
during which it seems to be induced and increase the concentration of active 
RNR complexes. More recently it has been proposed to have a role in 
mitochondrial dNTPs production (Wang et al, 2011). S. cerevisae also has a 
second version of R2 (RNR4 or β’) that is required, and is slightly different than 
RNR2 (β). Together they form a heterodimer, and even though RNR4 is not 
able to form the radical, RNR4 is important to correctly fold RNR2 in order to 
generate its radical and correctly function in the α2ββ’ complex (Elledge et al, 
1992) (Huang & Elledge, 1997) (Zhang et al, 2011). 
3.2 R2 in S. pombe    
The smaller subunit Suc22R2 was discovered as a suppressor of the 
Cdc22R1 thermo-sensitivity lethality (Fernandez Sarabia MJ, 1993 ). Suc22R2 
(SPBC25D12.04) encodes for the small subunit of the RNR, and the 1176 bp 
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gene is localized on the chromosome 2 (position: 3721755-3722930). The 
protein is 391 amino acid long, and the 45.5 kDa protein has an isoelectric point 
of 14.6 and a charge of -20. The suc22R2+ gene product has 62% amino acid 
identity with the mouse R2, and the similarity is particularly strong with the other 
species over the C-terminus (Kolberg et al, 2004).  
The essential tyrosine for the free radical is in position 173, and the 
important amino acids involved in the iron centre are: D135, E166, H169, E229, 
E263, H266. The residues E360 and Y366 which are thought to be required for 
the interaction with the large subunit R1, are conserved (Nordlund & Eklund, 
1993) (Eklund et al, 2001). (Figure I.25). 
Suc22R2 has consistent protein expression levels throughout the cell cycle 
and is localized mainly in the nucleus, but during S phase is relocalized to the 
cytoplasm. 
 
 
 
 
 
Figure I. 25 Suc22R2 protein expression during cell cycle and protein sequence  
These diagrams represent schematically the suc22R2+ gene expression during the cell cycle 
(Bahler’s data and confirmed by “CycleBase”). It has a regular level during the cell cycle.  Next 
image is a schematic representation of the protein sequence with associated domains and 
important amino acids (obtained from uniprot). 
 
Interestingly, the suc22R2+ gene has been described as having 2 
transcripts, one of 1.5 kb, which is present throughout the normal cell cycle, and 
is the single transcript detected. But after HU treatment, DNA damage, or heat 
shock a second transcript of 1.9 kb appears (it is only present at low levels 
during S-phase). The larger transcript has a different initiation site (550 bp 
upstream) but both seem to have MCB elements upstream the initiations sites, 
and appear to code for the same protein (Fernandez Sarabia MJ, 1993 ) (Harris 
P, 1996 ). 
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4.  Regulation of RNR  
4.1 General 
a. Cell-cycle specific gene regulation and protein localization 
To overcome the enormous demand of dNTPs during the full genome 
replication (S-phase) RNR activity increases partly due to the induction of the 
RNR genes. The same process happens after DNA damage where dNTPs are 
needed for DNA repair. 
It differs slightly from species to species, with E. coli’s aerobic and 
anaerobic RNRs regulated differently but following the same general pattern 
earlier described.  
In S. cerevisae all RNR genes are transcriptionally regulated during S-
phase and after DNA stress (Zhou & Elledge, 1992) (Huang & Elledge, 1997). 
Also, RNR2 and RNR4 proteins are localized in the nucleus, but relocated to 
the cytoplasm to presumably form the active complex. 
As for mammalian cells, the enzyme’s activity increases greatly during S-
phase too, but R1 and R2 have different regulation. Both R1 and R2 are in 
promoter-active regions, but in addition of transcription regulation; R2 seems to 
be degraded through a KEN box, for example during mitosis or after DNA 
damage (Chabes et al, 2003b). Also after DNA damage there is over-
expression of p53R2 and R1, which will then form a different RNR complex that 
will provide the cell with dNTPs for DNA repair. All RNR proteins are found 
throughout the cytosol in the case of mammalian cells (Zhou et al, 2003). 
b. dNTPs production by allosteric regulation 
Providing adequate quantities of dNTPs to the cell is not the only role of 
RNR; there is an important need for a right balance between the four DNA 
building blocks (Chabes & Thelander, 2003). This is achieved by allosteric 
regulation of the RNR enzyme’s activity. The active site will control the overall 
activity of the enzyme, while the specificity site will be part of a complex network 
in order to provide the right dNTPs. The active site can bind ATP (leading to the 
“switching on” of RNR) or dATP (turning off the overall activity). ATP has the 
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same affinity for both the activity site and the specificity site, whereas dATP has 
a much lower affinity for the activity site than the specificity site. Therefore, only 
at very high levels of dATP will this allosteric inhibitor bind to the activity site. An 
RNR mutant D57N is often used, as the mutation disables the activity site 
capacity to discern ATP or dATP (Chabes & Stillman, 2007). 
The specificity site can bind ATP, dATP, dTTP and dGTP, but does not 
bind dCTP efficiently. There is a quite precise physiological level of each dNTPs 
in the cell, which seems optimized to limit the mutation rate. 
ATP and dATP will stimulate the reduction of CDP and UDP, while dTTP 
will activate GDP reduction and dGTP will in turn encourage ATP reduction 
(Hofer et al, 2012). 
 
Figure I. 26 Simplified overview of the allosteric regulation of dNTPs production  
Diagram of the allosteric effectors on RNR: through the specificity site, ATP and low dATP will 
activate dCDP and dUDP synthesis, while dTTP will activate dGDP reduction, and dGTP in turn 
will increase dADP production. But through the activity allosteric site, high concentration on 
dATP will inhibit the while RNR machinery, but ATP will activate RNR. 
c. Inhibitors 
Small proteins were found as RNR inhibitors, first in S. cerevesiae, and 
also in S. pombe. So far, in mammalian, nothing comparable as been described 
yet. 
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In S. cerevisae R1 is inhibited by interaction with Sml1, a small protein that is 
degraded once cells enter S phase or in response to DNA damage, due to the 
Mec1/Rad53 DNA damage checkpoint pathway (Zhang et al, 2007) (Andreson 
et al, 2010). A further method of negative regulation is obtained with Dif1, which 
in cooperation with the nuclear anchor Wtm1, promotes R2 nuclear import (Lee 
& Elledge, 2006) (Lee et al, 2008). This redistribution from the nucleus to the 
cytoplasm appears to be yet another layer of regulation, as it was proposed that 
the active form of the RNR complexes would be formed when both RNR 
subunits are in the cytoplasm, which corresponds to S-phase or after DNA 
damage. A last regulator, Hug1 has been proposed to regulate the RNR by 
preventing a correct feedback, but its role is still indistinct (Lee et al, 2008) 
(Benton et al, 2006) . 
4.2 Regulation of RNR in S. pombe 
The cell cycle based regulation has been described previously: Cdc22R1 
expression induced during S phase and after DNA damage, whereas Suc22R2 
has a second transcript also induced after DNA damage.  
a. RNR Regulators: Spd1 and Spd2 
During a screen for new S. pombe genes for cell cycle arrest (Woollard A, 
1996), Spd1 (S-Phase delayed inhibitor) was found. When over-expressed 
(Borgne & Nurse, 2000), this small protein causes S Phase Delay (SPD). In 
normal circumstances, Spd1 is cell cycle regulated and degraded after DNA 
damage. 
Spd1 (SPAC29B12.03) is a 375 bp long gene situated on chromosome 1 
(position: 5412489-5412863) and encodes for a 14.2 kDa protein (124 amino 
acids) with 7.6 as isolectric point and a charge of 1.  
Its expression is anti-correlated with the RNR’s activity, as Spd1’s expression is 
high in G2 and G1 but mostly degraded in S-phase. Spd1 is also degraded after 
DNA damage and DNA replication stress. This degradation is controlled by the 
Cop9-Pcu4-Ddb1 complex (i.e. Signalosome CSN) (Liu et al, 2003) (Liu et al, 
2005) (Nestoras et al, 2010).  
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The signalosome is a complex of 6 subunits in S. pombe (Csn 1-5 and Csn 
7) but 8 subunits are described in other species; moreover it is conserved as it 
has a variety of essential roles in the cell (Nielsen, 2003). One of these roles is 
with the cullin-dependent ubiquitin ligase (Pcu4), therefore the 
COP9/signalosome is involved in ubiquitin mediated protein degradation (Wei & 
Deng, 2003). In S. pombe, Ddb1 associates with Cop9-Pcu4 to promote Spd1 
degradation and indirectly regulate RNR activity (Bondar et al, 2004). Two 
components of the CSN complex, Csn1 and Csn2 are essential for a correct 
regulation of RNR as during S-phase the ubiquitylation of Spd1 leading to its 
degradation happens in a Csn1- and Csn2-dependent manner. Whereas in G2, 
after DNA damage, Spd1 degradation requires both signalosome subunits Csn1 
and Csn2, but also the Rad3- and Chk1-dependent DNA damage checkpoint. 
Therefore the Cop9-Pcu4-Ddb1 is involved in genome stability via regulation of 
RNR activity through Spd1 control. The mutant strain Rad3ts Csn1-deletion is 
lethal, but can be reverted by over expression of Suc22R2 or Spd1 deletion (Liu 
et al, 2003) (Liu et al, 2005). Therefore, the reversion in the mutant strain 
Rad3ts Csn1-deletion is a good tool to measure Spd1 activity. Also, Ddb1 is 
needed for cells to progress through meiosis, as Spd1 degradation is essential 
at that time (Holmberg et al, 2005). 
 
The small protein Spd1 is found throughout the cells: both in the cytoplasm 
and nucleus. Spd1 is involved in the localization of Suc22R2: it was first 
described as a potential anchor (similarly to Wtm1 of S. cerevisae) but was later 
demonstrated to acts as a nuclear importer (Nestoras et al, 2010). Experiments 
with a nuclear export-blocking agent (leptomycin B) did not result in a Suc22R2 
nuclear accumulation, and in addition, when a nucleolus C-terminal signal was 
added to Spd1, it did not accumulate Suc22R2 to the nucleolus. When Spd1 is 
degraded or the spd1+ gene deleted, Suc22R2 accumulates in the cytoplasm 
due to lack of nuclear import giving Suc22R2 a clear pan-cellular phenotype. 
Similar observations are seen after treating the cells with HU (Nestoras et al, 
2010) (Liu et al, 2005). 
On the other hand, it has also been described to bind to Cdc22R1 and 
through that binding acts as an inhibitor. But as the data in this thesis and the 
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publication Nestoras et al. shows, we should rather consider Spd1 as an RNR 
regulator instead of an inhibitor.  
 
Figure I. 27 Schematic of the current model of RNR regulation during the cell cycle through 
Spd1  
This diagram represents the cell with the nucleus (central) and the localization of each protein 
during the cell cycle. During M and G1 phase, Spd1 is present and regulates negatively the 
RNR by binding to Cdc22R1 and importing Suc22R2 to the nucleus. During S phase, the 
signalosome degrades Spd1 and the RNR can be complexed into an active form to provide 
dNTPs. In G2 Phase, if there is DNA damage, the signalsome will act again after Rad3-Chk1 
checkpoint activation to degrade Spd1 and allow formation of active RNR for efficient DNA 
repair. 
 
Spd1 is an Intrinsically Disordered Protein (IDP) (Nestoras et al, 2010), 
which means that Spd1 has no fixed tertiary structure and can be modulated 
into different conformations. This peculiar feature correlates well with the role of 
Spd1 as an RNR regulator, because even though it is missing a well-structured 
three-dimensional fold, it has the capability to adopt transient structure and fold 
into their protein partners with low affinity but high specificity (Sugase et al, 
2007). 
Very recently, Spd2 was found by sequence homology and is now being 
described in more details with regards to its functions. Spd2 (SPAC3F10.19) is 
also found on chromosome 1 (position 2830517-2831209) and after splicing 
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(the Spd2 gene contains 2 introns) it is a small transcript of 309 bp. Spd2 is an 
even smaller protein than Spd1 with 102 amino acids, resulting into a 11.6 kDa 
protein (isolectric point: pH 4.9, charge: -4). 
b. Comparison between the regulators S. pombe and S. cerevisae 
Spd1 and Spd2 have some proposed domains, found in the sequence-
conserved S. cerevisae orthologues: Sml1, Dif1, Hug1. The HUG domain (a.a 
30 to 62) as in Hug1 and Dif1; and an R1 domain (a.a 83 to 97) which is a part 
of S. Cerevisae Sml1’s protein R1 binding domain.  
Work in S. cerevisae has shown that Dif1 and Wtm1 act as nuclear import 
and nuclear anchor respectively; and that Dif1 binds R2 by the HUG domain 
(Lee & Elledge, 2006) so the HUG domain can be considered as the R2 binding 
domain. 
Spd1 also binds to Cdc22R1 (Hankansson et al, 2006a) (Nestoras et al, 
2010) and seems to inhibit it, by which means is yet unclear, but in S. cerevisae 
Sml1 inhibits R1 by binding to the C-terminal part of the large RNR subunit 
(Zhang et al, 2007) and would therefore interfere not only with the R1 
dimerization, RNR structure formation but also the R1 reduction capacities 
(Cotruvo & Stubbe, 2011). 
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Figure I. 28 Comparison of the RNR regulators in S. cerevisae and S. pombe  
The alignment of the amino acid sequence of Spd1, Spd2, Hug1, Dif1 and Sml1 represented in 
the first image shows close sequence identity. The second picture is a diagram of the regulators 
with the different domains described. Again, there is a strong sharing of domains. 
4.3 RNR complex oligomerization and structural modification 
Many in vivo studies have informed us about the importance of RNR for 
genome stability, and in vitro studies have helped us understand how the RNR 
complex is structured and functions. But as RNR is very tightly regulated in vivo, 
it is hard to have a direct view of the RNR regulation in vivo in the cell. In vitro 
studies are very helpful, but do not reflect the exact reality, as in the cell there 
are some precise physiological levels of the proteins, inhibitors and especially 
allosteric effectors. In addition, the activity site and the specificity site are often 
occupied and there might be other unknown partners.  
R1 (α) has been described early on to be oligomerized (Brown et al, 
1968) and to sediment into a tetramer. The dynamics of the R1(α)/R2(β) 
aggregation status seems to be controlled in part by the ATP/dATP effectors. 
The ability to differentiate between the activator ATP and the inhibitor dATP at 
the ATP cone domain is one of the keys for better understanding of the RNR 
regulation. The discrimination between ATP and dATP seems to be due to the 
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structure of the effectors, as dATP can bind deeper. Thus specific 
conformational changes of the ATP cone domain recognizing one or the other 
effector will allow distinction between activation and inhibition. Interestingly, 
these conformational changes also involve the loops described in the 
dimerizaton of R1 (Cotruvo & Stubbe, 2011) (Hofer et al, 2012). 
The specificity site also influences the overall structural regulation, as it has 
been shown that the specificity site and the activity site have a long-range 
communication (Ando et al, 2011). 
The model is that the allosteric effectors would first promote R1(α) 
dimerization, which would in turn facilitate binding to the R2 dimer, forming the 
heterocomplex α2β2. The α2β2 was for long considered to be the active form, but 
the last few years publications have demonstrated that the stoichiometry of the 
RNR subunits can vary a lot: for eukaryotes α2β2-6 (Kashlan et al, 2001) 
(Rofougaran et al, 2006) (Xu et al, 2006) and in E. coli α2-4β2-4 (Rofougaran et 
al, 2008a). 
Even more recently the picture became a lot clearer with structural 
studies of dATP-induced inactive RNR forms. In human and S. cerevisae, the 
dATP induced RNR is indeed a α2β6 form with 3 dimers of R1(α) in a ring and 
the R2(β) dimer inside the α6 ring (Fairman, 2011). This protein architecture is 
proposed to abolish the electron transport (PCET) thus inhibiting the activity of 
RNR (Ando et al, 2011; Xu et al, 2006). Other data also demonstrated that the 
ATP induced active form in eukaryotes could be in a α6β2-6 form with a different 
α6 variant. The active and inactive forms could be structurally very different, as 
a mutation (D16R) at the interface between the dimer area would not allow 
dATP α6 formation anymore (Hofer et al, 2011), whereas with ATP the 
hexamers α6 could still be formed (Hofer et al, 2011). Some data suggest the 
big subunit α would also be in an hexameric ring while the stoichiometry of the 
small subunit is not clear yet, although some studies (Wang et al, 2009) with 
gemcitabine (substrate analogue) demonstrated that up to 3 β dimers can bind 
to the ATP induced α6, forming a α6β6 complex. 
In E. coli, the α2β2 form was the accepted model for the active RNR 
complex, but recently (Ando et al, 2011) the inactive form of RNR has been 
structurally solved and is also a ring structure although a quite different ring. 
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The α2β2 complex opens and a second α2β2 complex binds creating a ring of 
sequential α2β2 α2β2. 
It has been proposed and modeled that this quaternary structure modification 
would disrupt the radical pathway thus inactivating the RNR protein. The 
conversion between one form to the other could be quite dynamic and although 
the regulation between one form to the other is barely understood, it proves to 
be an ingenious system to control the dNTPs levels in the cell (Ando et al, 2011; 
Fairman, 2011; Hofer et al, 2011). 
This clearly deserves further investigation in order to understand the tight 
regulation of the RNR using higher order complexes and structural modification. 
 
Figure I. 29 Activity regulation in Class I RNR (Hofer et al, 2011) 
Diagram showing the quaternary structure related regulation of the RNR complexes. The dimer 
α2 will bind to the dimer β2 and form α2β2. In Eukaryotes, the dATP induced RNR α6β2 will be 
inactive and in a ring shaped of hexameric α with the β2 dimer in the centre. The ATP induced 
active RNR has been described to be composed of also a hexameric α, although structurally 
different, and the smaller subunit β could be in a dimer, tetramer or hexamer. In E. coli, the 
inactive RNR form is also a ring, although different as it is composed of 2 times α2β2 with 
sequential α2β2 α2β2. The active form is so far still described as a α2β2. 
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4.4 Aims of this project 
 
Albeit a good amount of qualitative work has been done on the RNR 
throughout different species, some questions remains. 
  On the structural side, more details are needed in order to understand 
the structural regulation of the enzyme, especially in vivo. In addition, the 
regulation of Spd1 and Spd2 are undefined but represent a good setting to 
study RNR regulation in the cell. 
It is clear that the RNR complex has flexibility in its structure, not only to achieve 
oligomerization but also conformational changes. But how exactly does this 
affect the activity of the RNR? Does it only influence the overall activity and thus 
dNTP pool? Are some complexes more active than others? How important are 
these oligomeric states, and how do they proceed? 
What about the roles of Spd1 and Spd2? How do they affect the RNR 
general structure? In what ways does Spd1 regulate the RNR, indeed it does 
interact with both subunits, controls Suc22R2 localization and RNR activity, but 
how does this relate to the general architecture of the complex enzyme? 
As some questions remain unanswered, in general but also in S. pombe, this 
project has for aim to uncover some of the RNR regulation, in particular the 
regulation by Spd1 and Spd2 and structural/architectural related regulation. 
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III.   Advanced Fluorescence Microscopy methods 
Various microscopy methods were used to investigate the regulation of RNR 
in vivo and in vitro, thus I will introduce fluorescence microscopy and methods 
used in this project. 
1.  Fluorescence, origins and applications 
1.1 Fluorescence origins 
 Sharing the 2008 Nobel Prize in chemistry, Tsien R., Chalfie M. and 
Shimomuru O. allowed huge steps in biology research by discovering, cloning 
and enhancing the Green Fluorescent Protein (GFP). 
The discovery and the isolation of GFP was done successfully by Osamu 
Shimomura in 1962 from Aequorea Victoria (Osamu et al, 1962). In the nineties, 
Douglas Prasher (Prasher et al, 1992) cloned the GFP gene (wtGFP), which 
was then used by the laboratories of Martin Shalfie and Frederik Tjusi, who 
successfully integrated and expressed GFP in E. coli and C. elegans (Chalfie et 
al, 1994). Other laboratories then provided the structure of GFP (Cody, 1993) 
(Ormo et al, 1996) thus also allowing the engineering of enhanced stable 
variants (Tsien, 1998). 
Since then, the GFP sequence has been manipulated extensively to provide 
improved proteins as well as a wide range of colors. Blue (BFP), Cyan (CFP), 
Yellow (YFP) just to name a few; and the additional fluorescent protein, 
providing the color red (RFP) has been added to the collection after being 
discovered in corals (Seward & Bagshaw, 2009). 
The use of fluorescent proteins is wide and varied, ranging from following 
proteins in vivo, staining cellular components, and more recently using 
fluorescence methods to study protein interaction, or protein dynamics for 
example. Additionally, cloning of these fluorescent proteins have been done 
successfully in many organisms and in most cases, without having a significant 
impact on the function of the labeled protein (Giepmans et al, 2006) 
(Nowotschin et al, 2009). 
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Figure I. 30 Origins and evolution of GFP 
GFP was isolated from the jellyfish Aequorea Victoria (a.: Picture from Steve Haddock, 
bioluminescence web page). Picture b. represents the GFP protein structure (source Protein 
Database Bank). And finally the extensive GFP improvements and GFP variants engineered (c.: 
R. Tsien Lab website) 
1.2 GFP and derivatives characteristics 
GFP is a small gene encoding for a 238 amino acids long protein, with 
actually only four amino acids directly producing the fluorescence effect. The 
protein is 27 kDa and is 4,2 nm long and 2,4 nm width (Cody, 1993) (Ormo et 
al, 1996) .  
The fluorescent protein GFP and its derivatives have a unique barrel shape 
structure. eleven β-strands make up the barrel, and a α-helix runs through the 
middle. The covalently bonded chromophore is located in the center of the 
barrel, as it needs to be protected by the fully correct folded protein. Mutations 
modifying the hydrogen-bonding network of GFP leads to a variety of color, 
intensity and stability (Hadjantonakis & Nagy, 2001) (Giepmans et al, 2006). 
All those fluorophores are excited by a certain wavelength (for wtGFP the 
excitation peak centered is at 395 nm), and will emit in another wavelength 
(emission peak centered at 509 nm). Fluorescent proteins are characterized by 
their excitation and emission spectrum, as well as their relative brightness 
(depending with the quantum yield and the extinction coefficient of the protein). 
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Figure I. 31 GFP characteristics and GFP variants 
Picture representing the GFP structure in a barrel with approximate sizes of 4nm on 2 nm (a.: 
source Zeiss campus website) In b. is an example of a fluorescent protein spectra, with its 
excitation and emission, for example here wtGFP has an excitation peak at 395 nm and 
emission peak around 509 nm.  
Picture c. represents the chromophore structural motif in GFP and two variants CFP (tryptophan 
residue instead of Tyr66) and YFP (stacking of a second tyrosine (Tyr203) on Tyr66 along with 
substitution of Ser65 for glycine), and how mutations change the spectra of these proteins. 
(Source: Olympus confocal website) 
1.3 Applications 
GFP and its derivatives have been extensively used in all fields of 
biology, biochemistry and chemistry. Other fluorophores (i.e. FITC) can be toxic 
to living cell, therefore GFP has improved the field of live cell imaging as it 
allows to follow proteins during the cell cycle, after damage, in presence of 
drugs; but also in whole organisms development. This brings a fourth dimension 
to microscopy, after x,y, and z, the time factor (t) allows to study in more depth 
biological processes (Giepmans et al, 2006). 
In addition, due to its non-invasive and versatile qualities, it has the capacity to 
be cloned into many organisms, ranging from virus to cat, which is also a 
novelty. 
One of the many ingenious usages of GFP is symbolized by the brainbow, 
which is very representative of the engineering and creative possibilities with 
genes encoding fluorescent proteins. Combining several GFP and RFP 
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variants, nervous cell will express a different combination resulting in different 
colors: the brainbow (Livet, 2007) (Figure I.32). 
 
Figure I. 32 Brainbow 
This figure shows the striking similarity between an old drawing from Cajal (a.: Santiago Ramón 
y Cajal. 1901. from “Herederos de Ramón y Cajal”) next to the brainbow (b.: Livet et al, 2007, 
from the Harvard brain centre) 
 
Although the brainbow is a success with regards to creativity, it does not 
allow studying particular molecular mechanisms. Thus, in order to study more 
precise protein interaction, dynamics structure, modifications, and localization; a 
few methods have emerged lately (Schmolze et al, 2011). Just to name a few: 
FRAP (Fluorescence Recovery After Photobleaching) will allow measuring the 
dynamics of proteins, FLIM (Fluorescence Lifetime IMaging) is a very precise 
methods to measure the lifetime of the emitted fluorescence, FCS 
(Fluorescence Correlation Spectroscopy) is rather for in vitro studies, for 
example to study protein binding. Another one of these is FRET (Fluorescence 
Resonance Energy transfer), which I will now explain in detail. 
2.  FRET: Fluorescence Resonance Energy Transfer 
2.1 FRET principle 
A powerful tool to investigate inter- and intra-molecular modifications is 
Fluorescence (or Förster) Resonance Energy Transfer (Truong & Ikura, 2001) 
(Pollok & Heim, 1999) (Pietraszewska-Bogiel & Gadella, 2011). An initially 
excited donor fluorophore can transfer non-radiative energy to another 
fluorophore, which will act as acceptor. In order to have this energy transfer 
between chromophores, a few requirements have to be met: a distance 
between 1-10 nm (10-100 Å), the right dipole-dipole conformation of both 
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chromophores, and a minimum of overlay of the donor emission spectra with 
the acceptor excitation spectra (Pietraszewska-Bogiel & Gadella, 2011) (Marc 
et al, 2006).  
This FRET phenomenon has been studied by physical chemistry laboratories, 
but has gradually made its way into biophysics, molecular biology and 
biochemistry as a technique to study protein folding (Truong & Ikura, 2001) 
(Heyduk, 2002), protein interaction (Truong & Ikura, 2001), DNA-protein 
interactions (Hillisch et al, 2001) and protein dynamics (Tadross et al, 2009). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure I. 33 Fluorescence Resonance Energy Transfer 
Simplified illustration explaining the FRET requirements: the donor fluorophore and the acceptor 
fluorophore have to be less than 10 nm distance; the chromophores need the right dipole 
conformaton i.e. orientation of the fluorophores. If all these standards are met, energy transfer 
will occur between the donor and the acceptor. This can be used on two different proteins, but 
as well as to observe dimerization, or even conformation change of a unique protein with the 
donor and the acceptor are tagged at the opposite ends of the protein.  
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 One of the most popular FRET pair used is cyan fluorescent protein (CFP) 
and yellow fluorescent protein (YFP) (Tadross et al, 2009). Both are color 
variants of GFP, and more color variants are available enabling different 
combinations of pairs (Marc et al, 2006). As CFP/YFP is a good FRET pair 
partly due to its ideal spectras (Figure III.5), it was the one used throughout this 
project. 
 
 
Figure I. 34 CFP/YFP FRET pair 
Image a. represents the excitations and emissions spectra of CFP and YFP and the overlap 
between the donor CFP’s emission and the acceptor YFP’s excitation. Image b. is a simplified 
Jablonski diagram illustrating the processes of FRET: the excited donor will transfer non-
radiative energy to the donor, resulting in emission of the donor fluorescence. 
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The FRET efficiency (E) is determined by the characteristic Förster distance R0 
at which 50% energy transfer occurs, and by the donor-acceptor distance r. The 
distance r is limited between 1-10 nm, because the efficiency of energy transfer 
is linked with the inverse of the sixth power of the distance over which FRET 
can occur (Periasamy & Day, 1998) (Pietraszewska-Bogiel & Gadella, 2011) 
(Figure I.35). 
 
Figure I. 35 FRET efficiency 
The FRET energy efficiency (E) is dependent on the Förster distance R0 and the distance r 
between the acceptor and the donor. 
 
FRET can be measured directly using FLIM (Wallrabe & Periasamy, 2005) to 
quantify the acceptor’s emission variation, and other methods have been 
established to measure FRET. FLIM could not be used in our case, as a special 
microscope is required to measure the lifetime of the fluorescence. But we 
decided to use another method, which could be done using the confocal 
microscope, called the acceptor photobleaching FRET method (Wang et al, 
2010) . 
2.2 Acceptor Photobleaching FRET 
 For FRET detection of the RNR in S. pombe a variant of the FRET 
method was applied. When quenching the acceptor (YFP), the acceptor energy 
transfer will not occur, and therefore will come back to the donor fluorophore 
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(CFP). By measuring the donor’s signal, we are then able to determine if the 
fluorophore pair undergoes FRET. Confocal imaging microscopy was used, 
which allowed to photo-bleach the acceptor at a wavelength of 514 nm, and 
detect the effect on the donor emission intensity (Nestoras et al, 2010). The 
following calculation process was applied to measure FRET efficiency: 
-  Normalization of the images (subtraction of the background, 
normalization of the CFP/YFP intensities) 
-  Measurement of the intensities of the bleached area in the pre-bleached 
images of the acceptor and donor, and the same area in the post-
bleached cell 
-  Intensity of the donor pre-bleach = IDA, Intensity of the donor post-
bleach = ID, and I Autofluorescence of the cells 
And finally: 
% FRET Efficiency = 1 – {(IDA – I Auto.) / (ID – I Auto.)} x 100 
 
These measurements were verified by various controls (see chapter II), and 
compared with a plug-in of ImageJ. 
3.  Single molecule methods: FCS and TIRFM 
In chapter 6, I will be using single molecule methods in vitro, which might 
require some brief introduction.   
3.1 Fluorescence Correlation Spectroscopy (FCS) 
 
Confocal microscopy can be used for cell imaging as we have just seen, 
but the confocal volume also brings an advantage to measure fluorescence in a 
very small volume.   
Fluorescence Correlation Spectroscopy (FCS) is a method to measure the 
fluctuation of fluorescence in a confocal volume. The analysis will provide 
information with regards to the parameters of the observed molecules. The 
molecules are moving due to Brownian motions, and the measurements of 
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these fluctuations over time will gather information of thousands of molecules 
(Kolin & Wiseman, 2007) (Al-Soufi et al, 2008).  
This data can then be correlated and supply us with the information of average 
number of molecules and average diffusion time. Eventually the size of the 
molecule can be determined. FCS is very sensitive due to the detection of very 
low concentrated molecules and in a small volume. It can also be used in vivo 
(Fitzpatrick & Lillemeier, 2011). 
 
 
Figure I. 36 Fluorescence Correlation Spectroscopy (FCS) 
Schematic of FCS: Fluorescence signal is acquired when molecules move through the confocal 
detection volume. A correlation process is then applied, providing a diffusion time τ d, while N 
represents the number of molecules. 
 
We used FCS as we wanted to observe the binding process of both RNR 
proteins, but also the binding with the regulators Spd1 and Spd2. In addition, if 
the conformational modifications are large enough or a clear population of 
oligomers is present, we could observe it. This opens a door to a lot of sensitive 
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in vitro experiments to understand protein complexes and interactions. 
Ultimately, FRET experiments could be repeated in a more controlled in vitro 
set-up, confirming the in vivo data with the advantage of obtaining the exact 
stoichiometry of the subunits present (Price et al, 2011). 
3.2 Total Internal Reflection Microscope (TIRFM) 
Another method I would like to mention briefly is the Total Internal 
Reflection Microscope, as I will be using it for investigation of the RNR in vitro. 
In TIRFM, the excitation laser is not perpendicular to the observation plane but 
in an angle thus the laser will be entirely reflected (Axelrod, 2001) (Reck-
Peterson et al, 2010). This produces an evanescent wave, due to the water-
glass interface (high different refractive index) and will illuminate the sample to 
a depth of 100-200 nm. It is used to observe cell membranes, or regions close 
to it; but can also be used for single molecules studies. TIRFM and the derived 
Near-TIRFM (which allows to modify the laser angle) are methods to achieve 
high contrast, lower background, high frame-rate and simultaneous dual-
channel imaging, ultimately for long-term live cell studies. 
 
Figure I. 37 Total Internal Reflection Microscope (TIRFM) 
Schematic of the TIRFM: the excitation laser will reflect on the glass slide due to its coming 
angle, and because of the glass/water interface refraction index, evanescence wavefront will be 
produced illuminating the plane to a depth of 100-200 nm. Images on the right represent 
examples of fluorophores observed on the TIRFM and their point spread function (PSF) 
reproduced in ImageJ. 
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3.3 Other advanced imaging techniques 
Microscopy is by it-self a whole field with constant new and updated 
methods to improve resolution, intensity, quality, quantification etc… Also, there 
seems to be a consensus for giving them interesting acronyms. There are too 
many of them to be listed but I wanted to mention at least a few which are 
relevant for the future of this project.  
To improve the resolution during imaging, a few methods have been developed 
(Wang et al, 2008) (Patterson et al, 2010). One of them is STED (StimulaTed 
Emission Depletion), which de-excite the surrounding fluorophores thus 
reducing the PSF (Point Spread Function); while SIM (Structured Illumination 
Microscopy) uses a combination of patterns during illumation therefore incasing 
the resolution after treatment due to the Moiré pattern characteristics. 
Another method with a lot of future is PALM (Photo Activable Light 
Microscopy) / STORM (Stochastic optical reconstruction microscopy) which 
uses photoactivable fluorophores (i.e. paGFP) to improve the localization. They 
can also be photoconvertible fluorophores (i.e. mEOS2) or photoswitchable 
fluorophores. This localization-enhanced technique allows super-resolution by 
reducing the background and activating sequentially and specifically some 
fluorophores at a time. In addition a lot of possibilities are conceivable, linking 
PALM (and even 3D PALM) with live cell imaging for some super-resolution 
protein tracking, FRAP, FRET ect… 
 
 
Figure I. 38 PALM/ STORM (PhotoActivable Light Microscopy /Stochastic optical reconstruction 
microscopy) 
Schematic of the photoconvertible mEOS2 (a.): the excitation laser will excite mEOS2 as a 
normal GFP, but upon conversion by UV light, the fluorophores will be a RFP thus excite and 
emit as a RFP.  
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In b. (picture from Xiaowei Zhuang, HHMI Harvard) Visualization of a Mitochondrial network in a 
mammalian cell in 3D STORM. Conventional fluorescence image (left), 3D STORM image with 
colors denoting z location (middle) and single xy cross-section from the 3D STORM image 
(right). 
 
Finally, other methods in post-acquisition are worth mentioning: treating your 
images with softwares for denoising, deconvolution, or others like SOFI (Super-
resolution Optical Fluctuation Imaging) can yield improved quality images. 
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CHAPTER II MATERIAL AND METHODS 
I.  General media and reagents  
1.  Media used for the S. pombe cultures  
 
The protocols used for preparing the necessary culture media for S. 
pombe during this project are listed below. For the use of the media in plates, 
as a solid form, agar (DIFCO) was added to a final concentration of 1.5% if not 
stated otherwise. Most components are from Sigma-Aldrich or specified. 
 
YE: Yeast Extract  (for normal S. pombe cell growth) 
Yeast extract 5g/l (0.5% w/v) 
Glucose 30g/l (3% w/v) 
 
EMM: Edinburgh Minimal media (for increased sensitivity to select of S. 
pombe strains) 
Na2HPO4: 25 ml/l of 0.4M Na2HPO4 (final: 10 mM) 
NH4Cl: 25 ml/l of 20% of NH4Cl (final: 0.5%) 
Glucose: 12,5 ml of 40% glucose (final: 0.5%) 
EMM Salts*: 50 ml of 20x EMM2 salts (final: 1x) 
Vitamins**: 1 ml of 1000x vitamins (final: 1x) 
Minerals***: 100 µl of 10000x trace elements (final: 1x) 
 
* 20X EMM2 Salts stock (filter sterilize): 
Potassium hydrogen phthalate: 61.2 g/l 
KCL: 20 g/l 
Mgcl2: 6H20: 21.4 g/l 
Na2S04: 0,2 g/l 
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CaCl2 2H20: 0.26 g/l 
 
**1000X Vitamins stock (keep in the dark at 4°C): 
Pantotenic Acid calcium salt: 1g/l 
Nicotinic acid: 10g/l 
Inositol: 10g/l 
Biotin: 10 mg/l 
 
***10,000X Mineral stock (trace elements) 
Boric acid 5g/l 
MnSO4 4g/l 
ZnSO4.7H2O 4g/l 
FeCl2.6H2O 2g/l 
Molybdic acid 0.4 g/l 
Kl 1g/l 
CuSO4.5H2O 0.4 g/l 
Citric acid 10g/l 
 
YNB: Yeast Nitrogen base (minimum media for S. pombe culture; 
sterilization required) 
YNB: 1,7 g/l (Formendium) 
Ammonium sulfate: 5 g/l 
Dextrose 20 g/l 
 
ELN: Extremely Low nitrogen (media for S. pombe crosses) 
EMM broth without nitrogen: 27.3 g/l (Formendium) 
Ammonium chloride: 0.05 g/l 
Uracil: 0.1 g/l 
Leucine: 0.1 g/l 
Histidine: 0.1 g/l 
Arginine: 0.1 g/l 
Adenine: 0.2 g/l 
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2.  Amino Acid mixes for the minimal media (sterilization required) 
 In order to select for specific markers in S. pombe stains, various amino 
acids can be added to the minimal medias. 
Leucine 100X: 7.5 g/l 
Adenine 100X: 7.5 g/l 
Histidine 100X: 7.5 g/l 
Uracile 50X: 3.75 g/l 
 
3.  Medias used for E. coli culture (sterilization required for all) 
 This project also required some extensive work with E. Coli and diverse 
medias. 
LB: Luria Broth 
Tryptone: 10 g/l 
Yeast extract: 5 g/l 
NaCl: 10 g/l 
 
TB: Terrific Broth 
Tryptone: 12 g/l 
Yeast extract: 24 g/l 
Glycerol: 4ml/l 
0.17M KH2P04, 0.72M K2HP04: 100 ml/l (autoclaved separately then added to 
the previous components after they have been autoclaved) 
 
SOC: Super Optimal broth with Catabolite repression 
Tryptone: 20 g/l 
Yeast extract: 5 g/l 
NaCl: 0.5 g/l 
250 mM KCL: 10 ml/l 
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Adjust pH to 7.0 with 5 N of NaOH: ~0.2ml/l and autoclave 
2 M Mgcl2:  5 ml/l (autoclaved) 
1 M glucose: 20 ml/l (filtered) 
 
4.  Some of the general buffers used 
10 mM Tris-HCL: 1,2 g/l 
1 M Tris-HCL: 121,1 g/l 
0.2 M Citric acid: 42 g/l (filter) 
2,4 M Sorbitol: 437 g/l  
5 M KAC: 490 g/l 
1 M EDTA pH 8: 372 g/l 
250 mM KCL: 18,6 g/l 
2 M Mgcl2: 190 g/l  
1 M glucose: 180 g/l  
3M Sodium Acetate: 408,3 g/l 
 
CSE: Citric Sorbitol (Filter sterilize) 
0.4 M Na2H2PO4: 70 ml/l (final: 28 mM) 
0.2 M Citric acid: 44 ml/l (final: 8.8 mM) 
EDTA: 14.9g/l Na2EDTA. 2H20 (final 40 mM) 
Sobritol: 218.6 g/l (final 1.2 M) 
 
Tris-EDTA (TE) 
10 mM Tris-HCL: 10 ml/l 
1 mM EDTA: 2 ml/l 
 
5X TBE 
Tris-Base: 54 g/l  
Boric acid: 27.5 g/l  
EDTA: 3.72 g/l Na2EDTA. 2H20 
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PBS (Phosphate buffered saline) 
137mM NaCl 
 2.7mM KCl 
10mM Na2HPO4 
1.76mM KH2PO4 
 
PBS-T: same as above but with 0.1 % Tween 20  
 
0.17M KH2P04, 0.72M K2HP04: 
 2.31 g of KH2P04 and 12.54 g of K2HP04 in 100 ml of H20 
 
4X Sample buffer (100ml):  
250mM Tris pH 6.8 
 8% SDS 
20% glycerol 
20% b-mercaptoethanol 
Bromophenol blue: final concentration 0.4% 
 
5.  Reagents 
Ampicillin (Sigma): 50 mg/ml 
Carbenicillin (Sigma): 50 mg/ml 
Chloramphenicol (Sigma): 34 mg/ml in Ethanol 
G-418 (Melford): 100 mg/ml in H2O 
1 M HU (Sigma): 0.7605 g in 10 ml of H20 
1 mM 4NQO (Sigma): 0.0019 g in 10 ml DMSO 
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II.  S. pombe protocols 
1.  Gene targeting protocols 
1.1 Gene targeting methodology 
 The methodologies for PCR-based gene targeting in S. pombe have been 
described before(Bähler et al, 1998) (Werler PJ, 2003), however I will describe 
them briefly. To modify the sequence of a gene of interest, in order to tag a 
gene of interest for example with the tags CFP or YFP; at least 80 bp of 
homology to the endogenous genomic site is cloned to the tag in 5’ and in 3’. By 
homologous recombination, the tag is inserted at the genomic sequence. If 
more homology is needed, fusion PCR will allow to reach up to 600 bp of 
homology, increasing the probability to insert the tag of interested to the 
endogenous target gene site.  In case of gene disruption, the same method of 
homology is used but instead of inserting a gene in 5’ or 3’ of the target gene, it 
will be cloned in order to exchange the entire target gene with another 
exogenous marker gene.  
1.2 General cloning method 
 Restriction with NEB enzymes and ligation with T4 DNA ligase (NEB), of 
plasmids and DNA fragments, were done following the manufacturer’s 
conditions (New England Biolabs: NEB). Fusion PCR was done with KOD hot 
start DNA polymerase (Novagen). The reaction mixture is: 
DNA: 50-100 ng 
dNTPs: 0.2 mM of each 
Primers: 0.3 µM of each 
KOD reaction buffer: 1x 
MgSo4: 1-6 mM 
KOD polymerase enzyme: 0.02 U/µl 
 
The PCR program is 98°C for 3 minutes, 5x 98°C for 30 seconds, 50°C for 1 
minute, 68°C for 1 minute, 24x 98°C 30 seconds, Tm°C for 30 seconds, ended 
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by 68°C during the extension time. The various primers used can be found later 
in the annexe in the primer list. 
The digested fragments as well as the amplified fragments were purified by gel 
extraction kit (Qiagen) or PCR clean-up (Machery-Nagel). 
1.3 S. pombe transformation 
 S. pombe cells are grown overnight to 1x107 cells/ml, from which 10 ml of 
cells are centrifuged at 3000 rpm for 5 min. The cells are washed with H20 and 
with LiAc-TE (0.1 M LiAc, 0.01 M Tris-HCl, 0.001 M EDTA pH7.5) and 
resuspended with 100 µl LiAc-TE. Single stranded sperm DNA (Invitrogen 
Salmon Sperm DNA) and 1 µg of plasmid DNA or PCR fragment (up to 10 µg) 
are added and incubated for 10 mins at room temperature. 260 µl of 40% PEG- 
LiAc-TE were added and incubated 30-60 mins at 30°C. Followed by addition of 
43 µl of DMSO and incubation at 42°C for 5 mins. Finally the samples are 
washed with 1 ml of H2O and resuspended in 500 µl YE. 300 µl and 200 µl were 
plated onto selective plates.  
1.4 Genomic DNA extraction 
 Cells were grown overnight in 10 ml YE at 30°C followed by centrifugation 
at 3000 rpm for 5 mins. Pellets were resuspended in 1 ml of CSE containing 
zymolyase 100T (final 1 mg/ml) and incubated for 15 minutes at 37°C. Correct 
cell lysis was checked under microscope. Cells were centrifuged at 3000 rpm 
for 5 minutes followed by pellet resuspension in 450 µl of 5X TE + 50 µl of 10% 
SDS, then incubated for 5 mins at room temperature. 150 µl of 5 M KAC was 
added and the samples were incubated 10 mins on ice. Centrifugation (13 000 
rpm for 10 min at 4°C) allowed recuperation of the supernatant. 1 volume of 
isopropanol was added to precipitate the DNA, and subsequently the samples 
were centrifuged (13 000 rpm for 10 mins at 4°C). The pellets were washed with 
500 µl of 70% ethanol followed by centrifugation (13 000 rpm for 10 mins at 
4°C). The supernatant was discarded and the pellet was resuspended in 200 µl 
of H20 containing RNAse A (10 µg/ml).  
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1.5 Verification by PCR 
 In case of absence of a selection marker, PCR has to be conducted to 
verify the correct insertion of the tag adjacent to the gene of interest. PCR was 
used routinely with the enzyme Taq polymerase, in a PCR reaction mixture: 
DNA: 50-100 ng 
dNTPs: 0.2 mM of each 
Primers: 0.3 µM of each 
Taq reaction buffer: 1x 
MgS04: 2-4 mM 
Taq polymerase enzyme: 0.02 U/µl 
 
The PCR program was: 94°C for 3 minutes, 29x (94°C for 15 seconds, Tm°C 
for 30 seconds, 72°C for 1 minute) and a final extension at 72°C.  
1.6 Strain crosses, random spore analysis and tetrad dissection 
 To obtain crossed strains, fresh strains with opposite mating type were 
streaked on ELN plates and mixed together with sterile water. The ELN plates 
were incubated for 2-3 days at 25°C. For random spore analysis, the spore’s 
asci were resuspended and incubated overnight in 1 ml sterile water containing 
helicase (helix pomatia juice) at 1:100 dilution. After washing with 1 ml of sterile 
water, 100 and 1000 spores were plated on YEA plates and incubated at 30°C 
until colonies reached a satisfactory size. Colonies were then replicated on 
selective plates and grown at 30°C. In addition, the selected cells were streaked 
again to form new single colonies. 
Tetrads were dissected by a micromanipulator on YEA plates, after incubation 
at 30°C for 3-5 days, as this allowed to select more carefully for spores scored 
on their genetic background. 
1.7 Diploids strains 
 In order to obtain stable diploids, crossing of an ade6-M210 strain with 
ade6-M216 strain is required. After 2-3 days of incubation at 25°C, a small 
loophole of cells were plated onto a minimal plate (YNBA) without any adenine. 
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Only the ade+ intra-complementing diploid cells will then grow. The growing 
colonies were restreaked on minimal medium without adenine for single 
colonies, and verified for sporulation on an ELN plate. The diploids strains were 
cultured in YE media without extra adenine, and maintained on YEA plates 
without extra adenine to ensure stabilization. 
1.8 S. pombe strains used during this project 
 Nearly all strains made and used have the genetic background: ade6-704 
leu1-32 ura4D-18. The strains with this background were often used as wild 
type strain, and they need media complemented with adenine, uracil and 
leucine for normal growth. The RNR single tagged strains (YFP-Suc22R2, CFP-
Suc22R2, Cdc22R1-CFP:KanMX and Cdc22R1-YFP:KanMX) as well as the 
double-tagged strains (YFP-Suc22R2 Cdc22R1-CFP:KanMX, CFP-Suc22R2 
Cdc22R1-YFP:KanMX) were made previously by Dr Adam Watson. I used the 
available Spd1::ura4+ strain, which will be referred as the Spd1 deleted strain 
for crossing to obtain a various set of single tagged RNR strains, double tagged, 
with spd1 deleted. 
The spd1 mutants constructs were created by independent alanine 
mutagenesis PCR by Dr Marius Poitela and Dr Konstantinos Nestoras and 
integrated by homology to the genomic spd1 sequence. 
 Finally, to make the strains needed for the microscopy and FRET 
experiments, I crossed the spd1 mutants to the double-tagged strains (YFP-
Suc22R2 Cdc22R1-CFP:KanMX Spd1::ura4, CFP-Suc22R2 Cdc22R1-YFP:KanMX 
Spd1::ura4) and selected for the different markers:  
- G418 resistance validating the presence of Cdc22R1-CFP/YFP:KanMX 
construct 
- Loss of uracile resistance proving the correct integration of the Spd1 mutant 
- PCR to confirm the CFP/YFP-Suc22R2 construct 
All the Spd1 mutants were incorporated in the YFP-Suc22R2Cdc22-CFPR1 
strains, and most of them also in the “swapped” tagged strain i.e. CFP-Suc22R2 
YFP-Cdc22R1 strain (see Table 1). After verification by sequencing of all the 
correct mutants inserted, the strains were ready for FRET experiments as well 
as other microscopy and biochemical studies. The same methods were used for 
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the spd2 deletion strains, although more PCR verifications were needed due to 
the redundancy of marker genes. 
 The cdc25-22 Ts strains (Table 1) have been used in the laboratory 
before, and as they are thermo-sensitive, they arrest in G2 phase when 
maintained 3 hours at 36°C. The Cdc25-22 Ts strain was used to cross with 
both double RNR-tagged strains with spd1 wt and spd1 deletion. Therefore, a 
collection of single tagged RNR and double-tagged RNR strains is available. 
The diploids strains were made by adenine complementation as described 
previously, and allowed to obtain a collection of RNR tagged diploids strains, 
with spd1 wt and spd1 deleted. All the strains used in this study are in Table 1. 
They have been stored in 50% glycerol stocks and are maintained at -80°C. 
 Genotype 
Mating 
type 
Base strains (“Wild types”)  
   
AS501 ade6-704 leu1-32 uraD18 h- 
AS503 ade6-704 leu1-32 uraD18 h+ 
   
spd1 and spd2 deleted  
   
AS128 Spd1::ura4 ade6-704 ura4-D18 leu1-32 h- 
AS129 Spd1::ura4 ade6-704 ura4-D18 leu1-32 h+ 
AS130 Spd2::ura4  ade6-704 ura4-D18 leu1-32   
AS140 Spd2:KanMX  
   
Mutants spd1 no tags  
   
AS01 Spd1::mutant 1 ade6-704 ura4-D18 leu1-32 h+ 
AS02 Spd1::mutant 2 ade6-704 ura4-D18 leu1-32 h- 
AS03 Spd1::mutant 3 ade6-704 ura4-D18 leu1-32 h+ 
AS04 Spd1::mutant 4 ade6-704 ura4-D18 leu1-32 h+ 
AS05 Spd1::mutant 5 ade6-704 ura4-D18 leu1-32 h+ 
AS06 Spd1::mutant 6 ade6-704 ura4-D18 leu1-32 h- 
AS07 Spd1::mutant 7 ade6-704 ura4-D18 leu1-32 h+ 
AS08 Spd1::mutant 8 ade6-704 ura4-D18 leu1-32 h- 
AS09 Spd1::mutant 9 ade6-704 ura4-D18 leu1-32 h+ 
AS10 Spd1::mutant 10 ade6-704 ura4-D18 leu1-32 h+ 
AS11 Spd1::mutant 11 ade6-704 ura4-D18 leu1-32 h+ 
AS12 Spd1::mutant 12 ade6-704 ura4-D18 leu1-32 h+ 
AS13 Spd1::mutant 13 ade6-704 ura4-D18 leu1-32 h- 
AS14 Spd1::mutant 14 ade6-704 ura4-D18 leu1-32 h+ 
AS15 Spd1::mutant 15 ade6-704 ura4-D18 leu1-32 h- 
AS16 Spd1::mutant 16 ade6-704 ura4-D18 leu1-32 h+ 
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AS17 Spd1::mutant 17 ade6-704 ura4-D18 leu1-32 h- 
AS18 Spd1::mutant 18 ade6-704 ura4-D18 leu1-32 h- 
AS19 Spd1::mutant 19 ade6-704 ura4-D18 leu1-32 h+ 
AS20 Spd1::mutant 20 ade6-704 ura4-D18 leu1-32 h- 
AS21 Spd1::mutant 21 ade6-704 ura4-D18 leu1-32 h+ 
AS22 Spd1::mutant 22 ade6-704 ura4-D18 leu1-32 h+ 
AS23 Spd1::mutant 23 ade6-704 ura4-D18 leu1-32 h+ 
AS24 Spd1::mutant 24 ade6-704 ura4-D18 leu1-32 h+ 
AS25 Spd1::mutant 25 ade6-704 ura4-D18 leu1-32 h- 
AS26 Spd1::mutant 26 ade6-704 ura4-D18 leu1-32 h+ 
AS27 Spd1::mutant 27 ade6-704 ura4-D18 leu1-32 h+ 
AS28 Spd1::mutant 28 ade6-704 ura4-D18 leu1-32 h- 
AS29 Spd1::mutant 29 ade6-704 ura4-D18 leu1-32 h+ 
AS30 Spd1::mutant 30 ade6-704 ura4-D18 leu1-32 h- 
AS31 Spd1::mutant 31 ade6-704 ura4-D18 leu1-32 h+ 
AS32 Spd1::mutant 32 ade6-704 ura4-D18 leu1-32 h+ 
AS33 Spd1::mutant 33 ade6-704 ura4-D18 leu1-32 h+ 
AS34 Spd1::mutant 34 ade6-704 ura4-D18 leu1-32 h+ 
AS35 Spd1::mutant 35 ade6-704 ura4-D18 leu1-32 h+ 
AS36 Spd1::mutant 36 ade6-704 ura4-D18 leu1-32 h+ 
AS37 Spd1::mutant 37 ade6-704 ura4-D18 leu1-32 h- 
AS38 Spd1::mutant 38 ade6-704 ura4-D18 leu1-32 h+ 
AS39 Spd1::mutant 39 ade6-704 ura4-D18 leu1-32 h- 
AS40 Spd1::mutant 40 ade6-704 ura4-D18 leu1-32 h+ 
AS41 Spd1::mutant 41 ade6-704 ura4-D18 leu1-32 h+ 
   
Mutants spd1 CFP-Suc22 Cdc22-YFP (CY)  
   
AS-CY2 
CFP-Suc22 Cdc22-YFP:KanMX spd1-m2 ade6-704 ura4-D18 
leu1-32   
AS-CY4 
CFP-Suc22 Cdc22-YFP:KanMX spd1-m4 ade6-704 ura4-D18 
leu1-32   
AS-CY7 
CFP-Suc22 Cdc22-YFP:KanMX spd1-m7 ade6-704 ura4-D18 
leu1-32   
AS-
CY10 
CFP-Suc22 Cdc22-YFP:KanMX spd1-m10 ade6-704 ura4-D18 
leu1-32   
AS-
CY11 
CFP-Suc22 Cdc22-YFP:KanMX spd1-m11 ade6-704 ura4-D18 
leu1-32   
AS-
CY12 
CFP-Suc22 Cdc22-YFP:KanMX spd1-m12 ade6-704 ura4-D18 
leu1-32   
AS-
CY13 
CFP-Suc22 Cdc22-YFP:KanMX spd1-m13 ade6-704 ura4-D18 
leu1-32   
AS-
CY14 
CFP-Suc22 Cdc22-YFP:KanMX spd1-m14 ade6-704 ura4-D18 
leu1-32   
AS-
CY19 
CFP-Suc22 Cdc22-YFP:KanMX spd1-m19 ade6-704 ura4-D18 
leu1-32   
AS-
CY21 
CFP-Suc22 Cdc22-YFP:KanMX spd1-m21 ade6-704 ura4-D18 
leu1-32   
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AS-
CY22 
CFP-Suc22 Cdc22-YFP:KanMX spd1-m22 ade6-704 ura4-D18 
leu1-32   
AS-
CY23 
CFP-Suc22 Cdc22-YFP:KanMX spd1-m23 ade6-704 ura4-D18 
leu1-32   
AS-
CY24 
CFP-Suc22 Cdc22-YFP:KanMX spd1-m24 ade6-704 ura4-D18 
leu1-32   
AS-
CY26 
CFP-Suc22 Cdc22-YFP:KanMX spd1-m26 ade6-704 ura4-D18 
leu1-32   
AS-
CY27 
CFP-Suc22 Cdc22-YFP:KanMX spd1-m27 ade6-704 ura4-D18 
leu1-32   
AS-
CY29 
CFP-Suc22 Cdc22-YFP:KanMX spd1-m29 ade6-704 ura4-D18 
leu1-32   
AS-
CY33 
CFP-Suc22 Cdc22-YFP:KanMX spd1-m33 ade6-704 ura4-D18 
leu1-32   
AS-
CY34 
CFP-Suc22 Cdc22-YFP:KanMX spd1-m34 ade6-704 ura4-D18 
leu1-32   
AS-
CY36 
CFP-Suc22 Cdc22-YFP:KanMX spd1-m36 ade6-704 ura4-D18 
leu1-32   
AS-
CY37 
CFP-Suc22 Cdc22-YFP:KanMX spd1-m37 ade6-704 ura4-D18 
leu1-32   
AS-
CY38 
CFP-Suc22 Cdc22-YFP:KanMX spd1-m38 ade6-704 ura4-D18 
leu1-32   
AS-
CY41 
CFP-Suc22 Cdc22-YFP:KanMX spd1-m41 ade6-704 ura4-D18 
leu1-32   
   
Mutants spd1 YFP-Suc22 Cdc22-CFP (YC)  
   
AS-YC1 
YFP-Suc22 Cdc22-CFP:KanMX spd1-m1 ade6-704 ura4-D18 
leu1-32  
AS-YC2 
YFP-Suc22 Cdc22-CFP:KanMX spd1-m2 ade6-704 ura4-D18 
leu1-32  
AS-YC4 
YFP-Suc22 Cdc22-CFP:KanMX spd1-m4 ade6-704 ura4-D18 
leu1-32  
AS-YC5 
YFP-Suc22 Cdc22-CFP:KanMX spd1-m5 ade6-704 ura4-D18 
leu1-32  
AS-YC9 
YFP-Suc22 Cdc22-CFP:KanMX spd1-m9 ade6-704 ura4-D18 
leu1-32  
AS-
YC12 
YFP-Suc22 Cdc22-CFP:KanMX spd1-m12 ade6-704 ura4-D18 
leu1-32  
AS-
YC13 
YFP-Suc22 Cdc22-CFP:KanMX spd1-m13 ade6-704 ura4-D18 
leu1-32  
AS-
YC14 
YFP-Suc22 Cdc22-CFP:KanMX spd1-m14 ade6-704 ura4-D18 
leu1-32  
AS-
YC15 
YFP-Suc22 Cdc22-CFP:KanMX spd1-m15 ade6-704 ura4-D18 
leu1-32  
AS-
YC16 
YFP-Suc22 Cdc22-CFP:KanMX spd1-m16 ade6-704 ura4-D18 
leu1-32  
AS-
YC17 
YFP-Suc22 Cdc22-CFP:KanMX spd1-m17 ade6-704 ura4-D18 
leu1-32  
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AS-
YC18 
YFP-Suc22 Cdc22-CFP:KanMX spd1-m18 ade6-704 ura4-D18 
leu1-32  
AS-
YC21 
YFP-Suc22 Cdc22-CFP:KanMX spd1-m21 ade6-704 ura4-D18 
leu1-32  
AS-
YC22 
YFP-Suc22 Cdc22-CFP:KanMX spd1-m22 ade6-704 ura4-D18 
leu1-32  
AS-
YC23 
YFP-Suc22 Cdc22-CFP:KanMX spd1-m23 ade6-704 ura4-D18 
leu1-32  
AS-
YC24 
YFP-Suc22 Cdc22-CFP:KanMX spd1-m24 ade6-704 ura4-D18 
leu1-32  
AS-
YC25 
YFP-Suc22 Cdc22-CFP:KanMX spd1-m25 ade6-704 ura4-D18 
leu1-32  
AS-
YC26 
YFP-Suc22 Cdc22-CFP:KanMX spd1-m26 ade6-704 ura4-D18 
leu1-32  
AS-
YC27 
YFP-Suc22 Cdc22-CFP:KanMX spd1-m27 ade6-704 ura4-D18 
leu1-32  
AS-
YC28 
YFP-Suc22 Cdc22-CFP:KanMX spd1-m28 ade6-704 ura4-D18 
leu1-32  
AS-
YC29 
YFP-Suc22 Cdc22-CFP:KanMX spd1-m29 ade6-704 ura4-D18 
leu1-32  
AS-
YC30 
YFP-Suc22 Cdc22-CFP:KanMX spd1-m30 ade6-704 ura4-D18 
leu1-32  
AS-
YC31 
YFP-Suc22 Cdc22-CFP:KanMX spd1-m31 ade6-704 ura4-D18 
leu1-32  
AS-
YC32 
YFP-Suc22 Cdc22-CFP:KanMX spd1-m32 ade6-704 ura4-D18 
leu1-32  
AS-
YC34 
YFP-Suc22 Cdc22-CFP:KanMX spd1-m34 ade6-704 ura4-D18 
leu1-32  
AS-
YC35 
YFP-Suc22 Cdc22-CFP:KanMX spd1-m35 ade6-704 ura4-D18 
leu1-32  
AS-
YC36 
YFP-Suc22 Cdc22-CFP:KanMX spd1-m36 ade6-704 ura4-D18 
leu1-32  
AS-
YC38 
YFP-Suc22 Cdc22-CFP:KanMX spd1-m38 ade6-704 ura4-D18 
leu1-32  
AS-
YC39 
YFP-Suc22 Cdc22-CFP:KanMX spd1-m39 ade6-704 ura4-D18 
leu1-32  
AS-
YC40 
YFP-Suc22 Cdc22-CFP:KanMX spd1-m40 ade6-704 ura4-D18 
leu1-32  
   
Double tags  
   
AS108 
CFP-Suc22 Cdc22-YFP:KanMX spd1 wt ade6-704 ura4-D18 
leu1-32 h- 
AS120 
YFP-Suc22 Cdc22-CFP:KanMX  spd1 wt ade6-704 ura4-D18 
leu1-32   
AS122 
CFP-Suc22 Cdc22-YFP:KanMX  spd1::ura4+ ade6-704 ura4-
D18 leu1-32 h- 
AS123 
CFP-Suc22 Cdc22-YFP:KanMX  spd1::ura4+ ade6-704 ura4-
D18 leu1-32 h+ 
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AS154 
YFP-Suc22 Cdc22-CFP:KanMX  spd1::ura4+ ade6-704 ura4-
D18 leu1-32 h+ 
AS155 
YFP-Suc22 Cdc22-CFP:KanMX  spd1::ura4+ ade6-704 ura4-
D18 leu1-32 h- 
AS131 
YFP-Suc22 Cdc22-CFP:KanMX  spd1 wt Spd2::ura4+ ade6-
704 ura4-D18 leu1-32   
AS132 
YFP-Suc22 Cdc22-CFP:KanMX  spd1::ura4+ Spd2::ura4+ 
ade6-704 ura4-D18 leu1-32   
AS141 
CFP-Suc22 Cdc22-YFP:KanMX  spd1 wt Spd2:KanMX ade6-
704 ura4-D18 leu1-32   
AS142 
CFP-Suc22 Cdc22-YFP:KanMX  spd1::ura4+ Spd2:KanMX 
ade6-704 ura4-D18 leu1-32 -1   
AS143 
CFP-Suc22 Cdc22-YFP:KanMX  spd1::ura4+ Spd2:KanMX 
ade6-704 ura4-D18 leu1-32 -2   
AS144 
CFP-Suc22 Cdc22-YFP:KanMX  spd1::ura4+ Spd2:KanMX 
ade6-704 ura4-D18 leu1-32 -3   
AS145 
CFP-Suc22 Cdc22-YFP:KanMX  spd1::ura4+ Spd2:KanMX 
ade6-704 ura4-D18 leu1-32 -4   
   
Single tags  
   
AS101 YFP-Suc22           ade6-704 ura4-D18 leu1-32  
AS102 Cdc22-YFP:KanMX  ade6-704 ura4-D18 leu1-32  
AS103 CFP-Suc22           ade6-704 ura4-D18 leu1-32  
AS104 Cdc22-CFP:KanMX  ade6-704 ura4-D18 leu1-32  
   
Cdc25-22 TS strains  
   
AS441 cdc25-22 TS ura deleted h - 
AS442 cdc25-22 TS ura deleted h + 
AS443 cdc25-22 TS ura4-D18  
AS444 cdc25-22 TS ura4-D18  
AS 450 YFP-Suc22  spd1 wt ade6-704 ura4-D18 leu1-32 Cdc25TS  
AS 451 YFP-Suc22  spd1::ura+ ade6-704 ura4-D18 leu1-32 Cdc25TS  
AS 452 
 Cdc22-CFP:KanMX  spd1 wt ade6-704 ura4-D18 leu1-32 
Cdc25TS  
AS 453 
 Cdc22-CFP:KanMX  spd1::ura4+ ade6-704 ura4-D18 leu1-32 
Cdc25TS  
AS 454 
YFP-Suc22 Cdc22-CFP:KanMX  spd1 wt ade6-704 ura4-D18 
leu1-32 Cdc25TS  
AS 455 
YFP-Suc22 Cdc22-CFP:KanMX  spd1::ura+ ade6-704 ura4-
D18 leu1-32 Cdc25TS  
AS 456 CFP-Suc22 spd1 wt ade6-704 ura4-D18 leu1-32  Cdc25TS  
AS 457 
CFP-Suc22 spd1::ura4+ ade6-704 ura4-D18 leu1-32  
Cdc25TS  
AS 458 
Cdc22-YFP:KanMX spd1 wt ade6-704 ura4-D18 leu1-32 
Cdc25TS  
AS 459 
Cdc22-YFP:KanMX spd1::ura4+ ade6-704 ura4-D18 leu1-32 
Cdc25TS  
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AS 461 
CFP-Suc22 Cdc22-YFP:KanMX spd1 wt ade6-704 ura4-D18 
leu1-32 Cdc25TS  
AS 462 
CFP-Suc22 Cdc22-YFP:KanMX spd1::ura4+ ade6-704 ura4-
D18 leu1-32 Cdc25TS  
   
Diploids   
   
AS 200 972 all wt h- h- 
AS 201 975 all wt h+ h+ 
AS 202 CFP-Suc22 spd1 wt - all wt  
AS 203 YFP-Suc22 spd1 wt - all wt  
AS 204 YFP-Suc22 spd1 wt ade216  
AS 205 CFP-Suc22 spd1 wt ade216  
AS 206 CFP-Suc22 spd1 wt ade210  
AS 207 YFP-Suc22 spd1 wt ade210  
AS 208 Cdc22-YFP:KanMX spd1 wt - all wt  
AS 209 Cdc22-CFP:KanMX spd1 wt - all wt  
AS 210 Cdc22-YFP:KanMX spd1 wt ade216  
AS 211 Cdc22-CFP:KanMX spd1 wt ade216  
AS 212 Cdc22-CFP:KanMX spd1 wt ade210  
AS 213 Cdc22-YFP:KanMX ade216 Cdc22-CFP:KanMX ade210 I  
AS 214 Cdc22-YFP:KanMX ade216 Cdc22-CFP:KanMX ade210 II  
AS 215 YFP-Suc22 ade216 CFP-Suc22 ade210 I  
AS 216 YFP-Suc22 ade216 CFP-Suc22 ade210 II  
AS 217 YFP-Suc22 ade210 CFP-Suc22 ade216 I  
AS 218 YFP-Suc22 ade210 CFP-Suc22 ade216 II  
AS 219 Cdc22-YFP:KanMX ade210 Cdc22-CFP:KanMX ade216 I  
AS 220 Cdc22-YFP:KanMX ade210 Cdc22-CFP:KanMX ade216 II  
AS 221 
Cdc22-YFP:KanMX ade210 Cdc22-CFP:KanMX ade216 
Spd1::ura4+ -1  
AS 222 
Cdc22-YFP:KanMX ade210 Cdc22-CFP:KanMX ade216 
Spd1::ura4+ -2  
AS 223 
Cdc22-YFP:KanMX ade210 Cdc22-CFP:KanMX ade216 
Spd1::ura4+ -3  
AS 224 
Cdc22-YFP:KanMX ade210 Cdc22-CFP:KanMX ade216 
Spd1::ura4+ -4  
AS 225 YFP-Suc22 ade216 CFP-Suc22 ade210 Spd1::ura4+ -1  
AS 226 YFP-Suc22 ade216 CFP-Suc22 ade210 Spd1::ura4+ -2  
AS 227 YFP-Suc22 ade216 CFP-Suc22 ade210 Spd1::ura4+ -3  
AS 228 YFP-Suc22 ade216 CFP-Suc22 ade210 Spd1::ura4+ -4  
   
AS250 ade6-210  h+ 
AS251 ade6-216  h- 
AS252 ade6-216  h+ 
Table1: List of strains used in this project 
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2.  Other S. pombe protocols 
2.1 Cdc25-22 TS synchronization 
 The S. pombe mutant strain cdc25-22 ThermoSensitive (TS) allows us to 
block the cells in G2 and after release, the cell population will be synchronized. 
First a pre-culture of 20 ml at 25°C of the strain is measured for the cell density, 
and a 100 ml culture is set at 25°C in order to obtain 3x106 cell/ml the next 
morning. The cultures are then put in a 36°C waterbath for 3.5 hours for the 
blocking of the cells. To release the cells into the cell cycle, the cultures are 
cooled down in a sink with ice for rapid decrease of the temperature, followed 
by culture in a 25°C shaking waterbath. The time point started at that moment, 
and sample were taken before the release, as well as after, every with 20 min 
intervals. The samples were prepared for FACS and microscopy. 
2.2 FACS (Fluorescence activating cell sorting) 
 Exponential cell cultures were used in order to have healthy cells for FACS 
analysis. 1 ml of the culture was centrifuged (3000 rpm) and the pellet was 
washed and resuspended with 500 µl of 50 mM sodium citrate. Next, addition of 
50 µl of 10 mg/ml RNaseA was done and the samples incubated at 37°C for 2-3 
hours. In FACS tube, 200 µl of the sample was mixed with 10 µl of 500 mg/ml of 
propidium iodide (PI) and 1 ml of sodium citrate buffer. After a throughout 
vortexing of the samples, they were used on the FACS machine (FACS canto) 
following the manufacturer’s protocol, and previously established calibrations for 
S. pombe cells. 
2.3 Chromosomal DNA and septum staining 
 1 ml of exponentially growing cells were pelleted at 3000 rpm, washed in 
1ml PBS and resuspended in methanol. Cells were spread onto a glass slide 
and stained with DAPI (1 µg/ml) and Calcofluor (50 µg/ml) in 50% Glycerol 50 
% H20 for analysis.  
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2.4 S. pombe protein extraction 
 Cells were grown in 10 ml of culture overnight. About 5 ODs of cells were 
harvested (3000 rpm 5 minutes) and washed with PBS. The pellets were 
resuspended in 200 µl 20% TCA (Trichloroacetic Acid) and transferred to 
ribolyser tubes. Cells were ribolysed by using glass beads (Sigma) for at least 2 
cycles (30 sec each) at speed 6.5, or until lysis of approximately 90% of the 
cells was accomplished. The contents of the ribolyser tubes were filtered and 
centrifuged at 3000 rpm for 2 minutes at 4°C into fresh centrifuge tubes. These 
were then centrifuged again at 14000 rpm for 5 minutes at 4°C. The 
supernatants were discarded and the pellet resuspended in 200 µl 1X sample 
buffer, and boiled at 95°C for 10 mins. 
Those samples were later visualized by SDS-PAGE gel and Western blot. 
2.5 S. pombe protein purification 
 Another method for protein extraction was “popcorn” making of the S. 
pombe cells and grinding with liquid nitrogen, allowing larger volumes of cells to 
be processed. The cells were pelleted at 6000 rpm for 5 mins, resuspended in 1 
ml of lysis buffer B (50 mM tris pH7.5, 250 mM NaCl, 50 mM NaF, 5mM EDTA, 
0.1% NP40) added with 1 tablet/50 ml Complete protease inhibitors EDTA-free 
(Roche) + 1mM AEBSF (Sigma). The samples were centrifuged again (3000 
rpm, 5 mins) and the pellets were thoroughly resuspended in buffer B with 
protease inhibitors, before being solidified drop by drop in liquid nitrogen. The 
“popcorn” samples were then grinded for 3 cycles of 2 mins at full power in 
tubes with a magnet, kept in liquid nitrogen. The supernatant was recuperated 
after centrifugation at 4000 rpm for 15 mins at 4°C. 
 Firstly, Co-immunoprecipitation was used with antibody-coated Dynabeads 
(Protein G, Invitrogen) to pull-down the CFP and YFP tagged endogenous 
proteins with the anti-GFP antibody (the cross-talk of the anti-GFP antibody 
allows to target CFP and YFP). The protocol provided by the manufacturers 
was followed. Cell extracts were incubated for 2 h with the anti-GFP dynabeads, 
washed 3 times with lysis buffer B, followed by elution in boiling sample buffer. 
 But as the yield was not enough, as well as the options for native elution 
was limited, the anti-GFP trap system (Chromotek) was used. The specificity of 
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the GFP-trap is extremely high, allowing purifying the endogenous protein from 
S. pombe. Both GFP-trap bound to agarose beads and magnetic beads were 
tried, but the following protocol is based on the agarose beads. 
The cells pellets were treated with lysis buffer (10 mM Tris-HCL pH7.5, 150 mM 
NaCl, 0.1% SDS, 1% Triton X-100, 5 mM EDTA, 1mM AEBSF and Complete 
protease inhibitors) centrifuged at 20 000 g for 10 mins at 4°C, and the 
supernatants were transferred to a pre-cooled tube followed by addition of 1 ml 
of dilution buffer (10 mM Tris-HCL pH7.5, 150 mM NaCl, 0.5 mM EDTA, 1mM 
AEBSF and Complete protease inhibitors). The beads were washed twice and 
resupended in dilution buffer, followed by addition of the cell lysate. Incubation 
of the GFP-Trap and cell lysates was done for 2 hours on a rotor at 4°C. The 
beads were then washed twice with ice-cold wash buffer (10 mM Tris-HCl 
pH7.5, 300 mM NaCl, 1mM AEBSF and Complete protease inhibitors) and 
native elution was done by adding 50 µl of 0.2 M glycine pH 2.4, incubated for 
30 seconds, and neutralized by 5 µl of 1 M Tris-base (pH 10.4). The purification 
was verified by SDS-PAGE gel, where the input, non-bound, washes, elution 
and native elution were loaded and observed by coomassie stain and western 
blot. The eluted native proteins were kept in aliquots at -20°C. 
III.  E. coli protocols and E. coli protein 
Expression/Purification 
1.  Preparation of competent E. coli cells (DH5α, BL21(DE3), BL21-
CodonPlus(DE3)) 
 A single colony is grown to saturation overnight at 37°C in 5 ml of LB 
(BL21 strains require 34 µg/ml of chloramphenicol). The preculture is used to 
inoculate a pre-warmed 1 L culture of LB, and grown with shaking until the 
O.D550nm is approximately 0.6. The cells were chilled on ice and in the cold room 
for 1 hour followed by centrifugation at 5000 rpm for 5 mins at 4°C. The cell 
pellet was resuspended in 25 ml of cold TRNS1 solution. 
After a short incubation of 5 mins, the tubes are centrifuged at 3000 rpm for 5 
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mins at 4°C, and the pellet resuspended again in 25 ml of cold TRNS1 solution. 
An incubation of the tubes on ice in the cold room for 1-2 h is then followed by 
centrifugation at 3000 rpm for 5 mins at 4°C, and the cells resuspended in 8 ml 
of cold TRNS2. The samples were incubated for 10 mins, followed by aliquoting 
in 100-300 µl and snap-frozen by liquid nitrogen in order to be stored at -80°C. 
TRNS1 (adjusted to pH 5.8 with acetic acid and filter sterilized) 
RbCl: 12.1 g/l 
MnCl2: 9.6 g/l 
CaCl2: 1.48 g/l 
CH3COONa: 2.88 g/l 
Glycerol: 66 ml/l 
 
TRNS2 (adjusted to pH 6.8 with acetic acid and filter sterilized) 
RbCl: 1.2 g/l 
CaCl2: 11 g/l 
MOPS: 2.1 g/l 
Glycerol: 66 ml/l 
 
2.  E. coli transformation 
 Competent E. coli cells were thawed on ice, DNA was added and 
incubated for 10-30 mins on ice before bacteria were heat-shocked at 42°C for 
60-90 seconds. Cells were incubated on ice further for 5 mins, followed by 
addition of 1ml of pre-warmed LB (or SOC) and the reactions were incubated at 
37°C for 1 h. 100µl and 900µl were plated onto LBA plates with the appropriate 
selective antibiotic and grown over night at 37°C. 
3.  Plasmid DNA preparation 
 Minipreparations of plasmid DNA were based on the Qiagen protocol. 2-5 
ml of E. coli cultures were grown overnight at 37°C in LB supplemented with the 
appropriate selective antibiotic. The cells were then pelleted (1 min, 13 000 rpm, 
room temperature) and resuspended in 200 µl P1 (50 mM Tris-HCl pH8.0, 10 
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mM EDTA, 100 µg/ml RNaseA), followed by addition of 300µl of P2 (200 mM 
NaOH, 1% w/v SDS). The samples were incubated at room temperature for 5 
mins. Next, 300 µl of P3 (3M KAC pH5.5) were added, and the samples were 
incubated on ice for 10 mins. The tubes were centrifuged (10 mins, 13000rpm, 
4°C) and the supernatants were transferred to a new tube and mixed with an 
equal volume of isopropanol. The samples were then incubated for 5 mins at 
room temperature and centrifuged for 10 minutes at 13 000 rpm at 4°C. The 
pellets were washed with 500µl of 70% Ethanol, centrifuged as before and 
resuspended in 20 µl of H2O added with 1 µg/ml of RNaseA. 
In addition Qiagen miniprep kits were used, as well as Machery-Nagel miniprep 
kits. Also, for Midipreps, the Qiagen Midiprep Kit was used and carried out 
according to the manufacturers instructions. 
4.  Cloning for protein purification 
4.1 PCR amplification of DNA 
 In general, the KOD enzyme (Agilent Technologies) was used for DNA 
amplification by PCR, as it is an error-free enzyme. The PCR mixture was: 
DNA: 50-100 ng 
dNTPs: 0.2 mM of each 
Primers: 0.3 µM of each 
KOD reaction buffer: 1x 
MgSo4: 1-6 mM 
KOD polymerase enzyme: 0.02 U/µl 
 
And the PCR program: 
1: Initial denaturation for 2 min at 94°C 
2: Denaturation for 20 seconds at 94°C 
3: Annealing of the primers for 30 seconds at the TM 
4: Extension for of the DNA synthesis for 1 min- 3 
mins at 68°C 
Return to step 2 for cycles of 20-35 
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5: Final extension for 3 mins at 68°C 
 
4.2 Site directed mutagenesis by PCR 
 PCR site directed mutagenesis was done by using primers with 
complementary sequence and containing the mutation of interest in the middle 
of the ~30 nucleotides long primers. The PCR was done with Pfu (Agilent 
Technologies) and the reaction mixture contains: 
 
DNA: 50 ng for 50 µl reaction 
dNTPs: 0.2 mM of each 
Primers: 1 µM of each 
Pfu reaction buffer: 1x 
Pfu Turbo polymerase enzyme: 2.5U/µl 
 
The program used was: 
 
1: 94°C for 3 mins 
2: 94°C for 30 sec 
3: Tm for 1 min 
4: 68°C for 120 seconds/kb of the plasmid 
length 
 
The PCR product was digested with 20 Units of Dpn1 (NEB) for 2 hours at 
37°C, which digest the parental methylated plasmid. The newly amplified 
plasmid containing the mutation was then transformed into E. Coli to provide 
larger stocks by midi-preparation of plasmid DNA. 
 
4.3 Digestion and ligation 
 Following NEB’s guidelines, 1 µg of plasmid DNA was digested in a total 
volume of 30 µl, with 1 µl of restriction enzyme and 3 µl of the appropriate 10x 
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buffer. Digestions were conducted for at least 1 h at 37°C, and verified by 
electrophoresis gel, followed by gel extraction and DNA purification by kits 
(Qiagen, MN). Ligations were done by T4 DNA ligase (NEB) overnight at 16°C 
according to the manufacturer’s guidelines. The vector and insert were ligated 
in a 1:2 – 1:3 ratio, in a mixture of 20 µl total reaction, the vector DNA and insert 
DNA were added (minimum 50-100 ng), along with 2 µl of 10X T4 DNA ligase 
buffer and 1 µl of the enzyme T4 DNA ligase. 
4.4 Classical cloning 
 The classical cloning method involves studying the plasmids maps, and 
using the multiple cloning sites to find appropriate enzymes for potential cloning 
of the gene of interest in the plasmid.  Those restriction enzyme sites are then 
added by PCR on the gene, and upon digestion and ligation the gene of 
interested is inserted in the plasmid. A list of primers used is available in the 
appendix. The expression vectors used were pET3a (Stratagene), pET21a 
(Stratagene), and pET28a (Stratagene). As some problems were encountered 
to clone in the recombinant genes (amplifications, introns, lack of restriction 
enzyme sites…), another method was used, the InFusion cloning (Clonetech). 
For XFP-Suc22R2 cloning, the steps were: first amplification using the primers 
suc22XFP_PET_F (gggaagcttcatatgtctaaaggtgaagaattattcactggt) and 
suc22_PET-R (ggggggatccctaaaatcctcatcgattgtaaatgtatgatc), and cloned into 
pUC19 in order to mutate out the NdeI site in CFP and YFP. Finally it was 
subcloned into the pET3a vector as an NdeI/BamHI fragment. 
4.5 InFusion cloning 
 The In-Fusion HD kit (Clonetech) was also used, following the 
manufacturer’s guidelines. The in-fusion reaction was: 50-200 ng of linearized 
vector, with 10-100 ng of purified PCR fragment with 15 bp overhang homology 
(the ratios plasmid/insert are 1:2 -1:3), 1X of In-Fusion HD Enzyme premix in a 
total of 10 µl. The samples were incubated at 50°C for 15 minutes, followed by 
cooling on ice. Transformaed E. coli cells with the newly in-fused DNA are 
finally plated. 
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4.6 Sequencing 
 Most of the DNA samples, plasmids or genomic-amplified DNA, were 
sequenced by sending the samples to GATC (GATC-biotech). 30-100 ng/µl of 
the DNA along with 30 pmol/µl of the corresponding primer were sent. Available 
programs were used to study the output files. 
5.  Protein expression and solubility  
 Protein expression was done using expression vectors, which are under 
the control of the T7 promoter, activated by the T7 polymerase. The bacterial 
strains BL21(DE3) and BL21-CodonPlus(DE3) (optimized for eukaryotic codon 
expression) were originally from stratagene. Both strains have a copy of the T7 
polymerase gene, under control of the lacZ promoter. The addition of IPTG will 
induce the expression of the T7 polymerase, thus also induce the expression of 
the gene of interest. Expression of the RNR tagged proteins were done in E. 
coli BL21-CodonPlus(DE3) competent cells, and pET3a was used for Suc22R2 
while pET21a was used for Cdc22R1. Determining the protein expression and 
solubility was done by testing different conditions (temperature, incubation 
times…), medias (LB, TB) and protocols.  
 Generally, a single colony (BL21-CodonPlus(DE3) was used to inoculate a 
50-100 ml pre-culture of TB with with 100 µg/ml of carbenicillin and 34 µg/ml of 
chloramphenicol, and left to grow overnight at 30°C. Next morning, a 1-2 L 
culture of pre-warmed TB added with 100 µg/ml of carbenicellin was inoculated 
with the pre-culture, and left to growth at adequate temperature and incubation 
times (see results) to reach an O.D of 0.9-1.2. At that moment, IPTG was added 
at concentrations varying from 0.2 mM to 0.8 mM, and left from 3 h to overnight 
(see results). Cells were centrifuged at 4000 rpm for 10 mins at 4°C and 
resuspended in lysis buffer (50 mM Tris, 250 mM Nacl, 10% glycerol, 20% 
Triton X-100, 1mM DTT, 1mM Orthovonate, 1mM AEBSF, 1 tablet/50 ml 
protease inhibitor cocktail and 50 mM NaF), and sonicated 4 times for 20 
seconds at 40%. The supernatant was obtained after centrifugation for 10 min 
at 14000 rpm at 4°C. To verify the expression as well as the solubility, the pellet 
(soluble) and supernatant (insoluble) were boiled in 4x or 6x Sample buffer and 
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loaded on a SDS-PAGE gel diverging from 6% to 12%. 
6.  Protein purification 
6.1 Classical method  
A classical protein purification method was first tested, following described 
protocols:  
- The supernatant was treated by streptomycin sulfate to precipitate the 
unwanted DNA. 30% w/v of streptomycin sulfate was added slowly, and 
left stirring overnight at 4°C, followed by 30 min centrifugation at 12 000 
rpm, and the supernatant was again treated as the previous step for 24 h 
-   12%, 50%, and 68% ammonium sulfate precipitation was done on the 
supernatant in order to precipitate the protein of interest. The ammonium 
sulfate powder was added slowly while stirring the samples at 4°C, and 
left to incubate 1 h. A sample of each step was loaded on a SDS-PAGE 
gel to assess the different purification steps.  
- Next step was to dialyse the proteins to obtain them in a suitable buffer for 
size exclusion chromatography. The samples were dialyzed (Slyde-a-
lyzer dialysis cassettes, Pierce) against PBS or Tris-HCL pH7 in the cold 
room for 3 h, and overnight in a dialysis buffer volume 500 times larger 
than the sample. 
- Size exclusion chromatography was performed on an AKTA purifier, where 
the column was equilibrated with 10 mM potassium phosphate. Once the 
proteins were loaded on the column, the elution was done by linear 
gradient of 0-500 mM NaCl or 0-500 mM KCL. 
But this method showed to give variable results, with low yield and especially 
precipitation problems at the dialysis step. 
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6.2 Co-Immunoprecipitation (Co-IP) 
 Firstly, anti-GFP bound dynabead (protein G, Invitrogen) were used. The 
beads were washed in PBS-T followed by antibody coating in PBS-T containing 
5µg of anti-GFP antibody for 10 mins at room temperature. Two anti-GFP 
antibodies were tried  (monoclonal and polyclonal from Roche) for 
immunoprecipitation with the cell lysates. The Co-IP was done following the 
manufacturer’s protocol. Cell extracts were incubated for 2 h with the anti-GFP 
dynabeads, washed 3 times with lysis buffer, followed by co-immunprecipitation 
done by boiling the beads in 4x sample buffer. 
 As there seemed to be a weak coating of the beads with the antibody and 
a generally low yield, a kit using already bound anti-GFP magnetic beads was 
used (µMACS epitope tag protein isolation kit). The cell pellets were treated 
with the µMACS lysis buffer (150 mM NaCl, 1% Triton X-100, 50 mM Tris-HCL 
pH8) implemented with 1mM DTT, 1mM orthovanadate, 1mM AEBSF and 
complete proteinase inhbitors. Sonication of the cells by 4 times for 20 seconds 
at 40% was followed by centrifugation for 14 000 rpm at 4°C for 10 mins. The 
supernatant was mixed to the magnetic microbeads, and left for incubation for 1 
h in the cold room. The entire procedure was done in the cold room, where the 
µMACS columns were washed with the lysis buffer. The cell lysate incubated 
with the magnetic anti-GFP beads are then run though the columns, which will 
retain the magnetic beads. The columns were rinsed 4 times with the wash 
buffer 1 (150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 
mM Tris-HCL pH8), followed by a rinse with wash buffer 2 (20 mM Tris-HCL 
pH7.5). The native elution consists of applying 20 µl of 0.1 M triethylamine pH 
11.8, 0.1% Triton X-100 to the column and leave to incubate at room 
temperature for 5 mins. 50 µl of 0.1 M triethylamine pH11.8, 0.1% Triton X-100 
was added to the column, and the eluate was collected in a tube with 3 µl of 
MES pH 3 for neutralization. 
Samples for the input, washes, normal elution and native elution were loaded 
on SDS-PAGE gel and revealed by coomassie staining and immuno-staining. 
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7.  SDS-PAGE and Immunostaining 
7.1 SDS- PolyAcrylamide Gel Electrophoresis 
 The gels for SDS-PAGE were prepared with ProtoGel (30%, 37.5:1 
Acrylamide to Bisacrylamide stabilized solution optimized for SDS-PAGE of 
proteins, National Diagnostics), TEMED: N, N, N’, N’-
Tetramethylethylenediamine, APS: Ammonium persulfate, SDS and Tris. 
Depending on the percentage of the separating gel, the composition for a total 
of 10 ml varied: 
Reagents to add in 
ml 
6% 8% 10% 12% 
H20  5.3 4.6 4 3.3 
30% acrylamide mix 2 2.7 3.3 4 
1.5 M Tris pH8.8 2.5 2.5 2.5 2.5 
10% SDS 0.1 0.1 0.1 0.1 
10% APS 0.1 0.1 0.1 0.1 
TEMED 0.008 0.006 0.004 0.004 
 
The gel solution was poured between glass plates with a separator and once 
polymerized, the gel was washed with water and the stacking gel was poured 
on top. The stacking gel composition for 5 ml is 3.4 ml of H20, 0.83 ml of 30% 
acrylamide mix, 0.63 ml of 1 M Tris pH6.8, 50 µl of 10 % SDS, 50 µl of 10% 
APS and 5 µl of TEMED. 
The gel was left to fully polymerize, mounted on the running apparatus 
(BIORAD) and was loaded with prestained protein markers (NEB), as well as 
the samples of interest. The gels were then run in 1x running buffer (0.025 M 
Tris-HCL, 0.19 M Glycine, 0.1% SDS pH8.6) at 80-120 V for 1-2 hours. 
To stain for total protein, coomassie brilliant blue staining (0.1% w/v Coomassie 
Brilliant blue, 20% Methanol and 10% acetic acid) was used. The gel was 
placed into a tray and stained by heating for 20 seconds in the microwave, 
followed by 15 mins of incubation on a shaker. Destaining was done with 
multiples washes using a solution of 50% methanol 10% acetic acid in water. 
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7.2 Immunostaining (Western Blot) 
 In order to proceed to immunostaining, the SDS-PAGE gels had to be 
transferred onto a nitrocelullose membrane (GE Healthcare) for ~2 h at room 
temperature at 300mM or overnight at 4°C at 10 V in transfer buffer (25mM 
Tris-HCL, 20% Methanol, 192mM Glycine pH 8.3). The membrane was blocked 
with shaking incubation in 3% milk powder in PBS-T for at least 1 hour at room 
temperature or overnight at 4°C. The primary antibody was added at a specific 
dilution factor (mouse anti-GFP 1:4000, Roche) in PBS-T including 3% milk and 
the membrane was incubated for 1 hour at room temperature. The membrane 
was washed trice in PBS-T for 10 minutes. The secondary antibody was added 
(anti-mouse HRP 1:5000) in PBS-T including 3% milk and the membrane was 
incubated for 1 hour at room temperature with agitation. The membrane was 
washed trice in PBS-T for 10 minutes and the bound antibody was detected by 
chemiluminescence (ECL Plus Western Blotting Detection Reagents, GE 
Healthcare). The reaction was detected with a film (GE Healthcare Hyperfilm 
ECL), and was developed with a Xograph Imaging Systems. 
IV.  Microscopy methods 
1.  Cell Sample preparation  
1.1 Cell Sample preparation for imaging on the Zeiss, DV, Confocal 
microscopes 
 Cells were grown in culture at 30°C in YE media (unless otherwise 
specified), with or without drug as specified. HydroxyUrea (HU) was added to a 
final concentration of 20mM, and 4 NitroQuinoline 1-Oxide (4NQO) was added 
to a final of 5 µM, and both were used for 4 hours in the cultures. In case of time 
points (during Cdc25-22 TS synchronization) or heat shock cultures, samples at 
every time point were taken from the cultures. 1 ml of the culture was 
centrifuged to pellet the cells, washed with PBS, and the final cell pellet was 
fixed with 500 µl cold methanol. Cells were spread on glass slides and left to 
dry, upon which the glass slides were rinsed with PBS and dried again. Finally, 
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the mounting agent was added, 50% glycerol 50% water for FRET experiments 
but vectashield-mounting agent (Vector Laboratories) containing DAPI was 
used for other applications. 
 The Zeiss Axioplan and CoreDV were used following the guidelines and 
imaged for the present fluorescence: CFP, YFP, GFP, and DAPI using the sets 
of excitation and emission filters available. For FRET analysis, the fluorescent 
proteins were visualized using a laser scanning confocal microscope (LSM 510, 
Zeiss). More details of the LSM confocal microscope settings will be given. 
1.2 Cells sample preparation for other fluorescence methods 
 In case of imaging cells on the Total Internal Reflection Microscope 
(TIRFM), the cells were grown in EMM media, harvested and washed with PBS. 
This allowed reduction of the auto-fluorescence and performing FRET on live 
cells. 
Cells were sampled the same way for measuring the fluorescence of the CFP 
and YFP tagged proteins in the cells by FACS and fluorometer.  
2.  Fluorescence Resonance Energy Transfer (FRET) 
2.1 Confocal microscope settings 
 A laser-scanning microscope (LSM 510, Zeiss) was used to image and 
perform FRET experiments. The argon ion gas laser is switchable via a long 
pass dichroic beam splitter (in our case either mainly 458 nm or 514 nm were 
used). The excitation laser is directed through a tube lens and objective lens (C-
Apochromat NA 1.2 x63, Zeiss) to the sample. Due to its confocal capacities, 
emission emerging from above and below the plane of focus will be rejected at 
the pinhole and only fluorescence from the focal plane will pass to the 
photomultiplier (PMT) detector. The emissions wavelengths are separated at a 
dichroic beam splitter (545 nm) and filtered through band pass filters: 475-525 
nm for CFP and 530-600 nm for YFP. Photobleaching of the acceptor (YFP) 
was performed by scanning with the 514 nm argon ion laser across a specific 
region of interest (ROI) within a cell (cytoplasm or nucleus) for 1000-3000 
iterations. At satisfactory photobleaching of the YFP (>70%), images were 
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collected in a set of pre-bleach and post-bleach in both the CFP and YFP 
emission spectrum channels. 
2.2 Controls 
Although FRET is a good tool, various controls have to be done to ensure the 
presence of genuine FRET signal:  
- Verification of the natural autofluorescence in non-tagged strains, 
measuring the intensities as well as positive photo-bleaching in both the 
CFP and YFP channels 
- No FRET in the single tagged strains, when the acceptor or donor only is 
present 
- Also, having a positive and negative FRET control for every new day of 
experiment, as there can be unwanted modifications due to the confocal 
microscope 
2.3 FRET imaging and calculation 
 After that, those images were collected and processed in Image-J (NIH). 
Different measurements are done on each image in each channel: 
- Measurement of the background (outside the cell) 
- Measurement of a non-bleached cell area before and after photobleaching 
(provides general photobleaching of the sample, and will allow to 
normalize the images) 
- Measurement of the photobleached ROI, providing the fluorescence 
intensity of the donor pre- and post-bleach (will provide the FRET 
efficiency), as well as the acceptor pre- and post- bleach (will provide the 
% of photobleaching) 
The FRET efficiency can then be calculated and expressed as a percentage: 
 
FRET efficiency % = 1-[(IDA – IAuto)/(ID – IAuto)] x 100 
 
With the parameters being 
IDA = Intensity of the donor in the presence of acceptor (pre-bleach) 
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ID = Intensity of the donor in the absence of acceptor (post-bleach) 
IAuto = background intensity  
 
We also verified the FRET efficiencies using a dedicated Image-J macro, for 
which they corresponded. 
3.  Live cell imaging 
The pDV, a wide field microscope, was used with a 100x magnification 
and 1.40 oil objective. Three channels were used: DIC, CFP and YFP with the 
appropriate filter. The microscope was housed in a climate control chamber with 
the temperature set to 30˚C. The transmission and exposure times were tailored 
to each channel to achieve the best signal without damaging the cells. Various 
systems were used for immobilizing live S. pombe cells: agar pads, 
ConcanavallinA (ConA, Sigma) coated chambers (Lab-tek), and microfluidics 
chambers (CellAsic).  
The CellAsic (Imsol) microfluidic chambers were chosen as they allow 
performing long imaging with the possibility of constant fresh media flowing as 
well as addition of drugs at different times points. The preparation of the 
microfluidic chambers were used following the manufacturer’s guidelines, with 
many washes using sterile water as well as YE medium. The strains of interest 
were grown overnight in 100 ml at 30˚C to obtain the required cell concentration 
(1x106 - 2x107 cells per ml) for loading on the microfluidic plates.  
The software was programmed as indicated by the manufacturer’s 
guidelines with a constant flow of media for 2-10 h. Imaging required some 
initial calibration to ensure no photo-damage was done to the cells, but still 
aiming to obtain reasonable quality images. At least 4 points per cell chamber 
were imaged through 20 z-stacks every 10 or 30 mins. Post-imaging process 
were done, including Z-stacking, deconvolution, and denoising softwares were 
applied. 
4.  Proteins preparation 
 The purified proteins were prepared for the various single molecule 
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methods used. The protocols were experimental and I will only present the most 
optimal ones. 
4.1 Fluorescence Correlation Spectroscopy (FCS) 
 The native purified recombinant proteins were thawed on ice and diluted 
with filtered PBS to the single molecule concentration established previously. In 
the case of proteinase K addition, 50% v/v was added to the protein and left to 
incubate at 37˚C for 1 h. The corresponding control of the same reaction but 
without the proteinase K was done to prove the direct effect of the proteinase K 
on the purified proteins. Denaturation of the proteins was done by heating at 
95˚C for 1 h and snap-freeze on ice.  Hydroxyurea, Salts (MgCl2, NaCl) and 
other reagents were tried. 
 For the antibody binding experiments, increasing concentrations of 
antibody were added to a constant concentration of purified proteins. The total 
volume remained the same, and they were all incubated for at least one hour. 
The interpretation columns show the sample and the theoretical bound 
population of anti-GFP to the purified CFP- or YFP-tagged proteins. The mock 
purification (the empty vector) was also mixed to the antibody to ensure the 
specificity of the binding; as well as unrelated antibodies to the purified proteins 
were tested as additional negative control. 
 
Sampl
e 
Protein at 0.4 mg/ml in 
µl 
Anti-GFP at 0.4 mg/ml (Ab) 
in µl 
PBS in 
µl 
Interpretation 
1 0 20 20 Ab alone 
2 10 0 30 Protein alone 
3 10 2 28 9% bound 
4 10 4 26 20% bound 
5 10 7 23 32% bound 
6 10 9 21 42% bound 
7 10 11 19 51% bound 
8 10 13 17 60% bound 
9 10 15 15 70% bound 
10 10 17 13 80% bound 
11 10 20 10 93% bound 
12 10 22 8 100% bound 
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13 10 30 0 Saturation 
14 10 10 + 10 of 2nd antibody 10 Secondary 
 
The FCS microscope is a custom-built confocal microscope, using 532 nm for 
the excitation and 593 ± 40 nm as emission filter for YFP fluorescence. The 
detector is a photon counting TSPC. 
4.2 Total Internal Reflection Fluorescence Microscope (TIRFM) 
 The preparation of the purified proteins for the TIRFM was mainly done for 
the photobleaching step assay. Pre-cleaned cover slips for single molecule 
studies were used. First, a drop of 500 µl of 0.01 mg/ml of antibody is incubated 
for 15 mins, followed by two washes with filtered PBS with 5% of BSA (NEB) 
and a further 15 mins of incubation. The cover slip was washed with filtered 
PBS, and the purified protein was left to incubate for 30 mins on the coverslip. 
Alterations can be done to the protocol without affecting the assay.  
The controls effectuated here were the antibodies alone, the BSA alone, as well 
as the PBS 5% BSA solution. The mock protein purification also allowed 
assessing the background, and imaging the protein in various channels 
provided the specificity of the signal. 
The near TIRFM is a custom-built microscope inverted microscope coupled to a 
mixed gas ion tunable laser. Using the adequate microscope setting (ex.458 
nm, filters 457 nm and 514 nm) the images were taken by an I-CCD camera. 
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CHAPTER III  Ribonucleotide Reductase 
(RNR): Dynamic regulation and 
architecture 
I.  Introduction: The architecture and dynamics of RNR   
Although discovered and described in the fifties (Reichard & Estborn, 
1951) (Reichard et al, 1961), many questions remain with regards to the 
accurate stoichiometry ratio, conformation and general architecture of the 
enzyme RiboNucleotide Reductase (RNR). In S. pombe, while the regulation of 
RNR through transcription control (induced during S-phase, and after DNA 
damage) (Liu et al, 2003) (Liu et al, 2005) (Hankansson et al, 2006b) and cell 
cycle checkpoint control through the RNR regulator Spd1 (Liu et al, 2005) 
(Nestoras et al, 2010) is well described, the regulation of RNR by architectural 
modification has yet to be fully understood.  
 
Originally RNR was described as a heterotetramer: 2x R1 and 2x R2 
(α2β2), but recently many reports of higher order oligomers formed upon 
activation, and inhibition have been published (Kashlan et al, 2001) 
(Rofougaran et al, 2008a) (Fairman, 2011). Higher order oligomerization is one 
of the keys for a better understanding of this essential enzyme’s activity and 
regulation. 
The big RNR subunit R1 (α) needs to be at least in a dimeric conformation. 
Diverse allosteric regulation sites are present on R1. The overall activity site 
(ATP cone domain) which binds ATP (activator) or dATP (inhibitor) regulating 
general RNR activity. This activity site is positioned at the N-terminus (Cotruvo 
& Stubbe, 2011).  
The C-terminal part of R1 is structurally flexible and contains the other important 
features of R1, the specificity site and the catalytic site. The specificity site binds 
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dNTPs to allow a balanced supply of dNTPs to the cell of dNTPs and is found 
near the dimerisation domain. The catalytic site with the active dithiols (-SH) is 
important for the NDP reduction (Hofer et al, 2011). Finally, “loop 2”, a major 
determinant for specificity regulation by conformational flexibility, is also found 
near the dimer interface. 
The small subunit R2 is also active as a dimer, and each monomer 
contains a binuclear ferric iron centre that generates and maintains the tyrosyl 
radical (Y•) essential for the enzyme’s activity (Hofer et al, 2011). Tyr122 is 
buried some 10 Å (1nm) inside the structure and therefore cannot interact 
directly with R1, thus the need for the active cysteines network of R1 to transfer 
the electron from the tyrosyl radical on R2. The distance between the tyrosyl 
radical (Y•) site of R2 and the thiyl radical site of R1 is ~35 Å or 3.5 nm (Zhang 
et al, 2011). 
The free radical is essential to have an active enzyme, and its loss transforms 
the protein in a “metR2”, leaving the iron center intact, whereas an “apoR2” has 
lost both the iron centre and the free radical (Stubbe & Cotruvo Jr, 2011). 
In addition to the unclear conformational status, there are uncertainties 
about the stoichiometry of RNR. Different heterocomplexes have been 
described between species with a wide range differences for the active and 
inactive states of the enzyme. The classical proposed model is α2β2 (Thelander 
& Reichard, 1979), but recent studies have modified this model. In mice 
(Rofougaran et al, 2006), the α6β2 complex has been described as being the 
primarily active enzyme form. In addition, a α6β6 form has also been portrayed 
in mouse after addition of gemcitabine (Wang et al, 2009). In humans α6β2 is the 
major form present, especially after inactivation. Similarly in S. cerevisae, α2β2 
is the inactive form described in vitro, but the active form in yeast has not been 
fully described yet (Ando et al, 2011). In contrast, studies have demonstrated 
that in E. coli, RNR forms α4β4 complexes (Rofougaran et al, 2008a) 
representing the inactive form. 
The architecture of RNR clearly deserves further investigation in order to 
understand its tight regulation. In S. pombe, RNR is part of the class Ia of the 
RNR classification (as most eukaryotes) and the big subunit is called Cdc22R1 
(β) while the smaller subunit is Suc22R2 (α). 
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II.  Ribonucleotide Reductase subunits labelled with 
fluorophores: Characterization and Quantification  
In order to study the RNR subunits, the genes suc22R2 and cdc22R1 were 
tagged with CFP and YFP fluorophores (Nestoras et al, 2010). Suc22R2 is 
labeled at the N-terminus, as the C-terminal tagging causes lethality to the 
strain, which is not surprising, as it is known that the C-terminus of Suc22R2 is 
most probably necessary for interaction with Cdc22R1. Cdc22R1 is tagged at the 
C-terminus, which should not disrupt the ATP cone domain at the N-terminus, 
which is important for different functions (Lee et al, 2008). 
In both cases, a linker is present between the protein and the fluorescent 
tag, which confers flexibility to the structure between the proteins and the 
fluorescent tags. The strains used in this study are shown in Figure III.1. The 
parameters used to image the cells with the use of the confocal Zeiss LSM 
throughout the experiments are described in the figure legend. 
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Figure III. 1 Images of CFP-Suc22R2 Cdc22-YFPR1 strain and YFP-Suc22R2 Cdc22-CFPR1 strain 
Example of images of both S. pombe strains used throughout the experiments: both subunits of 
the RNR tagged with the fluorophores CFP or YFP. Images were collected with a 63x objective 
lens (N.A 1.2) on a confocal microscope (LSM500, Zeiss) in bright field DIC, CFP channel (band 
pass filer 475-524 nm) and YFP channel (band pass filter 550-650 nm), after excitation with a 
458 or 514 nm Argon laser. Images were processed in Image-J as well as the provided program 
of the confocal (Zeiss LSM). 
 
The relative intensities of both subunits were measured (Figure III.2), and 
compared between S-phase cells and G2 phase cells in the different sub-
cellular compartments. Cdc22R1 showed little difference in intensity throughout 
the cell and cell cycle phases  (around 100 to 170 arbitrary units).  
On the other hand, Suc22R2 has quite dynamic and fluctuating protein 
intensities. In S-phase cells, the levels of Suc22R2 in the cytoplasm are 
comparable with the levels in the nucleus. Also, Suc22R2 has about half the 
fluorescence intensity of Cdc22R1. Suc22R2 protein concentration in G2-phase 
cells is quite distinctive, with only a fraction of the Suc22R2 proteins in the 
cytoplasm, and the rest of the Suc22R2 being nuclear. All these measurements 
are similar to semi-quantitative measurements done by SDS-PAGE gel with the 
double-tagged strain. Indeed the small RNR subunit Suc22R2 is about half as 
concentrated than Cdc22R1 when detected by immunostaining after SDS-PAGE 
Gel. 
Taking into account that S. pombe cells are mostly in G2 phase, Suc22R2 can 
be considered typically nuclear. 
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a. 
b.  
Figure III. 2 Comparison of the RNR subunits intensities in S-phase cells and G2-phase cells in 
both compartments 
a. Measurements of the intensities are in arbitrary units (a.u) done in specific ROI (regions of 
interest) followed by average and standard deviation calculation. Cells were visually 
distinguished and categorized, and measurements done in the different strains of single tagged 
RNR subunits i.e.. RNR subunits tagged with either CFP or YFP. 
Cdc22R1 is localized throughout the cell, without significant difference about the localization in 
the nucleus versus cytoplasm during the cell cycle. 
Suc22R2 is localized in the whole cell but is predominately present in the nucleus in G2 phase. 
b. Immunostaining of the RNR tagged proteins: TCA extract followed by loading of the samples 
on SDS-PAGE gel. The protein extract of RNR double-tagged strain CFP-Suc22R2 Cdc22R1-
YFP, and single tagged strains CFP-Suc22R2 and Cdc22R1-YFP are then immunostained by 
anti-GFP (recognizes CFP and YFP) indicating the endogenous levels of the RNR tagged 
proteins. Indeed, the smaller subunit Suc22R2 (expected around 75 kDa) is approximately half 
the level of the big subunit Cdc22R1 (expected around 119 KDa). Immunostaining done in 
collaboration with Dr. Adam Watson. 
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III.  Fluorescence Energy Transfer (FRET) assay between the 
RNR subunits  
The FRET experimental set up is illustrated Figure III.3. CFP-Suc22R2 is 
present throughout the cell but mostly in the nucleus, whereas Cdc22R1-YFP is 
pan-cellular. Each fluorophore, thus protein, is imaged in a specific channel as 
mentioned before.  
As explained in the introduction, due to an overlap in the emission of the donor 
and the excitation of the acceptor, an energy transfer will be possible between 
the donor and acceptor fluorophores. But a few conditions need to be met: if the 
fluorophores are at a larger distance than 10 nm, or are not in an aligned dipole 
conformation, there will not be an energy transfer from the donor to the 
acceptor. Our chosen method is the Acceptor Photobleaching Fluorescence 
Resonance Energy Transfer. Once the acceptor is photobleached, there will be 
a decrease in the acceptor’s channel (in our case YFP). In addition, there will be 
a slight decrease in the donor channel (CFP) due to overlap of spectrums and 
bleed-through between the channels. This inter-fluorophore bleed-through has 
been previously characterized (Wang et al, 2010). As a result, in case of no 
FRET there will be a decrease in the fluorescent intensity in both channels.  
 
On the contrary, if the fluorophores are closer than 10 nm and in the 
correct alignment, there will be an energy transfer between the donor (CFP) and 
acceptor (YFP). This time, after photobleaching of the acceptor (YFP), there will 
be a decrease in the acceptor channel (YFP) but an increase in the donor 
channel (CFP), as the donor’s emission will increase (Wang et al, 2010). 
The lack of FRET signal does not necessarily mean that proteins do not 
interact, but only demonstrates that all the required conditions for energy 
transfer are not present. Specifically, in our RNR analysis, we know that the two 
RNR subunits are able to interact and that they do, as this is required for cell 
survival.  
In order to include another level of controls in the experiments, we also 
swapped the fluorophores i.e. the donor CFP on the Cdc22R1 and the acceptor 
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YFP on Suc22R2. This strain has then been used in every experiment to verify 
the results.  
 
Figure III.3 Acceptor Photobleaching Fluorescence Resonance Energy Transfer (FRET) assay 
set up between the RNR subunits Suc22R2 and Cdc22R1 in S. pombe. 
Suc22R2 tagged at the N-terminus with CFP is localized throughout the whole cell but 
predominately in the nucleus. In the case of CFP, an excitation source of 458 nm will give an 
emission with a peak at 500 nm. Cdc22R1 is tagged with YFP and localized throughout the cell. 
The fluorophore YFP has an excitation peak at 515 nm and will emit at ~ 530 nm.  
If Suc22R2 and Cdc22R1 are in close proximity and therefore their respective fluorophores are 
within 10 nm, an energy transfer can occur (providing the right dipole conformation of the 
donor/acceptor pair) due to the overlap of the CFP/donor emission spectra and the 
YFP/acceptor excitation spectra. 
If the YFP/acceptor is photobleached with a 514 nm laser, the energy transfer will not occur due 
to inactivation of the acceptor, and the result will be an increase in the donor’s emission 
fluorescence.  
In the case where there is no FRET, the photobleaching will decrease the YFP/acceptor 
fluorescence as well as slightly decrease the CFP fluorescence due to the overlap of spectra 
(bleed-through). 
 
Next Figure (fig. III.4) is an example of images of the acceptor 
photobleaching FRET assay, in a set of images taken in each channel before 
and after bleaching. In this example, the strain is CFP-Suc22R2 Cdc22R1-YFP, 
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and the FRET between both RNR subunits is positive. As shown in the previous 
diagram, after photobleaching of the YFP/acceptor, there is a decrease in the 
YFP channel. Whereas in the CFP channel, those bleached regions have now 
an increased intensity in the CFP channel. Arrows mark the regions of interest 
(ROI). 
 
Figure III.4 Image of the donor photobleaching FRET experiment in the CFP-Suc22R2 Cdc22-
YFPR1 strain 
Images were taken on a confocal microscope (LSM500, Zeiss): A set of images consists of pre-
bleach images in the CFP channel (band pass filer 475-524 nm) and YFP channel (Band pass 
filter 550-650 nm), as well as images after bleaching, again in each channel. The bleaching is 
done in a ROI (region of Interest) at 514 nm for 2000-6000 iterations.  
In this case, the increase of fluorescence in the CFP channel is very clear, as shown by arrows, 
and corresponds with the photobleached zones in the YFP channel. Measurements of the CFP 
fluorescence pre- and post- bleach are then used to calculate the FRET efficiency.  
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IV.  Ribonucleotide Reductase complex formation measured 
by Suc22R2 and Cdc22R1 FRET throughout the cell cycle in 
distinct cell compartments 
Sets of images such as those previously shown (fig. III.4) were used to 
calculate the FRET efficiency by measuring the intensity in both channels 
before and after bleaching in the regions of interests. General photobleaching of 
the cells as well as background autofluorescence are taken into account in the 
calculations, as described in material and methods. Also, this method of FRET 
calculation cannot be considered quantitative per se; but considering the 
numbers of repeat and the consistency of the FRET efficiencies, they can be 
used as semi-quantitative estimates. The FRET efficiency between Suc22R2 
and Cdc22R1 were measured specifically in the cytoplasm and the nucleus. In 
addition, distinction was made between S-phase cells and G2-phase cells 
(Figure III.5).  
We aimed to use the FRET experiment to observe the fluctuation of the 
RNR activity throughout the cell cycle and therefore we expected to have 
positive FRET between the RNR subunits in the cytoplasm, specifically of S-
phase cells. During the S-phase, the RNR complexes are thought to be 
assembled and activated in the cytoplasm (due to R2 re-localization to the 
cytoplasm) in order to provide dNTPs to the cell during DNA replication. We 
were surprised to observe a positive FRET between the RNR tagged subunits, 
in the cytoplasm as well as in the nucleus. In addition, the FRET signal was also 
positive during the whole cell cycle. 
 In general, the FRET efficiency was around 35% in the cytoplasm of 
both S-phase cells and G2-phase cells. In contrast, we had not expected to 
detect a positive FRET signal between the RNR subunits in the nucleus, where 
it was not thought that they would interact. Although it has to be considered that 
the upper layer of the ROI can be composed of cytoplasm, the observation of 
positive nuclear FRET signal in G2 cells and S-phase cells, when Suc22R2 is 
largely relocated to the cytoplasm, is interesting. 
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Considering the levels of each subunit as described before (Figure III.2), there 
is some discrepancy between Suc22R2 levels and the FRET efficiency, as there 
is relatively little Suc22R2 present in the cytoplasm in G2-phase cells, but still a 
high FRET signal is observed. On the contrary, there is much more Suc22R2 
present in the nucleus, while the FRET efficiency is then lower.  This FRET 
efficiency increases in the nucleus during S-phase when Suc22R2 re-localizes to 
the cytoplasm. 
 
Figure III. 5 FRET efficiencies between CFP-Suc22R2 and Cdc22R1-YFP in different cell 
compartments during the cell cycle 
The FRET efficiencies have been calculated by keeping the measurements separate for cells in 
S-phase or in G2-phase (as distinguished by the stage of cell division and nucleus). In addition, 
the measurements in the nucleus and the cytoplasm have also been separated. 
The FRET efficiency is positive in all cases, thus demonstrating an interaction (formed complex) 
between Suc22R2 and Cdc22R1 at all times, both in the cytoplasm and the nucleus. 
 
Thus, it can be said that there is an interaction and potential complex formation 
between Suc22R2 and Cdc22R1 at all times, in both compartments of the cell, 
contrary to what was thought: i.e. active RNR complex in the cytoplasm only 
during DNA replication  (S-phase); and after DNA damage of G2 phase cells. 
These results provide a novel insight of the complexity of the formation and 
regulation of the Ribonucleotide Reductase enzyme. 
The positive FRET signal in both cell compartments during the cell cycle was 
also verified in collaboration with Dr Asma Mohammed on live cells using 
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another microscope (TIRFM) with similar levels of FRET efficiencies. (Figure 
III.6) 
 
Figure III. 6 FRET efficiencies between CFP-Suc22R2 and Cdc22R1-YFP in live cells on the near 
TIRFM 
The FRET efficiencies have been calculated as mentioned above, but these cells have not been 
fixed therefore these FRET signal are from live cells. The near Total Internal Reflection 
Microscope (TIRFM) has been used. Although less precise photobleaching is possible, the 
imaging is done by dual channel at very fast acquisition. Two examples are presented in a. with 
the cells in CFP and YFP, before and after bleaching. b. The FRET efficiencies are again 
positive in all cases and to very similar levels to the ones obtained on the confocal microscope 
in fixed cells, thus demonstrating an interaction between Suc22R2 and Cdc22R1 at all times, both 
in the cytoplasm and the nucleus. This has been done in collaboration with Dr. Asma 
Mohammed. 
V.  Ribonucleotide Reductase activity after drug treatment 
Two very distinct drugs were used to observe the effects on the RNR 
complexes measured by FRET. Hydroxyurea (HU), which is a radical scavenger 
and thus inactivates the activity of Suc22R2 required for functional RNR. HU has 
been used extensively to inhibit the RNR, resulting in depletion of dNTPs, and 
subsequent stalling of replication forks, thus blocking cells in S-phase. Some of 
the visual characteristics when using HU are a clear re-localization of Suc22R2 
from the nucleus to the cytoplasm as well as an elongation of the cells due to 
the cell cycle arrest (see Figure III.7).  
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The second drug used is 4-Nitroquinoline 1-oxide (4NQO): a DNA damaging 
agent that causes DNA adducts. It is considered to be a UV mimetic leading to 
the damaged DNA being repaired by the nucleotide excision repair (NER) 
pathway .  
When treating the strain CFP-Suc22R2 Cdc22R1-YFP with 4NQO, a noticeable 
elongation of the cells length is observed, however in contrast to HU, the RNR 
small subunit Suc22R2 remains clearly nuclear. This is an important observation, 
as it demonstrates that the hypothesis of Suc22R2 re-localization to the 
cytoplasm after DNA damage is not applicable in these circumstances. 
From the images presented in Figure III.6, we can observe that after HU 
treatment there is no FRET (clear decrease in the CFP channel). Whereas after 
treatment with 4NQO, there is a clear FRET signal, indicated by an increase in 
the CFP channel. 
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Figure III. 7 Images set of the FRET experiment in the CFP-Suc22R2 Cdc22-YFPR1 strain after 
treatment with hydroxyurea (HU) and 4NQO 
Images were taken on a confocal microscope (LSM500, Zeiss) as described in Figure III.4, and 
the FRET analyzed by Acceptor Photobleaching. The cells treated with hydroxyurea (radical 
scavenger) for 4 hours at 20 mM have a decrease in fluorescence intensities in both channels in 
the ROI, indicating no FRET. Cells treated with 4 Nitroquinoline 1-oxide (a UV mimetic inducing 
DNA lesions) for 4 hours at 5 µM, maintain the Suc22R2 nuclear (in opposition with the HU). The 
cells also show an increase in the CFP fluorescence (donor) after bleaching of the YFP 
(acceptor) indicating the occurrence of FRET.  
 
Figure III. 8 FRET efficiencies between CFP-Suc22R2 and Cdc22R1-YFP after treatments with 
HU and 4NQO 
As shown before, the CFP-Suc22R2 and Cdc22R1-YFP strain displays positive FRET signal 
(around 38% FRET efficiency). This FRET is lost after treatment with hydroxyurea (a radical 
scavenger) for 4 hours at 20 mM. Whereas after treatment of the cells with 4 Nitroquinoline 1-
oxide (a UV mimetic inducing DNA lesions) for 4 hours at 5 µM, the FRET signal is maintained. 
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These experiments have been repeated in the YFP-Suc22R2 Cdc22-CFPR1 strain, where the 
fluorophores tags have been swapped. 
The graph shown in figure III.8 is the comparison of the FRET 
efficiencies of the subunits Suc22R2 and Cdc22R1 after treatment with the 
indicated drugs. Consistent with previous data, in case no treatment, the FRET 
efficiency is approximately 40%, which is lost upon treatment with HU 
(treatment of 4 hours at 20 mM). The negative FRET efficiency value represents 
the decrease in CFP fluorescence due to the bleed-through of the channels.  
This negative FRET signal could be explained by the scavenging activity of HU, 
and thus inactivation of Suc22R2. How precisely HU affects the FRET is not 
entirely clear: it could be that the loss of the tyrosyl radical in the Suc22R2 
affects the structure of the subunit, and induce a change in conformation, which 
will therefore affect the energy transfer. It has been described that the apoR2 
and metR2 have a different structure of the iron centre. An alternative 
explanation could be a change in oligomerization where the stoichiometry of 
dimer Suc22R2 is modified.  
After treatment with 4NQO (4 hours at 5 µM), the FRET efficiency is 
positive and the FRET efficiency is comparable to the efficiency before 
treatment. This is consistent with the DNA damaging activity of 4NQO, and the 
need for dNTPs for repair.  
VI.  Verification of the effect of HU in G2 arrested cells 
In order to investigate further the effect of HU on the FRET assay, cells 
were arrested in G2 phase using a temperature sensitive mutant Cdc25-22. 
The cells are kept at 36°C for 3 hours resulting in a population of cells 
synchronically blocked in G2. This was verified by FACS profile in addition to 
septation index monitoring. Cells were blocked in G2 and while a control culture 
was not treated with HU, the other culture was treated with HU in the same 
conditions as described before. Samples for the FRET assay were taken every 
30 mins, as well as for FACS analysis.  
In the control experiment, it is clear that there is FRET between the two RNR 
subunits, during the whole experiment (Figure III.9). 
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 Whereas in the cells treated with HU at time 3h, the FRET signal is lost, and 
becomes negative. This effect is independent of S-phase and could represent a 
direct effect of HU inhibiting RNR consequently modifying the energy transfer 
from YFP-Suc22R2 to Cdc22R1-CFP fluorophores.  
Also, there is a clear nuclear localization of Suc22R2 even after HU treatment, 
whereas Suc22R2 is usually relocated to the cytoplasm upon HU treatment after 
checkpoint activation and degradation of Spd1. In this case, cells are in G2 
phase thus Suc22R2 is nuclear.  
 
 
Figure III. 9 FRET measurements of synchronized cells arrested in G2 treated with HU  
The YFP-Suc22R2 and Cdc22R1-CFP strain has been crossed with the cdc25-22ts mutant, 
allowing G2 arrest of the cells at 36°C. FACS profile shows the correct G2 arrest of the cells 
(samples taken every 30 mins from the shift to 36°C), and the color-coded FRET on the side is 
the result of the FRET experiment using the same sample (green: positive FRET, red: negative 
FRET). HU was added to the cells arrested in G2 (at time 3 hours) and almost instantly the 
FRET signal was lost. This experiment shows that the loss of FRET signal is most probably due 
to the action of the HU directly on the Suc22R2, and S-phase independent. In parallel non-
arrested cells were assayed to verify the correct cell cycle of these cells. 
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VII.  FRET assay of the RNR homo-complexes of subunits 
Suc22R2 and of Cdc22R1 in diploids strains  
To have a clearer view of the RNR complex as well as the stoichiometry 
ratio of each of the subunits and their modifications, diploids strains were made 
to perform FRET. The diploid strains have each Suc22R2 subunit tagged, one 
with the FRET donor and the other with the acceptor.  Another diploid strain 
was constructed to achieve Cdc22R1 homo-FRET. Using ade6 intragenic 
complementation (as explained in chapter II), CFP-Suc22R2 YFP-Suc22R2 
diploid strains were made as well as Cdc22R1-CFP Cdc22R1-YFP strains.  
In Figure III.10, part a., images show the cells of both diploids strains, and 
below (part b.) the results of the FRET: Suc22R2 subunits do interact closely 
enough for FRET to occur between the donor (CFP) on one monomer of 
Suc22R2 and the acceptor (YFP) on the monomer copy of Suc22R2. This 
indicates that the complexes of Suc22R2 seem to be a close dimer. However, 
the Cdc22R1 diploids strains do not FRET. We do know that Cdc22R1 subunit 
does form a multimer, but it is possible that due to its large size and unknown 
stoichiometry (2, 4 or 6 subunits) the FRET pair fluorophores are too far apart 
for FRET to occur.  
Once quantified (Figure III.10 part b.), it is clear that the FRET observed in the 
Suc22R2 homo-dimer complex is reasonably high efficiency (around 30%) and is 
observed in the nucleus as well as in the cytoplasm. 
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        a. 
b.  
Figure III. 10 FRET measurements in Suc22R2 and Cdc22R1 diploids: images and FRET 
efficiency   
Diploids strains have been made (using the ade6 intragenic complementation) in order to have 
CFP-Suc22R2 YFP-Suc22R2 and Cdc22R1-YFP Cdc22R1-CFP, which are potential tools to 
observe the FRET between the subunits in the formation of homocomplexes. Above (a.), an 
image set of FRET conducted on the diploids strains. In the case of the Suc22R2 tagged with the 
donor CFP on one copy and the acceptor YFP on another protein, there is FRET (quantified in 
b.). Whereas in the Cdc22R1 diploid strain, there is clearly no FRET, allowing us to speculate 
that the distance between the fluorophores is too great or the dipole conformation is incorrect. 
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VIII.  FRET assay between the RNR subunits homo-
complexes after drug treatment 
In order to obtain a better understanding of the effect of the drugs used 
previously on RNR, HU and 4NQO were used on the diploid strains. 
In the case of the Suc22R2 homo-dimer FRET, the FRET signal was positive 
with approximately 30% of FRET efficiency (Figure III.10). After HU treatment, 
this FRET was lost. We can speculate again that the effect of HU on Suc22R2 
could be important, modifying its structure or conformation. As the free tyrosyl 
radical is embedded inside the small RNR subunit’s structure, it could be that 
during the scavenging process, the structure is relaxed and/or the general 
conformation of Suc22R2 is modified.  Another possibility is the modification of 
stoichiometry of Suc22R2. 
In contrast, after treatment with 4NQO, a UV mimetic that will create 
DNA damage thus activate (or hyper-activate) RNR, the positive FRET signal is 
maintained. Suc22R2 might maintain its dimeric form, allowing the energy 
transfer.  
The same drugs have been applied to the diploids Cdc22R1-CFP 
Cdc22R1-YFP (data not showed), but as in the non-treated strain, no FRET is 
observed. 
 
 
Figure III. 11 FRET efficiencies measurements in Suc22R2 diploids strains 
The diploid strain CFP-Suc22R2 YFP-Suc22R2 was used to observe the FRET of the subunits in 
the formation of Suc22R2 homocomplexes. The FRET is positive (28%), translating a close 
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interaction of the small RNR subunits thus possibly form a dimer in vivo. This FRET is lost after 
treatment with hydroxyurea (a radical scavenger) for 4 hours at 20 mM. But, after treatment of 
the cells with 4 Nitroquinoline 1-oxide (a UV mimetic inducing DNA lesions) for 4 hours at 5 µM, 
the FRET signal is maintained. 
IX.  Ribonucleotide Reductase after heat shock 
 The transcriptional response to heat shock is conserved in eukaryotes 
organisms, and is controlled by Heat Shock Factors (HSF). In S. pombe, this 
transcription factor is essential for growth (Gallo et al, 1991). 
It has been described that a suc22R2+ larger transcript (Harris P, 1996 ) 
is highly induced after heat shock (42°C), while cdc22R1+ transcripts are 
reduced. This strong induction of suc22R2+ has been demonstrated to be part of 
a separate pathway from the DNA damage pathway. We wanted to investigate 
how the heat shock might affect the FRET experiments.  
Using the RNR double-tagged strain CFP-Suc22R2 Cdc22R1-YFP, the FRET 
efficiencies between Suc22R2 and Cdc22R1 were compared in cells from 
cultures at 30°C and 42°C (heat shock temperature). Samples were taken every 
20 mins, and the FRET efficiencies were measured in both compartments of 
cells in S-phase or G2-phase (Figure III.12). 
In general, the cells at 30°C show FRET efficiencies consistent with the ones 
measured before: around 40% in the cytoplasm at any cell stage, and around 
15-20% in the nucleus of cells in S-phase, and 5-10% for nuclei in G2 cells. 
After approximately 100 mins of heat shock, the cells exhibit a higher FRET 
efficiency, in particular in cells with septa (S-phase cells). Interestingly after 
shifting the heat shock cultures back to 30°C (at time 145 mins), this FRET 
efficiency is reduced back to the control’s FRET efficiency level. 
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Figure III. 12 FRET efficiencies between Suc22R2 and Cdc22R1 in cell after heat shock at 42 
degrees Celsius 
The different FRET efficiencies have been calculated as described before, and compared in 
parallel with cells maintained at 30°C and cells in heat shocked cultures  (42°C.) Samples were 
taken every 20 minutes and prepared for FRET.  At 145 min, the heat shock cultures were 
shifted back to 30°C.  Interestingly, there is an increase in FRET efficiencies after about 100 
min, which was most apparent in S-phase cells. Furthermore, after the shift to normal 
temperature, the FRET efficiencies revert back to normal levels. 
X.  Ribonucleotide Reductase dynamics during live cell 
imaging 
These experiments aim to visualize the dynamics of the RNR enzyme 
during unperturbed cell cycle but also after addition of various drugs. As there 
were some technical issues with the stability of the focus of the microscopy 
system, only movies of a couple hours were possible, thus not ideal for drug 
treatment yet (over 5 hours necessary). 
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In Figure III.13 part a., although we expected to see Suc22R2 release to 
the cytoplasm during S-phase, we instead observed the constant nuclear 
localization of Suc22R2 throughout the cell cycle. 
We also observed (Figure III.13 part b.) formation of foci-like or aggregations of 
both Suc22R2 and Cdc22R1. We hypothesize that these aggregations could be 
degradation vesicles for the RNR subunits perhaps reflecting some photo-
damage induced aggregation as those foci seemed to be correlated with the 
laser power, strength and frequency of exposure. They are mainly nuclear and 
very dynamic, although they can become cytoplasmic.  
Other hypotheses to explain these observed foci are for example 
replisome/replication factory aggregation. It could be a possibility, and there are 
some reports  that the RNR is required near the replication sites.  The same can 
be said for DNA repair, as RNR could be recruited to the DNA to facilitate the 
repair by providing dNTPs locally . 
In humans, PML bodies have been described as “nuclear dots” and are 
thought to be a vesicle-like formation for recruitment of proteins involved in a 
range of roles including DNA damage response, gene regulation, apoptosis 
(Carracedo et al, 2011) . Although not described in yeast, maybe some similar 
formation could be present. 
Although the foci-like formation are interesting to investigate further, we must 
first verify if there is a correlation between photo-damage and foci formation, as 
it could be a secondary effect of live cell imaging. Then, the study could lead to 
colocalization with the above-mentioned proteins and foci, including the DNA 
repair machinery and the DNA replication proteins. 
a. 
 
 
 
 
 
 
 In vivo structure-mediated regulation of Ribonucleotide Reductase in S. pombe – PhD thesis by Ann-Sofie Schreurs 
 
137 
b. 
 
 
Figure III. 13 Ribonucleotide Reductase subunits dynamics using live cell imaging 
Movies were acquired on the personal DeltaVision (pDV) with a 100x magnification, 1.40 oil 
objective. Three channels were used: DIC, CFP and YFP with the appropriate filter provided. 
Pictures were taken in different Z-levels and stacked afterwards as well as deconvolved. The 
microscope was in a climate control chamber and set to 30˚C and the cells were imaged using 
microfluidics chambers  (CellAsic) with a continuous flow of medium, enabling the cells to be 
theoretically immobilized and focused for over 16 hours. The transmission and exposure times 
were tailored to each channel to achieve the best signal whilst minimizing the damage to the 
cells. Images were taken every 2-10 mins for total times of 2 – 16 hours. 
Presented are snapshots of some movies. The two main observations are: Suc22R2 does 
remain nuclear, even during what approximates for S-phase (a.). Secondly, aggregates of both 
RNR subunits are visualized (b.) in shapes of “foci” or “spots”. Those are at first nuclear and 
very dynamic, but at later times are spread to the rest of the cell.  They could be linked to 
photodamage, thus being assembled in degradation vesicles. 
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CHAPTER IV RNR regulation by Spd1: a 
multiple level regulator 
I.  Introduction: Multiples roles of Spd1 as regulator of the 
RNR 
Spd1 (S-Phase Delayed 1) is a small intrinsically disordered protein 
(IDP) with no fixed tertiary structure (Figure IV.1). Using various predications 
tools to assess the structure of Spd1, the results strongly suggest that Spd1 has 
no regular secondary structure and indeed no fixed tertiary structure. Spd1 is 
mainly unfolded and is an Intrinsically Disorder protein (IDP). This has been 
demonstrated in (Nestoras et al, 2010). 
  Other in silico tools provided some predictions about the small protein 
Spd1: estimation of a possible size (~5 nm on ~3 nm) and a high flexibility of the 
structure (Figure IV.2). IDP have been described to have a low affinity but high 
specificity in order to bind to enzymes in a coupled folding and binding manner. 
The high flexibility of IDP allows conformational changes that could be required 
for enzyme activities. 
 
Spd1 is degraded during S‐phase, after DNA damage and DNA 
replication stress by the Cop9‐Pcu4‐Ddb1 complex (Liu et al, 2003). The 
degradation occurring in S-phase is done through ubiquitylation of Spd1 in a 
Csn1‐ and Csn2‐dependent manner. Whereas in G2 Phase, after DNA damage 
or DNA replication stress, Spd1 degradation requires both the signalosome 
subunits (Csn1 and Csn2), as well as the rad3‐ and chk1‐ dependent DNA 
damage checkpoint (Liu et al, 2003) (Liu et al, 2005).  
Spd1 regulates Suc22R2 nuclear import and also binds to Cdc22R1 in order to 
inhibit it (Hankansson et al, 2006a).  
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Figure IV. 1 Spd1 is an Intrinsically Disordered Protein (IDP) protein 
Using some in silico softwares, Spd1 is indeed a typical IDP with 2 main globular regions linked 
by disorder regions (a), has many regions without fixed secondary structure (b) and is mainly 
unfolded (c). 
 a. GlobPlot: exploring protein sequences for globularity and disorder. Regions with high 
propensity for globularity on the Russell/Linding scale   
b. DisEMBL: LOOPS (regions devoid of regular secondary structure); HOT LOOPS (highly 
mobile loops); REMARK465 (regions lacking electron density in crystal structure)  
c. Foldindex: Regions that have a low hydrophobicity and high charge (either loops or 
unstructured regions) based on Charge/hydropath analyse 
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Figure IV. 2 Predicted structure of Spd1 
Using Phyre2 software, as well as I-TASSER, this figure shows a predicted structure of Spd1. 
Due to its highly disorder nature, the structure cannot be meaningful predicted, but it is however 
interesting to compare the predicted secondary structure with the Spd1 domains. 
In a. the secondary structure is indicated on the amino acid sequence of Spd1, as well as the 
disordered structure. Using this predicted structure, it was possible to visualize Spd1, estimate 
its size and surface. Finally, the known domains of Spd1 are reminded in c. 
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spd1 was deleted using an ura4+ marker, and a few characteristics were 
observable: complete loss of Suc22R2 nuclear localization as well as a normal 
cell cycle, although slightly faster (Figure IV.3). 
 
 
 
Figure IV. 3 spd1 deleted strain simple characterization 
Spd1 was deleted with an ura4+ gene marker (Nestoras et al. 2010), and was characterized by 
2 features mainly: slightly faster growth, as seen on the FACS profile and septation index. 
Suc22-R2 is not localized in the nucleus anymore but spread throughout the cell (fig. IV.4). spd1 
Δ was crossed with the both FRET strains: CFP-Suc22R2 Cdc22-YFPR1 and YFP-Suc22R2 
Cdc22-CFPR1, as explained in material and methods. 
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II.  Spd1 is required for FRET of the RNR subunits 
 When Spd1 is absent, the small RNR subunit Suc22R2 localization is pan-
cellular due to the loss of nuclear import activity of Spd1 (Figure IV.4). The 
FRET experiment was conducted with the expectation to observe an increase of 
interaction between Suc22R2 and Cdc22R1, as the “inhibitor” Spd1 is deleted. 
Although no FRET was observed this cannot mean that there is no interaction 
per se between the different subunits, as the cells would not survive. Instead it 
can be interpreted as a large distance between the acceptor/donor fluorophore 
pair, or not the right dipole alignment resulting most probably from a 
conformational change or modification in the stoichiometry ratio. 
 
Figure IV. 4 Images the FRET experiment in the CFP-Suc22R2 Cdc22-YFPR1 Spd1 deleted 
strain 
In the spd1 deleted strain, Suc22R2 is now throughout the whole cell as is Cdc22R1.  
The decrease of fluorescence in the CFP channel is very clear, as shown by arrows, and 
verified by the photobleached zones in the YFP channel. The bleach in the CFP channel is due 
to the overlap in spectrums of the fluorophores, therefore the FRET efficiency will be negative. 
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III.  RNR FRET experiments in Spd1 Δ  after HU and 4NQO 
treatment 
The negative FRET is quantifiable although its “FRET efficiency” is not 
interpretable. In Figure IV.5, the deletion of Spd1 (Spd1 Δ strain) abolishes the 
FRET signal observed in presence of Spd1. Furthermore; none of the 
treatments with the drugs used previously (HU and 4NQO) change this negative 
FRET result. Clearly, Spd1 is required for some specific architecture of the RNR 
complex allowing it to perform FRET between the fluorophores pairs. 
 
Figure IV. 5 FRET efficiencies between CFP-Suc22R2 and Cdc22R1-YFP in spd1+ wildtype (wt) 
versus spd1 deleted (Spd1 Δ) strains, and after treatment with HU (RNR inhibitor) and 
4NQO (UV mimetic) 
The FRET efficiencies have been calculated as described before, the FRET efficiency is 
positive only in the spd1+ wt strain. In the spd1 deleted strain the FRET signal is lost, and even 
negative due to the overlap of spectrums. But we know that Suc22R2 and Cdc22R1 do bind and 
form complexes, if not the cells would not survive. Thus, the loss of FRET can be explained in a 
few ways: the fluorophores are further apart than 10 nm and/or they are not in the right dipole 
conformation. After addition of the drugs: HU (a radical scavenger) for 4 hours at 20 mM and 
4NQO (a UV mimetic inducing DNA lesions) for 4 hours at 5 µM, the FRET signal is still 
negative. These results have been confirmed with swapped fluorophores tagged on the RNR 
proteins: YFP-Suc22R2 and Cdc22R1-CFP. 
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IV.  RNR subunits homo-dimers and homo-complexes after 
spd1 deletion  
In the spd1 Δ background, diploids strains were made using ade6 
intragenic complementation in order to observe the formation of the homo-
complexes CFP-Suc22R2 YFP-Suc22R2, and Cdc22R1-CFP Cdc22R1-YFP. 
Previously, in the presence of Spd1, the small subunit Suc22R2 probably 
was in a homo-dimer conformation (as observable by the positive FRET signal), 
whereas after deletion of spd1, there has been some alteration, as the FRET is 
no longer positive. Most probably a change in conformation or maybe change in 
stoichiometry ratio modified the fluorophores inter-distance. Considering the 
intrinsically disordered protein Spd1 could act in some ways as a scaffold for 
the RNR complex, the loss of Spd1 could modify the complex of the homo-
dimers of Suc22R2 subunits. 
While with the Cdc22R1 homo-dimer FRET experiments, the result was 
negative FRET in presence of Spd1, it is the same result without Spd1. Not 
much conclusion can be drawn from that observation, apart from the fact that 
the FRET pair is not in a correct condition to perform FRET. 
 
Figure IV. 6 FRET measurements in Suc22R2 Spd1 deleted diploid and in Cdc22R1 spd1 deleted 
diploids  
Diploids strains have been made in order to have CFP-Suc22R2 YFP-Suc22R2 and Cdc22R1-YFP 
Cdc22R1-CFP in addition of Spd1 deletion. This enables us to observe the FRET between the 
subunits in the formation of homo-complexes after deletion of Spd1.  
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In the case of Cdc22R1, there is still no FRET after deletion of Spd1 whereas Suc22R2 subunits, 
which had the capacity to FRET in presence of Spd1, have lost that capacity after deletion of 
Spd1.   
V.  Spd1 mutants  
Using alanine scanning mutagenesis, 41 mutant were made scanning 
the entire spd1 gene . The mutations were made in a group of 3 amino acids 
(see Figure IV.7). The aim was to distinguish domains and functions already 
described, by using those set of mutants in different assays. The inhibition 
capacity of RNR has been measured in the 41 Spd1 mutants, as well as the 
nuclear import function of Suc22R2. In addition the stability of the Spd1 mutants 
were monitored. Later, I will go through those findings and compare them with 
my FRET data. 
I used these mutants and crossed them in an spd1 Δ background with 
both RNR subunits tagged for the FRET assay as described in Chapter II 
Material and Methods. After final verification of the strain, the 41 mutants were 
sequenced to ensure the correct assignments of the mutants. 
 
Figure IV. 7 spd1 mutants 1-41 made by alanine scanning mutagenesis per group of 3 amino 
acids 
This diagram illustrates the 41 spd1 mutants made previously in the laboratory. The 2 identified 
domains (by sequence homology with orthologues) are colored: the HUG domain (green) and 
the R1 domain (purple). These 41 strains have then been crossed with the CFP-Suc22R2 
Cdc22-YFPR1 spd1 Δ as well as the swapped fluorophores FRET strain YFP-Suc22R2 Cdc22-
 In vivo structure-mediated regulation of Ribonucleotide Reductase in S. pombe – PhD thesis by Ann-Sofie Schreurs 
 
146 
CFPR1 Spd1 Δ. These strains have then all been verified and the Spd1 mutants have been 
sequenced. 
 
The FRET experiments have been quantified and are shown in Figure 
IV.8. Of a total of 41 spd1 mutants, 12 did have a positive FRET between 
Suc22R2 and Cdc22R1, whereas the others did not. The positive FRET 
efficiencies of the spd1 mutants are comparable with the spd1 wt strain, 
although Spd1 mutant 8 and mutant 36 have a notably lower FRET efficiency. 
Even though this FRET method is semi-quantitative, this information can still be 
taken into account allowing us to speculate that there might be less complexes 
where FRET occurs or different complexes conformations. 
The spd1 mutants with a positive FRET result are dispersedly covering the 
gene, except maybe for two groups of mutants that are clustered (mutants 2-4 
and mutants 33-36). The other FRET positive strains are the spd1 mutants 8, 
12, 23, 25 and 41. 
It is important to remember that even though two mutants can have the 
same FRET result, they might not have the same conformation or architecture 
to achieve this positive FRET read-out. Thus the FRET does not distinguish 
between different FRET positive conformations. 
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Figure IV. 8  FRET efficiencies between CFP-Suc22R2 and Cdc22R1-YFP in spd1 mutant strains 
The different FRET efficiencies have been calculated as described before; the FRET signal is 
positive in 12 mutants: mutant 2,3,4,8,12,23,25,33,34,35,36 and 41. All of these have FRET 
efficiencies above 25% apart from mutant 8 and 36 who seem to have consistently lower FRET 
efficiencies. 
The other mutants have a negative FRET, meaning that the fluorophores are too far apart or in 
a different conformation, therefore not allowing energy transfer. Most of them were confirmed 
with swapped tags YFP-Suc22R2 and Cdc22R1-CFP (see Figure IV.14) 
 
Most of the spd1 mutants have been crossed in both RNR double-tagged 
strains (CFP-Suc22R2 Cdc22R1-YFP and YFP-Suc22R2 Cdc22R1-CFP) allowing 
us to control our results in a different strain, which were all consistent. 
The images below (Figure IV.9) are examples of some of the spd1 mutants: 
spd1 mutant 2 has no Suc22R2 localization but a clear FRET signal. Mutants 12 
and 25 also have a FRET positive signal observed by CFP fluorescence 
increase in the ROI after photobleaching, whilst the mutant 31 has no FRET. 
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Figure IV.  9 Example of the FRET experiment in some spd1 mutant strains 
Images were taken on a confocal microscope (LSM500, Zeiss) as described before, and the 
FRET experiment also as described previously. Here is an example of 4 mutants: spd1 mutant 
2, 12 and 25 that all have positive FRET. spd1 mutant 31 does not have FRET occurring 
between CFP and YFP. 
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Figure IV. 10 FRET efficiencies comparison in both cellular compartments during the cell cycle 
in spd1 mutant strains  
The different FRET efficiencies have been calculated as described before, discriminating the 
nucleus from the cytoplasm and the approximate cell cycle phase. The FRET efficiency of the 
12 FRET positive mutants has been measured (Spd1 mutants 2,3,4,8,12,23,25,33,34,35,36 and 
41). The different FRET efficiencies are similar, as are the ratios S-phase Nucleus/ S-phase 
Cytoplasm and G2-phase Nucleus/ G2-phase Cytoplasm. Again, there are noticeable 
differences for the Spd1 mutants 8 and 36 as reported earlier, as their FRET efficiencies are 
quite low in each category. 
 
In the same manner than spd1+ wt, the FRET positive spd1 mutants 
exhibit a FRET occurring during all phases in both compartments of the cell. As 
described earlier, it most probably reflects that there are already RNR 
complexes formed and present. The RNR is tightly regulated, but there might be 
some basal activity or some immature complexes present to allow a quick 
response and supply of dNTPs. 
Also, the FRET efficiencies measured of the spd1 mutants are comparable to 
the spd1+ wt. 
VI.  spd1 mutants after treatments  
The same drugs used previously on the spd1 wt strain and spd1 deleted 
strains, were also used on the 41 spd1 mutants in order to investigate the effect 
of each spd1 mutant and RNR regulation after the addition of the drugs. HU 
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(RNR inhibitor) and 4NQO (UV mimetic) were used as described before, 
followed by FRET assay and quantification. 
After addition of HU, none of the spd1 mutants has FRET occurring between 
the RNR subunits (Figure IV.11). Even the 12 spd1 mutants that did undergo 
FRET before treatment lost their ability to transfer the energy between the 
FRET pair (CFP/YFP).  
 
 
Figure IV. 11 FRET signal negative of all spd1 mutants after treatment with HU  
After addition of HU to the spd1 mutant strains, the FRET signal is negative for all of them. This 
is the same result as the spd1 wt strain and the spd1 deleted strain. Knowing that HU is a 
radical scavenger and inhibits the RNR activity, it might affect the structure or the stoichiometry 
of the RNR. 
 
In Figure IV.12 the FRET efficiencies after treatment with 4NQO are 
shown. These have been calculated in S-phase and G2-phase cells, comparing 
the FRET values in the nucleus and the cytoplasm. Also, the positive controls of 
the spd1 wt strain and the negative control of the spd1 Δ strain were used in 
parallel during the FRET experiment as well as for the calculations. 
When DNA damage is induced after 4NQO treatment, all spd1 mutants 
strains do FRET, even the spd1 mutants strains that without any treatment were 
FRET negative. Those have now the ability to perform FRET between the 
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fluorophores. The FRET efficiencies are variable but following the general trend 
of the spd1+ wt FRET efficiencies i.e. higher FRET efficiencies in the cytoplasm 
compared to the nucleus.  
This result could be explained by the fact that after DNA damage the 
RNR complex is more active as the dNTPs levels are increased (Chabes & 
Stillman, 2007). Therefore the RNR complex could be modified into a 
mature/active complex in which the conformation allows FRET between the 
fluorophores.  
Also observable are the different levels of FRET efficiency, some spd1 
mutants (11, 14, 16, 26 especially) have very low FRET efficiency, which could 
reflect a low population of FRET positive RNR complexes. 
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Figure IV. 12 FRET signal positive for all spd1 mutants after treatment with 4NQO  
All the 41 spd1 mutants were treated with a UV mimetic (4NQO) for 4 hours at 5 µM in order to 
induce DNA damage. There is a positive FRET signal in all the spd1 mutant strains; even the 
ones that did not have FRET occurring between the RNR subunits without any treatment.  
The FRET efficiencies were measured and compared in S-phase cell and G2 phase cells, in 
both cellular compartments as described before. In general, the FRET efficiencies of the spd1 
mutants are at similar levels as the spd1+ wt apart from mutants 11, 14, 16, 19, and 26 that are 
very low. Noticeably, the FRET is always more efficient in the cytoplasm. 
 In vivo structure-mediated regulation of Ribonucleotide Reductase in S. pombe – PhD thesis by Ann-Sofie Schreurs 
 
153 
VII.  Suc22R2 nuclear localization in the spd1 mutants  
In order to investigate the correlation between RNR regulation, 
represented in part by the Suc22R2 nuclear delocalization, with the FRET 
results, all the spd1 mutants strains were scored for the small RNR subunit 
Suc22R2 nuclear localization in non-treated and drug treated conditions. 
The same drugs were used i.e. HU (RNR inhibitor) and 4NQO (UV 
mimetic) and 100 cells were scored for clear nuclear accumulation of Suc22R2. 
In an spd1 wt strain Suc22R2 is mainly nuclear (~90%) but after HU treatment 
for 4 hours, this localization is lost and most cells have Suc22R2 localized 
throughout the cell. After HU treatment, Spd1 is degraded leading to Suc22R2 
being relocalized from the nucleus to the cytoplasm. Interestingly, after 4NQO 
treatment, Suc22R2 is nuclear, with similar nuclear localization levels as without 
treatment.  
In the spd1 deleted strain, Suc22R2 is never localized in the nucleus, 
which has been described before (Liu et al, 2003) and is due to the nuclear 
import function of Spd1. None of the treatments modify these observations. 
Finally, the spd1 mutants strains have a vast array of different 
phenotypes: most spd1 mutants behave like the spd1 wt, except mutants 2, 14 
and 26 which have no nuclear localization of Suc22R2. Other mutants for 
example spd1 mutants 10, 11 and 12 have lower Suc22R2 nuclear localization, 
which is quickly lost upon HU treatment. On the contrary, some spd1 mutants, 
for example spd1 mutants 21, 31, 38 – 41 have a stronger Suc22R2 nuclear 
localization after HU treatment than the spd1 wt.  
With the 4NQO treatment, the small subunit Suc22R2 localization is similar to 
the cell without treatment. If Suc22R2 is ~80% nuclear in an spd1 mutant strain, 
it will be the same level after treatment with 4NQO. 
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Figure IV. 13 Suc22R2 nuclear localization in the spd1 mutant strains after drug treatment 
Around 100 cells were scored for Suc22R2 nuclear localization in the spd1+ wt strain, spd1 
deleted and all the 41 mutants. spd1+ wt strain retains Suc22R2 nuclear localization in most 
cells (up to 90%) but is mostly lost after addition of HU (around 18%) but still nuclear localized 
after addition of 4NQO. In the spd1 deleted strain, the localization of the small RNR subunit in 
the nucleus is completely abolished. Neither drug treatments change anything to this 
phenotype.  
The 41 spd1 mutants have a different display of Suc22R2 nuclear localization. Some mutants, for 
example mutant 2, 14, 26 have the same phenotype as the spd1 deleted strain. But on the 
opposite, some mutants, i.e. spd1 mutant 38 has a strong Suc22R2 nuclear localization even 
after HU treatment. Also spd1+ wt and most mutants have a clear Suc22R2 nuclear localization 
after 4NQO treatment. 
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VIII.  Discussion of the role of Spd1 in the RNR architectural 
regulation 
This is an intermediate discussion about the results from this chapter, in 
order to understand the role of Spd1 in the regulation of RNR through 
conformational modification.  
Figure IV.14 is a summary of the FRET results of this chapter. What is 
striking is that Spd1 is necessary for FRET to occur, as the spd1 deleted strain 
never has a FRET positive result. The deletion of spd1 even abolishes the 
positive FRET between the Suc22R2 dimers. The regions of the Spd1 protein 
necessary for FRET are diverse: mutant 1, mutants 5-32 (apart from mutant 8, 
12, 23 and 25) as well as mutants 37-40. The other spd1 mutants do not affect 
the positive FRET signal. Interestingly, after treatment with HU the FRET signal 
is lost for all the strains (spd1 wt and 41 mutants) as well as for the homo-dimer 
Suc22R2 strain.  
The complete opposite 4NQO results are interesting giving us insight into the in 
vivo RNR complex upon DNA damage. We can even assume that the structure 
of the RNR complex after 4NQO is an active one as dNTPs are necessary for 
the DNA repair machinery. In this case, all the spd1 mutants exhibit a positive 
FRET signal, even the ones that did not have the capacity to provide FRET in 
non-treated conditions.  
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Figure IV. 14 Summary of FRET with the spd1 wt, spd1 deleted and spd1 mutants strains 
The Figure is a simplified summary of the FRET experiments on the spd1+ wt, spd1 deleted 
and spd1 mutant strains, in normal conditions or after addition of drugs: HU and 4NQO.  
 
Subsequently, comparing the results with Spd1’s structure and domains 
is done in figure IV.15. It seems like the few structured domains are necessary 
for FRET occurrence: spd1 mutants 8-11 are probably part of an α-helix, and 
they are needed for positive FRET. The same applies to the spd1 mutants 13-
14 and 38-40 which are probably β-strands and do not FRET when mutated. On 
the contrary, there does not seem to be any correlation with solvent accessibility 
(Figure IV.15 part a.).  
Other in silico data provides the predicted protein binding sites of Spd1 
(Figure IV.15 part b.), while no DNA binding sites were predicted, 33 amino 
acids were assigned as possible binding sites with proteins. Unfortunately, this 
does not seem to correlate with the FRET results.  Regions of no FRET (i.e. 
mutants 5-7) can be regions of predicted protein binding but as are regions that 
do FRET (i.e. mutants 33-36).  
The assigned domain regions of Spd1 (by homology to other RNR 
regulators) are annotated as well: the HUG region (spd1 mutants ~10-19) and 
the R1 region (spd1 mutants ~28-31). Although with one exception (mutant 12) 
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when those two regions are affected, Spd1 looses the ability to provide FRET 
between the RNR subunits. 
 
Different assays have been done in parallel with the spd1 mutants to 
assess the degradation of Spd1 and other roles. The nuclear importer role as 
well as the inhibition of RNR was studied. I will incorporate those results in the 
final discussion. 
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a. 
b.  
Figure IV. 15 Comparison of the FRET experiments with in silico data 
In silico research on Spd1 has been done to have more precise information of the secondary 
structure as well as predicted protein interaction domains. The images shown here are from the 
online software “PredictProtein” which uses a suite of structure prediction programs in order to 
give an output file of compiled data with detailed predictions. In picture a. the PROF prediction 
is given with the relevant information (pH_sec: probability for assigning an α-helix; pE_sec: 
probability for assigning a strand, pL-sec: probability for assigning neither an α-helix nor a 
strand, PROF_acc: predicted solvent accessibility). And the data in part b. is provided also by 
the “ProteinPredict” software, through the PROFisis program to predict protein-protein binding. 
These data are then compared with the predicted domains HUG and R1, as well as with the 
FRET results.  
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CHAPTER V Ribonucleotide Reductase 
regulation by Spd2, a novel RNR regulator 
I.  Spd2 description   
Spd1 was first thought to be the sole S. pombe ortholog to S. cerevisae’s 
Dif1, Sml1, and Hug1. During this project, a new gene has been found by 
sequence alignment with Spd1, and named Spd2 for its very high sequence 
identity with Spd1.  
Spd2 is a small protein of 11.8 kDa, and some early investigation demonstrates 
it is very similar to Spd1. Spd2 is also an Intrinsically Disordered Protein (IDP) 
and has a role in RNR inhibition.  One of the main differences is that Spd2 is not 
involved in Suc22R2 nuclear localization.  In the spd2 deleted strain, Suc22R2 is 
nuclear. 
 While collaborators are further characterizing the Spd2 role in RNR inhibition 
and the Spd2 protein cycle and degradation (data not published), I investigated 
whether Spd2 has also a role in the RNR complex architecture. 
spd2+ has a high similarity DNA sequence to spd1+ (Figure V.1 part a.), 
with mainly the ~20 first bases missing, as well as the ~10 last ones. Thus Spd2 
is shorter resulting in an even smaller protein than Spd1. In Figure V.1 part b., 
the amino acid alignment of Spd1 and Spd2 enables to compare the 
conservation of the domains. Notably, the HUG and R1 domains are highly 
conserved between the two proteins. In addition, the spd1 mutants are noted 
allowing comparison of the conserved amino acids between Spd1 and Spd2. 
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a. 
 
b. 
Figure V. 1 Spd1 and Spd2 sequence alignment 
Spd1 and Spd2 DNA sequences have been aligned using the EBI tool ClustalW2, and show a 
high sequence identity (a. alignment using coding DNA sequences). Comparison of the amino 
acid sequence of Spd1 and Spd2 (b.) also reveals high domain similarity and conservation (Hug 
domain in green and R1 domain in purple). The spd1 mutants have also been annotated above 
the sequences for comparison. 
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Using a prediction tool to assess the secondary structure of Spd1 and 
Spd2, it seems that Spd2 is also an IDP with very little structure and most 
probably no fixed tertiary structure. Even if Spd2 seems to have slightly more α-
helices predicted when compared to Spd1.  
 
Figure V. 2 Comparison between Spd1 and Spd2 secondary structure predictions 
This structure prediction is the alignment for secondary structure type. The 3-state (H: Helix, E: 
Strand, C: Coil) secondary structure for each sequence is represented by a color: red for α-helix 
and blue for β-strand. It is clear that Spd2 has similar predicted structure to Spd1, mostly being 
unstructured with some possible α-helices. Therefore it is probable that Spd2 is also an IDP 
(Intrinsically Disordered Protein). This secondary structure prediction was done using PSIPRED 
(Jones, 1999). 
II.  Spd2 has also a role in RNR architecture   
spd2+ was deleted with ura4+ and kanamycin cassettes (by Dr K. Netsoras 
and Dr R. Vesjstrup). This allowed me to cross them in the FRET strains CFP-
Suc22R2 Cdc22 R1-YFP and YFP-Suc22R2 Cdc22 R1-CFP. The first observation 
was the nuclear localization of Suc22R2 in the spd2 deleted strain (Figure V.3). 
Spd2 is not necessary for the nuclear localization of the small RNR subunit. 
Next, FRET experiments were done as described before and the images are 
shown in Figure V.3. There is a decrease in both the donor and the acceptor 
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channels, thus no energy transfer has occurred.  Therefore, the RNR subunits 
Cdc22R1 and Suc22R2 are too far apart or not in the right conformation for FRET. 
 
Figure V. 3 FRET experiment images in the CFP-Suc22R2 Cdc22R1-YFP spd2 deleted strain  
Images taken as described earlier. The decrease of fluorescence in the CFP channel is very 
clear, as shown by arrows, and verified as well as by the photobleached regions in the YFP 
channel. Measurements of the CFP fluorescence in pre- and post- bleach ROI (Region Of 
Interest) will then be used to calculate the FRET efficiency.   
 
 
The negative FRET efficiency is shown in figure V.4, and compared with 
the spd1+ wt and the spd1 deleted strain. In addition, the FRET signal is 
negative in both cellular compartments. (Figure V.4 b.) 
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a.      b. 
 
Figure V. 4 FRET efficiencies between CFP-Suc22R2 and Cdc22R1-YFP in Spd2 deleted strain 
Spd2 may have a role in regulating the RNR structure (a.). Using the RNR FRET strain (CFP-
Suc22R2 Cdc22R1-YFP) in addition of the deletion of Spd2, it was clear that no FRET occurs 
between Cdc22R1 and Suc22R2, both in the nucleus and in the cytoplasm (b.). 
 
Therefore, we can speculate that Spd2 is also needed for an optimal 
RNR structure, allowing FRET between the two subunits. 
III.  FRET in the spd2 deletion strain after drug treatment 
To assess further the role of Spd2 in the structure-related RNR 
regulation, the drugs HU and 4NQO were used. This allowed us to compare the 
drug effects on the FRET results of the spd1 deletion and spd1 mutants. None 
of the drug treatments changed the previously shown negative FRET in spd2 
deleted strains, as under no circumstances is the FRET signal positive. It 
concurs with the spd1 deletion strain, and we can consider that Spd2 is 
necessary for a correct RNR conformation, enabling FRET to occur. 
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Figure V. 5  Images of the FRET experiment in Spd2 deleted strain after drug treatment 
The decrease of fluorescence in the CFP channel is clear. Spd2 deletion abolishes FRET 
between the RNR subunits, and neither HU nor 4NQO modify this FRET result. 
 
The FRET results have been measured, and are negative  (Figure V.6). 
 
 
Figure V. 6 RNR FRET efficiencies in spd2 deleted strain after drug treatment 
spd2 deletion leads to loss of the FRET signal between CFP-Suc22R2 and Cdc22R1-YFP. 
Treatment with HU or 4NQO does not modify the FRET result, as the FRET remains negative. 
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IV.  FRET experiments on spd1 spd2 double delete strain  
The next step was to have both RNR regulators deleted and observe the 
FRET results. One of the first observations in the CFP-Suc22R2 and Cdc22R1-
YFP spd1 Δ spd2 Δ strain is the clear loss of Suc22R2 nuclear localization. Thus 
the Spd1 nuclear importer role is abolished and gives the dominant phenotype 
of pan-cellular Suc22R2 (Figure V.7). 
FRET experiments resulted in no energy transfer between CFP-Suc22R2 and 
Cdc22R1-YFP, without treatment or with HU treatment (Figure V.8). 
 
Figure V. 7 Images of the FRET experiment in spd1 Δ spd2 Δ strain  
The double deleted strain shows a clear spd1Δ phenotype (loss of Suc22R2 nuclear 
localization). Additionally, the FRET signal is negative, visualized by the decrease in both the 
donor and acceptor’s channels. Deletion of both RNR regulators therefore results in no FRET 
between CFP-Suc22R2 and Cdc22R1-YFP. 
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Figure V. 8 CFP-Suc22R2 and Cdc22R1-YFP FRET efficiencies in spd1 Δ spd2 Δ strain  
Deletion of both RNR regulators Spd1 and Spd2 results in loss of the FRET signal between 
CFP-Suc22R2 and Cdc22R1-YFP. Treatment with HU does not modify the FRET result, as the 
FRET remains negative. 
V.  Conservation of the RNR regulators 
The recent discovery of Spd2 shows that not all RNR regulators have 
been described yet, and that there might be more partner proteins involved in 
efficient RNR regulation than previously thought. Although Spd2 is not yet fully 
characterized, some early data shows that Spd2 is also involved in the inhibitory 
function of RNR, and that Spd2 is degraded after HU treatment in a Ddb1-
dependent manner.  
Despite the high similarity in sequence between Spd1 and Spd2, the two 
proteins seem to have different functions in the cell. It is therefore of interest to 
compare the proteins sequences for conservation as well as differences. In 
addition, the alignment with the S. cerevisae RNR regulators (Sml1, Dif1, Hug1) 
might give some further indications about the domains and their functions. 
The HUG domain is conserved, and is between amino acid 32 to 62 according 
to the prediction. The second domain described and considered conserved is 
the R1 domain (a.a 91 to a.a 104). The HUG domain is considered as the R2 
binding domain, while the R1 domain has been described as the domain for 
interaction with the large RNR subunit R1. 
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It is striking how some parts of the protein sequences are conserved, not only 
the HUG domain and the R1 domain, but also the domain 15-18 seems 
moderately conserved. 
 
Figure V. 9 Amino acid alignment of RNR regulators from S. pombe and S. cerevisae  
Comparison between the amino acid sequence alignment of the RNR regulators, in S. pombe 
and S. cerevisae. There is a strong conservation at the amino acid level, especially in the 
previously described conserved domains HUG and R1.  
The conservation scoring is performed by PRALINE. The color assignments are in a color 
scheme indicating the amino acid conservation level, in addition the conservation consistency is 
annotated. 
 
Comparing the structure between the RNR regulators was also done. 
Secondary structures of Sml1 and Dif1 shows more α-helices in the N-terminus, 
and are in general more structured proteins. A common feature for all the RNR 
regulators is the α-helix corresponding to the start of the HUG domain (~a.a 30 
to 50). Also conserved between Sml1, Spd1 and Spd2 is a small α-helix 
prediction at the site of the R1 domain. 
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Figure V. 10 Prediction structures of RNR regulators from S. pombe and S. cerevisae  
Comparison of predicted secondary structures of the RNR regulators in S. pombe and S. 
cerevisae. Most appear to have low amounts of predicted secondary structure. Some α-helices 
domains seem to be conserved between the five RNR regulators. (Done in PSIPRED) 
 
Although Spd2 has not been extensively described yet, it has a role in 
RNR regulation, by affecting the structure and/or conformation of the RNR 
complex. How exactly Spd2 regulates RNR is not entirely clear at this time.  
The conservation of some domains and structures in the RNR regulators 
through the species can allow us to compare the functions of these RNR 
regulators and understand how the RNR complex is regulated by a variety of 
small proteins. 
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CHAPTER VI Studying the RNR at the single 
molecule level 
I.  RNR structurally-induced regulation  
To further investigate the Ribonucleotide Reductase complex, especially 
at the level of the stoichiometry and structural conformation, single molecules 
experiments were done.  
Through the data collected in the previous three chapters, we can 
assume that there is indeed structural-dependent regulation of the RNR through 
Spd1 and Spd2, but also other effectors. We know that Spd1 and Spd2 are 
necessary for FRET to occur between the donor and the acceptor, because 
upon deletion of spd1 and spd2 no FRET is observed. During the two previous 
chapters of this thesis, we observed how the regulators influence the 
oligomerization or modify the conformation of the RNR complexes, allowing the 
tagged RNR to have a positive FRET signal or not. In addition, HU abolished 
the FRET, while 4NQO maintains the positive FRET signal (Fig. VI.1).  
All these conditions can be repeated in vitro, keeping the components to 
a bare minimum and investigating the RNR regulation models in vitro. The aim 
is to be able to evaluate the number of each subunit, as well as observing 
conformational changes. Finally, repeating the FRET in vitro will allow us to 
understand our in vivo results, and push the interpretation further. 
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Figure VI. 1 Simplified model of the working model for structure-dependent RNR regulation  
Schematic of the current model and possibilities for interpreting the FRET data in vivo. Spd1 
and Spd2 are necessary for positive FRET to occur. The RNR complex could be in a α2β2 or 
α6β2 conformation, and the regulators Spd1 and Spd2 could modify the quaternary structure by 
oligomerization or conformational change. Also, ATP and dATP could have opposite effects. HU 
abolishes completely the FRET signal while 4NQO does maintain it and even recovers the 
FRET signal in Spd1 mutants. 
II.  Prediction structure of the small RNR subunit Suc22R2 
In order to better understand the RNR complex, investigating each 
subunit and their structure was done, as well as the predicted structure of the 
modified RNR for FRET. Using different in silico prediction softwares, the 
secondary structures composing XFP-Suc22R2 (XFP stands for any CFP, GFP, 
and YFP) as well as the tertiary structure (Fig. VI.2) could be observed. There 
are some very dense helical domains in Suc22R2, as well as some flexible loops 
between those domains.   
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Figure VI. 2 Prediction structure of XFP-Suc22R2  
 Using the softwares Phyre2, and I-TASSER the prediction structures were generated. The 
secondary structures clearly demonstrate the GFP-like fluorophore in N-terminus followed by 
the linker and the RNR subunit Suc22R2. Suc22R2 is mainly composed of α-helices and when 
folded in its tertiary structure has a small size. 
 
 
 
 
 
 
 
 
Figure VI. 3 Prediction structure of the CFP-Suc22R2 YFP-Suc22R2 dimer  
Using the prediction structure of XFP-Suc22R2 as well as the established dimer structure of R2 
in E. coli, we were able to superpose the structures and obtain the predicted dimer structure of 
Suc22R2 and assess the inter-fluorophore distance. Indeed, it seems that the distance between 
CFP and YFP in the Suc22R2 dimer is less than 10 nm, therefore FRET can occur.  
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The tertiary structure allows us to evaluate the size of the fusion protein, 
and remark how the fluorophore is almost as large as the Suc22R2 itself. Also, 
the flexible linker between “XFP” and Suc22R2 is in evidence and moreover is 
ideal for FRET to occur.  
Having this predicted structure enabled us to evaluate the dimer 
conformation we should observe in vivo, and estimate the inter-fluorophore 
distance. Indeed, the distance between CFP and YFP appears to be less than 9 
nm in the dimer conformation. The predicted structure has been aligned with the 
available R2 dimer of E. coli. Although it is only a prediction, this encouraging 
observation could corroborate with our in vivo homo-FRET data. In addition, the 
fluorescent proteins CFP and YFP have been cloned with a linker, allowing 
flexibility for closer juxtaposition and dipole alignment. 
 
For the following single molecules studies, information about the studied 
proteins are important, as for some experiments i.e. FCS; weight and volume 
can be used to calculated theoretical values and compare it to the experimental 
data. 
III.  Prediction structure of the big RNR subunit Cdc22R1 
The same in silico methods have been used to obtain more information 
about the predicted structure of Cdc22R1-XFP. Again, the secondary structure is 
very dense with α-helices and some flexible loops. The tertiary structure of 
Cdc22R1-CFP Cdc22R1-YFP shown in Figure VI.3 is a mere reconstruction of 
predicted structures, but allows us to have some views into the dimer. 
Unfortunately due to the large length of the protein, I was not able to obtain the 
full tertiary structure of the fusion protein through the size limitations of the 
prediction software. Nonetheless I could reconstitute a theoretical model by 
positioning the fluorescent proteins CFP and YFP at the C-terminus of the R1 
dimer. The N-termini, where the ATP cones can be found, are clearly at the 
opposite ends of the subunit, as are the fluorophores. This can therefore explain 
the lack of homo-dimer FRET. 
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Figure VI. 4  Prediction structures of Cdc22R1-XFP  
Using the software “Phyre” the secondary structure predictions were determined. Cdc22R1 is a 
big protein constituted by many α-helices. In the N-terminus GFP is linked providing the 
Cdc22R1-XFP fusion protein. No tertiary structure prediction was possible with Cdc22R1 but 
using the available R1 structures we could reconstitute what could possibly be the Cdc22R1-
CFP Cdc22R1-YFP dimer. 
IV.  Fusion protein XFP-Suc22R2 expression and purification 
To study the RNR through single molecules techniques in vitro, the 
fusion proteins had to be purified. After cloning CFP-Suc22R2 and YFP-Suc22R2 
into pUC19, followed by cloning into the E. coli expression vector pET3a, 
expression of the fusion proteins were optimized by medium (TB), culture 
temperature and time of incubation. In addition, due to high protein degradation 
and cleavage of the fluorescent tag, significant amounts of proteinease 
inhibitors and efforts were done to avoid such degradation.  
In first instance classical protein purification methods were approached (see 
chapter 2 material and methods): streptomycin sulfate precipitation, followed by 
25%, 50% and 68% ammonium sulfate precipitation of the stable soluble fusion 
protein. But these methods were not optimal as the yield and specificities were 
too low (Fig VI.5 a.). In addition, the polishing steps of dialysis and size 
exclusion chromatography were unsuccessful due to the precipitation of the 
protein during dialysis and/or low levels of protein input. (Fig VI.5 b) 
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a. 
 
b. 
Figure VI. 5 Classical protein purification of CFP-Suc22R2 and YFP-Suc22R2 from E. coli 
Figure VI.5 represents the SDS-PAGE gel and immunostaining of protein purification of 
the recombinant proteins. Suc22R2 tagged with the fluorophores was cloned into pET3a, and 
expressed and induced by IPTG in TB medium at 30°C or 25°C. 
 In vivo structure-mediated regulation of Ribonucleotide Reductase in S. pombe – PhD thesis by Ann-Sofie Schreurs 
 
176 
In a., the empty vector was used as mock purification and control, and is annotated “pet3”, CFP-
Suc22R2 is annotated “sc”: and YFP-Suc22R2 is noted as “sy”. For these 3 purifications, a 
sample was taken from each expression test and step of purification: 
30 - 0: sample of the culture in TB medium at 30°C at 0 mm IPTG 
30 - 0.4: sample of the culture in TB medium at 30°C at 0.4 mm IPTG 
25- 0.4: sample of the culture in TB medium at 25°C at 0.4 mm IPTG 
Strepto. Pellet: sample of the streptomycin precipitation pellet 
As 1: sample of the ammonium sulfate precipitation at 12% supernatant 
As 2: sample of the ammonium sulfate precipitation at 50% supernatant 
As 3: sample of the ammonium sulfate precipitation at 50% pellet 
As 4: sample of the ammonium sulfate precipitation at 68% supernatant 
As 5: sample of the ammonium sulfate precipitation at 68% pellet 
Although the recombinant protein did precipitate at 50% of ammonium sulfate, the specificity 
and yield were not optimum. 
The part b. illustrates one of the trials of dialysis on the partially purified protein samples. But 
the recombinant proteins did precipitate during dialysis, therefore yielding no signal on the gel 
filtration (Size Exclusion Chromatography). 
 
Although cloning into a vector with a histidine affinity tag (pET28) was 
done, we wanted to limit the modifications on the protein, and unfortunately, 
even after cleavage of the histidine tag, some unwanted amino acids remain. 
We decided to avoid this, as we did not want to encounter false negative FRET 
results in vitro. Therefore the recombinant proteins needed to be exactly the 
same as the one in vivo. Thus we used the expression vector pET3a, as 
explained in material and methods. 
 
Due to the unsuccessful classical protein purification, we decided to try 
immuno-precipitation (IP) using anti-GFP antibodies. Although at first it seemed 
to be an option, it became clear that most of the expressed recombinant 
proteins were lost during the washes. Various protocols were used (different 
concentrations of antibody -2 µg to 8 µg-) as well as two different sources of 
antibodies (mouse anti-GFP and rabbit anti-GFP). As seen in Figure VI.6, there 
seemed to be a problem to retain the CFP-Suc22R2 and YFP-Scu22R2 proteins. 
One of the reasons for this problem could be due the incorrect and inefficient 
binding of the antibodies to the dynabeads (Invitrogen). 
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a. 
 
b. 
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Figure VI. 6 Immunoprecipitation with anti-GFP dynabeads of CFP-Suc22R2 and YFP-Suc22R2 
from E. coli 
These images represent the trails done at different antibody concentration, as well as different 
antibodies (In a. the mouse anti-GFP from Roche was used, and in b. the rabbit anti-GFP was 
used). The protein purification samples are shown by specific anti-GFP immunostaining after 
SDS-PAGE gel as well as staining of the membrane with ponceau red for total protein staining. 
In both gels, the samples loaded were:  
Pet: empty vector 
SY lysate: sample of the lysis after expression of YFP-Suc22R2 in E. coli 
IP sample 1 SN: sample of the supernatant after the incubation 
IP sample 2 wash 1 SN: sample of the supernatant after the first wash 
IP sample 3 wash 2 SN: sample of the supernatant after the second wash 
IP sample 4 wash 3 SN: sample of the supernatant after the third wash 
IP sample 5 wash 2 SN: sample of the supernatant after the third wash 
Sample IP: sample of the Immunoprecipitation  
Sample 6 2nd elution: sample of a second elution of the immunoprecipitation 
 
As the IP method seemed a good tool to increase the specificity, but due 
to technical problems, the dynabeads were not the most efficient method. 
Alternative protocols were tried, using beads already bound to anti-GFP. Three 
methods were tried on the recombinant proteins expressed in E. coli: 
- GFP-TRAP agarose beads (Chromotek), this variant antibody has high 
affinity to GFP and is available bound to agarose beads 
- GFP-TRAP magnetic beads, the same as above but bound to magnetic 
beads 
- µMAC anti-GFP magnetic beads (Miltenyi) are classical magnetic beads 
but already bound with anti-GFP. In addition, the protocol uses efficient 
columns to allow a flow through of the lysate while retaining the magnetic 
beads. This system allows high throughput. 
 
Figure VI.7 is an example of the trials done with the mock purification, the CFP-
Suc22R2 and YFP-Suc22R2 proteins.  This figure shows the end result of input, 
wash and IP done in parallel in the three systems to compare. 
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Figure VI. 7 Trials of three different IP methods with the CFP-Suc22R2 and YFP-Suc22R2 from E. 
coli 
Three methods were tried the GFP-TRAP magnetic beads (“magnetic beads”), the GFP-TRAP 
agarose beads (“agarose beads”) and the µMAC anti-GFP magnetic beads (“µMAC beads”) 
The empty vector was used as control negative vector for mock purification (“pet”) while CFP-
Suc22R2 (“SC”) and YFP-Suc22R2 (“SY”) were also used. The samples loaded represent the 
input, a sample from the wash (unbound) and the final elution. 
 
Because of the very high yield and the available columns for high 
throughput the µMAC anti-GFP magnetic beads were used. After increasing the 
yield and modifying the protocol to obtain native eluted protein (Figure VI.8), this 
method was used routinely, procuring us with enough quantities of pure fusion 
proteins for the single molecule experiments (Figure VI.9). 
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Figure VI. 8  Native elution of CFP-Suc22R2 and YFP-Suc22R2 purification from E. coli 
The µMAC anti-GFP magnetic beads were used, but improvements had to be done to obtain 
the recombinant proteins pure and in a native state to be used for the single molecule 
experiments.  This figure represents a trial comparing normal elution (boiling of the beads in 
sample buffer) and native elution. CFP-Suc22R2 was used (“SC”), YFP-Suc22R2 (“SY”) and the 
empty vector (“P”). 
For each protein, the input was loaded (“input”), a sample of the supernatant after the wash 
(”wash”) and a sample of the elution. In parallel, the same procedure was done loading the 
input, a sample of the wash and the native elutions 1 (first elution), 2 (2nd) and 3 (3rd). 
The results are shown by commassie gel and by immunostaining with anti-GFP. 
There was an error in the loading of the first lane of the empty vector “P”.  
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Figure VI. 9 Purified fusion protein CFP-Suc22R2 and YFP-Suc22R2 from E. coli 
Suc22R2 tagged with the fluorophores was cloned into pET3a. Expression was induced by IPTG 
in TB medium at 30 °C. Both tagged Suc22R2 proteins (CFP and YFP) were purified with the 
most efficient method found, by microMAC anti-GFP magnetic beads columns and native 
elution by pH shift. The end result is shown on the commassie gel and western blot (anti-GFP 
antibody), and the proteins can be found around the expected size of 75 kDA. The lanes are: 
Empty vector input and native elution, CFP-Suc22R2, followed by, CFP-Suc22R2 and YFP-
Suc22R2 with similar input and native elution loading. 
 
Those proteins were verified by mass spectrometry to confirm the 
purification of the proteins of interest as well as assessing the length of the 
protein purified. They are indeed the corresponding proteins of the small RNR 
subunit and are expressed in their full length (Figure VI.10) 
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Figure VI. 10 Expression and Purification of E. coli expressed CFP-Suc22R2 and YFP-Suc22R2 
proteins and verification by mass spectrometry (MS/MS) 
These proteins were confirmed by mass spectrometry to be the correct protein expressed, but 
also confirming the full-length protein is expressed. (Mass spectrometry done in association with 
the proteomics department of the University of Sussex) 
 
In addition, the purified recombinant proteins from E. coli were compared to the 
endogenous CFP-Suc22R2 and YFP-Suc22R2 (see Figure VI.11) 
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Figure VI. 11 Comparison of the purified CFP-Suc22R2 and YFP-Suc22R2 proteins from E. coli 
and endogenous proteins  
This immunostaining using anti-GFP shows samples of TCA extracts (total protein extracts from 
yeast cells) of the strains 501 (wt, untagged RNR), TCA CFP-Suc22 (single tagged CFP-
Suc22R2 strain), TCA YFP-Suc22 (single tagged YFP-Suc22R2 strain), TCA CFP-Suc22 Cdc22-
YFP (double tagged CFP-Suc22R2 Cdc22R1-YFP strain), CFP-Suc22 E. coli (purified CFP-
Suc22R2 from E. coli), YFP-Suc22 E. coli (purified YFP-Suc22R2 from E. coli) and pET3a E. coli 
(mock purification). 
V.  Cdc22R1-XFP Protein Expression and Purification 
The fusion proteins Cdc22R1-CFP and Cdc22R1-YFP were expressed as 
well. The aim was to obtain the purified recombinant proteins for the in vitro 
experiments. The cloning of the fusion genes was slightly more complex due to 
the presence of an intron in the Cdc22R1 gene. Various methods of cloning were 
tried: 
- Due to the presence of an intron, creation of a linker (including the first 
exon and the enzyme restriction sites) using the primers  
pET3a_L_F TATGTTTGTATACAAAAGAGACGGACGTCGTAGGCGCGCCG 
and  
pET3a_L_R 
GATCCGGCGCGCCTACGACGTCCGTCTCTTTTGTATACAAACA 
- Cloning of linker as a NdeI/BamHI fragment into pET3a 
- Amplifying the exon 2 and cloning as an AatII/AscI fragment 
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Technical problems with the linearization of pET3a were encountered, 
partly due to the redundancy of the AatII restriction enzyme site. Unfortunately, 
even after a PCR based mutagenesis of the site, a clear linearization of the 
fragment was not obtained. Finally, the cDNA of Cdc22R1 from Dr. Kostas 
Nestoras was used, enabling me to obtain the pET3a-Cdc22 no codon stop 
plasmid (using the InFusion method). The linker followed by the CFP as well as 
YFP genes were cloned into the C-terminus of Cdc22R1, although with 
difficulties to find appropriate enzymes (as Cdc22R1 contains two BamH1 sites 
and pET3a had limited possibilities). Finally the cloning was done using NheI 
into another E. coli expression vector, pET21a. 
The expression of the fusion proteins proved to be also tedious but there 
seems to be some expression (Fig. VI.12). The expression of Cdc22R1-XFP has 
now to be improved (various temperatures, longer incubations), and most 
probably the same purification (anti-GFP magnetic beads columns) can be 
used. 
 
Figure VI. 12 Purification of E.coli expressed Cdc22R1-CFP and Cdc22R1-YFP proteins  
Cdc22R1 tagged with the fluorophores was cloned into pET21a, and expressed in LB medium at 
16 °C, followed by induction with IPTG and growth overnight. The lanes of the SDS-PAGE gel 
are empty vector pET21a without IPTG induction (P 0), and the supernatant as well as pellet 
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were loaded. Followed by the empty vector but at 0.1 mM IPTG (P 0.1) at 0.2 mM IPTG (P 0.2). 
The exact same protocol and loading was done for Cdc22-CFP (C-C 0 mM IPTG, C-C 0.1 mM 
IPTG and C-C 0.2 mM IPTG) as well as for Cdc22-YFP (C-Y 0 mM IPTG, C-Y 0.1 mM IPTG, C-
Y 0.2 mM IPTG). Protein expression revealed by coomassie and western blot by anti-GFP 
antibody.  
VI.  RNR tagged proteins purified from S. pombe 
The CFP and YFP tagged RNR proteins from S. pombe were also 
directly purified by anti-GFP immunoprecipitation (Dynabeads, Invitrogen), and 
although partially successful, the yield was quite low. (Figure VI.13) 
 
 
 
 
 
 
 
 
Figure VI. 13 Immunprecipitation of endogenous CFP-Suc22R2, Cdc22R1-YFP and CFP-Suc22R2 
Cdc22R1-YFP proteins  
Using the classical IP procedure with Dynabeads and mouse anti-GFP on S. pombe cell lysates 
after grinding in liquid nitrogen, the endogenous RNR-tagged proteins were 
immunoprecipitated. The non-tagged control was loaded, followed by the IP sample from single 
tagged strain CFP-Suc22R2, as well as Cdc22R1-YFP. Finally, the double-tagged strain was 
loaded. The proteins are at the expected sizes of ~75 kDa for CFP-Suc22R2 and ~119 kDa for 
Cdc22R1-YFP. 
 
Therefore the three methods of IP used for the purification of over-
expressed proteins in E. coli were also tried for the S. pombe cells. The µMAC 
anti-GFP showed too much non-specific binding; therefore the GFP-TRAP 
methods were used and compared to obtain the best conditions. (Figure VI.14) 
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Figure VI. 14 Purification of endogenous XFP-Suc22R2 and Cdc22R1-XFP proteins  
Using the GFP-TRAP method, the RNR proteins were directly purified from the S. pombe 
strains. The strains used were 501: negative control as the RNR is not tagged, GFP-Suc22 (“S-
g”), CFP-Suc22 (“S-C”) and Cdc22-CFP (C-C). In parallel the GFP-TRAP bound to magnetic 
beads was tried (“M”) and bound the agarose beads (“A”). Samples of the pellet (“pellet”), the 
input (“input”) and the wash (“wash”) were loaded. Also the final elution, thus the bound proteins 
were loaded (“IP”) 
 
Using the “GFP-trap” protocol vastly improved the yield and specificity of the 
purification of endogenous proteins. After ameliorating the conditions for native 
elution this method could be used on a range of strains. This procured us with 
enough quantities of pure fusion proteins for the single molecule experiments.  
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Figure VI. 15 Purification of endogenous XFP-Suc22R2 and Cdc22R1-XFP proteins  
Using a “GFP TRAP” method, the RNR proteins were directly purified from the S. pombe 
strains. Lysis of the cells followed by agarose beads bound to an anti-GFP variant. The 4 strains 
represented here are: single tagged Suc22R2-YFP, single tagged Cdc22R1-YFP, double tagged 
Suc22R2-CFP Cdc22R1-YFP and double tagged Suc22R2-CFP Cdc22R1-YFP spd1 Δ. For each 
strain the input, washes, and various elutions have been loaded. The purified proteins are 
revealed by SDS-PAGE after coomassie staining and western blot with the anti-GFP antibody. 
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VII.  Photobleach step assay to determine stoichiometry 
using TIRFM (Total Internal Reflection Microscope) 
One method we use to answer more precisely the oligomeric state of the 
purified proteins is the photobleaching step assay done on a total internal 
reflection microscope (TIRFM) (Reck-Peterson et al, 2010). After immobilizing 
the proteins on a slide using anti-GFP antibodies (Fig. VI.9 part a.), and washed 
with buffer and BSA, the purified proteins are being imaged and exposed until 
completely photobleached. Therefore the number of steps necessary to be fully 
photobleached can be observed, consequently revealing the number of 
fluorophores present (see Figure VI.16 part b.). If only one fluorophore is 
present, one step of photobleaching will be visible, but in the presence of two 
fluorophores there will be two steps of photobleaching and so on. 
 
 
Figure VI. 16 Photobleach step assay set up on the TIRFM and principle  
Schematic of the photobleach assay. In part a. the proteins of interest are tagged with  
fluorophores and will be immobilized by specific antibodies. Imaged on a TIRFM the proteins 
will be exposed until fully photobleached, and the number of steps a single molecule will take 
will be imaged and measured. Finally it will provide the number of proteins present. 
 
The controls for the photobleach step assay were various: buffers and 
antibodies alone, but as well controls with purified eGFP proteins provided the 
calibration for the experiment. It also provided us with the expected result of a 
majority of single photobleach step population, meaning a preponderance of 
monomer population.  
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The photobleach step assay was used to reveal the stoichiometry of the 
purified XFP-Suc22R2. Imaging the purified small subunit proteins supplied us 
with some information of the intensity of the fluorophores, which can be shown 
into a point spread function (PSF) with a scale for the intensity of the 
fluorescence (Figure VI.17 part a.). The assay revealed a majority of 1 step, 
although some 2 steps were observed as well (fig. VI.17 part b.). Purified XFP-
Suc22R2 proteins have a mixed population: mostly monomers in addition of 
some dimers (Figure VI.17). 
 
 
 
 
 
Figure VI. 17 Photobleaching step assay on XFP-Suc22R2 to determine the stoechiometry 
The purified XFP-Suc22R2 proteins were first used on the Total Internal Reflection Microscope 
(TIRFM), and fixed on a slide before imaging. On the far left (a.) is an example of an obtained 
image, as well as the 3D point spread function reconstruction of a certain area. Next, each 
single molecule is photobleached and the bleaching profile of one single molecule will provide a 
number of steps, in this example two steps (b). This is done on a number of molecules. The 
result for YFP-Suc22R2 is a mixed population of monomer but as well some dimers (c). (Done in 
collaboration with Remi Boulineau) 
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VIII.  Single molecule experiment using the FCS 
(Fluorescence Correlation Spectroscopy)  
Another method used was Fluorescence correlation spectroscopy (FCS), 
which will ultimately provide us a characteristic diffusion time of the proteins 
dependent on their radius of gyration Rg (Fitzpatrick & Lillemeier, 2011; Price et 
al, 2011). 
FCS is a method where in a small detection volume, diffusing fluorescent 
molecules are detected, and their signal intensities are measured during a 
certain time followed by correlation in order to have a diffusion time.  
If the molecule aggregates, binds to other proteins or goes through large 
conformational changes, its diffusion time will increase and the correlated 
function will be shifted due to an increased molecular weight.  
A fitting of the curve allows obtaining more information from the measurements, 
using the equation below: 
 
N is the number of molecules, d the diffusion time, A the intramolecular 
contribution and b the intramolecular time. 
 
In first instance we verified the system with the purified GFP proteins, 
and could set up the calibration of the experiment references (done by Remi 
Boulineau).  As FCS is very sensitive to autofluorescence, appropriate controls 
were done: the buffers alone, as well as mock protein purification from E. coli 
were used to assess the background. (Fig. VI.18) 
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Figure VI. 18 Controls with GFP purified proteins and negative control with no correlation  
The controls were done using purified GFP proteins (a), the buffers alone, as well as the mock 
purification from E. coli should give no correlation of the signal (b.), as this signal should be 
background. This figure is an example of a negative control ensuring that the signal observed is 
background, and random, thus no correlation is possible. 
 
The specificity on the other hand was measured by measuring the CFP-
Suc22R2 proteins on the YFP-Suc22R2 set up system, providing us with a strong 
negative control. 
The purified YFP-Suc22R2 proteins were tested and diluted to low 
concentrations (~0.001mg/ml). The correlation of the signal from the single 
molecule fluorophores on the FCS was done by a software through ImageJ with 
our collaborators, consequently providing us with a diffusion time (Figure VI.19). 
Next, additional controls were done to ensure that the signal was 
genuine and originated from the YFP-Suc22R2 fusion protein. The observed 
signal and assigned diffusion time were measured before and after treatments 
to the proteins. (Fig. VI.19) Denaturation of YFP-Suc22R2 by heating did result 
in the abolishment of the signal, and the remaining signal was background and 
random, thus not able to produce a correlation function. Same results were 
obtained after treatment of the proteins with the enzyme proteinase K in order to 
degrade the fusion proteins (Fig. VI.19). 
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Figure VI. 19 Controls and verifications of the fluorescents single molecule on the Fluorescent 
Correlation Spectroscopy (FCS)  
After obtaining the optimum conditions to measure the YFP-Suc22R2 protein at the single 
molecule level on the FCS, we verified if the signal was abolished after various controls. Indeed 
denaturation of YFP-Suc22R2 by heating, or degradation by enzyme treatment did reduce the 
signal and resulted in no real correlation function anymore, as it only the background was 
visible. 
A recurring question was the stoichiometry of the purified YFP-Suc22R2, 
therefore by using FCS we wanted to review this question as well as determine 
the effect of the mixed population of monomers and dimers observed by TIRFM. 
The diffusion times of YFP-Suc22R2 in monomer or dimer can be 
calculated theoretically; in addition the correlation functions (Fig VI.20 a.) can 
also be simulated by which a diffusion time can also be obtained. The 
experimental diffusion time of YFP-Suc22R2 is 1.002 ms (Fig VI.20 b.). This can 
be compared to the theoretical calculations and simulations diffusion times, 
which are lower (Fig VI.20 c.).  Thus the experimental YFP-Suc22R2 diffusion 
time does not entirely correspond to the expected diffusion times as a monomer 
or dimer. We can speculate that the mixture of population of monomeric and 
dimeric forms of YFP-Suc22R2 affects the results, as well as some cleaved YFP 
that could influence the measurements.
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Figure VI. 20 Comparison of the diffusion times of YFP-Suc22R2 with theoretical values  
The diffusion times of YFP-Suc22R2 in monomeric form or dimeric form can be calculated, 
depending on the molecular weight of the complex. Simulations of the correlation function will 
also provide us diffusion times (a.). The experimental measurements (b.) on YFP-Suc22R2 give 
the genuine diffusion time of the purified proteins. But as the table of diffusion times shown in c., 
the experimental data does not match any theoretical value, nor for the monomeric diffusion 
times, nor dimeric ones. (Done in collaboration with Remi Boulineau) 
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IX.  Protein binding measured by FCS 
In order to prove the principle of this new method, but as well to set up 
the standards of the experiment, we proceeded to a protein binding experiment. 
To the optimum YFP-Suc22R2 concentration established beforehand, an 
increased amount of antibody anti-GFP was added. The increase of antibody 
concentration was concomitant with the shifting diffusion time, thus describing 
protein binding. 
 In addition, at the saturation conditions of anti-GFP bound to YFP-
Suc22R2, a secondary antibody to the anti-GFP was used. This resulted in 
additional protein binding and an even larger shift in the diffusion time (Fig. 
VI.21 a.). The data can then be fitted into a model, which can provide us with a 
ratio of bound/unbound proteins. (Fig. VI.21 b.) 
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Figure VI. 21 Proof of principle of protein binding measured by FCS  
Using the YFP-Suc22R2 in the optimum conditions as described earlier, an increased 
concentration of anti-GFP antibody was added. Indeed a shift in the correlation function is 
observed, meaning a higher diffusion time. At the saturation of YFP-Suc22R2 bound with anti-
GFP, a secondary antibody binding to anti-GFP was added, shifting the diffusion time even 
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further. The correlation functions can than be fitted and provide the ratio (F) of bound/unbound 
population, for example here 21% of the population is bound, very close to the theoretical value 
of 20% bound. 
(Done in collaboration with Remi Boulineau) 
 
The endogenous RNR proteins from S. pombe were also purified and 
therefore used on the FCS. The diffusion times of YFP-Suc22R2 and Cdc22R1-
YFP were also measured. The protein binding experiments on the FCS were 
also done with the endogenous purified YFP-Suc22R2 proteins as well as 
Cdc22R1-YFP, giving similar results i.e. upon binding with the anti-GFP 
antibodies, a shift in the diffusion time is observable therefore there is positive 
protein binding (Fig. VI.22). Finally the comparison of Cdc22R1-YFP and YFP-
Suc22R2 gave the expected result of a higher diffusion time for the bigger RNR 
subunit Cdc22R1 compared to the smaller subunit Suc22R2 (Fig VI.22 c). 
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Figure VI. 22 Protein binding with the endogenous purified YFP-Suc22R2 and Cdc22R1-YFP  
The purified tagged RNR proteins from S. pombe YFP-Suc22R2 (a.) and Cdc22R1-YFP (b.) were 
also used on the FCS and measured. The protein binding assay with the anti-GFP antibodies 
demonstrated a binding therefore a shift in the diffusion time for both RNR proteins (+Ab). In 
addition, the Cdc22R1-YFP proteins show a higher diffusion time than the YFP-Suc22R2 proteins 
(c.). 
(Done in collaboration with Remi Boulineau) 
 
Figure VI. 23 Protein binding comparison with endogenous and E. coli expressed YFP-Suc22R2  
In this Figure the YFP-Suc22R2 from E. coli (Ec) is compared with the YFP-Suc22R2 from S. 
pombe (Sp), as well as their binding to the antibodies.  
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The diffusion times of YFP-Suc22R2 and Cdc22R1-YFP were also 
measured. Interestingly enough, the diffusion time of YFP-Suc22R2 purified from 
E. coli (Ec, Figure VI.23) is slightly different than the YFP-Suc22R2 purified from 
S. pombe (Sp), the latter one having a smaller diffusion time. This could be 
explained by a different ratio of dimer/moner population, or an increase in 
cleaved proteins leading to a modification of the diffusion time by contamination 
of YFP. Other aspects should be considered, for example secondary 
modifications, different quaternary structure, or simply differences in the 
purification protocols. 
 
Now that the system is set up and functioning, many experiments can be 
done, giving more insight of the RNR in vitro with regards to its stoichiometry 
and FRET capacities. 
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CHAPTER VII DISCUSSION: An insight into 
the complexity of the RNR Complex 
RNR is a key enzyme for genome integrity, and the RNR complex is 
consistently tightly regulated. Parts of this regulation have been studied, for 
example the allosteric regulation by the effectors and the transcription control of 
the RNR proteins; but some aspects of the regulation of the RNR still remain 
unclear, especially the structure-mediated regulation. With recent publications 
supporting the structure-dependent regulation of RNR, the aim of this project 
was to investigate such a regulation in vivo in S. pombe. 
Even though RNR has been studied for decades, the many layers of RNR 
regulation are still being revealed. The last years have seen numerous 
publications about the RNR structure in different species, with particular regard 
to the active form and the inactive form. Consequently, the mechanisms behind 
the “switching off” and “on” of the RNR are of interest, and observations suggest 
this might be linked to the quaternary structure of the complex . 
 In addition, the various functions of the RNR regulators (Spd1 and Spd2 in S. 
pombe) are not fully described yet. These were also investigated in this project. 
In particular the possible role of the regulators in the structure or conformation 
modification of the RNR have been studied.  
My results have shed some more light on the in vivo complex dynamics of RNR, 
as well as further characterizing the architecture-related regulation of RNR. 
I.  Established FRET assay with Ribonucleotide Reductase  
The FRET assay allowed us to investigate RNR in vivo, and we obtained 
positive FRET between the RNR subunits, as well as homo-FRET between the 
Suc22R2 subunits.  
This is consistent with the knowledge that the RNR subunits are able to interact, 
and form the RNR complex, which is essential for cell survival. A negative 
FRET readout for RNR in viable cells means a modification of the distance or 
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alignment of the fluorophores, indicating a stoichiometric and/or conformational 
change, rather than no protein interaction. However it has to be remembered 
that the readout of the FRET assay is indirect and we cannot distinguish the 
nature of the modification leading to the FRET result.  
 The RNR fluorescent-tagged strains allowed us to estimate the relative 
abundance of the big subunit Cdc22R1, and the small subunit Suc22R2 in both 
cellular compartments of S-phase cells and G2 phase cells. Cdc22R1 is at least 
twice as abundant as Suc22R2, and evenly distributed in the cells. Suc22R2 
levels and localization are more dynamic, with a predominantly nuclear 
localization in G2 cells. In S-phase cells the levels of Suc22R2 are equally 
distributed in the two nuclei and a concomitant increase in the cytoplasm is 
observed. Thus the ratio of both RNR subunits and their quantification and 
localization shows that they are both present in the nucleus as well as in the 
cytoplasm during the whole cell cycle at similar protein levels. 
 The FRET assay between CFP-Suc22R2 and Cdc22R1-YFP (as well as 
YFP-Suc22R2 and Cdc22R1-CFP) was designed as a tool to investigate the in 
vivo formation of RNR complex in both cellular compartments and cell cycle 
stage specific cells. 
The early observations of Suc22R2 relocalization from the nucleus to the 
cytoplasm, leading to colocalization of both RNR subunits in the cytoplasm in S-
phase, partially supported the hypothesis of active RNR complex formation in 
the cytoplasm during S-phase, when dNTPs are needed. Therefore, the 
expectation was a positive interaction mostly in the cytoplasm during S-phase, 
which is when the active heterocomplexes were predicted to form. However we 
could demonstrate an interaction between the subunits throughout the cell cycle 
in both cell compartments. Thus RNR heterocomplexes are formed in 
heterocomplexes at all times throughout the cell and Suc22R2 and Cdc22R1 are 
in close proximity as their fluorphores are not further apart than 10 nm. 
 In addition, the FRET experiment between Suc22R2 homo-complexes 
proved to be a potential assay to assess the architecture of the complex, as the 
Suc22R2 subunits are in a close dimer. In contrast, the Cdc22R1 homo-
complexes do not seem to be in a correct conformation to allow FRET, probably 
due to the fact that in the Cdc22R1 dimer structure the C-termini ends are at 
opposite ends as well as in an uncertain oligomeric state. 
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II.  Spd1 and Spd2 are required for structure-related RNR 
regulation  
As Spd1 has been considered as an RNR inhibitor, upon Spd1 deletion it 
was anticipated that there would be an increase in active RNR complexes and 
therefore an increase in FRET positive RNR complexes. Surprisingly the FRET 
signal was lost and no energy transfer between CFP-Suc22R2 and Cdc22R1-
YFP (nor YFP-Suc22R2 and Cdc22R1-CFP) was observed. Although no clear 
nuclear and cell cycle phase distinction is possible in those strains (due to 
complete lack of Suc22R2 nuclear localization), the negative FRET result was 
detected throughout the cells in a range of different sizes cells (i.e. different cell 
cycle stages). The positive FRET signal obtained between the homo-complexes 
Suc22R2 is lost after deletion of spd1.  
Since that in spd1 Δ strains RNR is active and providing even higher levels 
of dNTPS to the cells, this indicates that the FRET assay is measuring 
structural modifications and not a loss of RNR protein interactions. These are 
Spd1-dependent modifications in the association of Cdc22R1 and Suc22R2, as 
well as the Suc22R2 dimer. This strongly suggests that Spd1 has a role in 
regulating the architecture of the RNR complexes. This additional level of RNR 
regulation controlled by Spd1 correlates with the inherent qualities, with regards 
to structural flexibility, of intrinsically disordered proteins (IDP or IUP -
unstructured-), a group of proteins to which Spd1 belongs.  
IDPs have been described in different cellular pathways, and their peculiar 
characteristics are thought to have biological roles with regards to protein 
interactions. They can be flexible linkers to recruit and connect partner proteins, 
as IDPs can freely rotate and move, thus modifying proteins conformations. 
Another feature of the IDPs is the “coupled binding and folding”: they can 
acquire a more structured state upon binding to their target proteins. These 
structural transitions are considered to be dynamic and have roles in regulating 
protein complexes with a variety of biological functions (Gunasekaran et al, 
2003) (Galea et al, 2008b) . 
Spd1 has the capacity to bind both subunits of RNR, hence as an IDP 
could mediate the conformation or stoichiometry of the RNR complex. However 
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size exclusion chromatography has indicated that no higher order structures are 
observed in vivo with or without Spd1 being present (Nestoras et al, 2010) .   
It could be proposed that Spd1 mediates a conformational change in the 
RNR complex by forming an immature inactive RNR complex. These 
complexes could be in an optimal conformation (observed by a positive FRET 
signal) for activation once Spd1 is degraded. In the complete absence of Spd1 
(spd1 Δ), the cells lack the scaffolding role of Spd1 to build RNR into these 
complexes, thus FRET is never observed. 
The novel S. pombe RNR regulator Spd2 also has a role in regulating 
RNR inhibition through a yet unknown mechanism. During this project it was 
shown that Spd2 has also a role in the architecture-dependent regulation of 
RNR. Spd2 is required for positive FRET of Suc22R2 and Cdc22R1. As Spd2 
seems to be also an IDP, we can consider a similar RNR scaffolding role for this 
small protein. 
 
 
 
 
 
 
 
 
 
 
 
Figure VII. 1 Intermediate working model: Role of Spd1 and spd2 in architectural-dependent 
RNR regulation 
This diagram represents an intermediate hypothesis of the role of Spd1 and Spd2 in the 
regulation of RNR activity through structural methods. The stoichiometry of the RNR in S. 
pombe in vivo is as yet unknown. It could be 2-6 big subunits Cdc22R1 (α) and 2 small subunits 
Suc22R2 (β). In presence of the RNR regulators, the RNR complexes adopt a different 
conformation, enabling FRET between the fluorophores. Before its degradation, the IDP Spd1 
will have fulfilled its role of scaffold protein. 
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Further research is needed to understand the interplay between Spd1, Spd2, 
and the RNR. It is possible that Spd1 and Spd2 form a dimer, as in S. cerevisae 
Sml1 is a dynamic dimer (Andreson et al, 2010).  
III.  Spd1 domains and functions 
Three possible in vivo functions of Spd1 can be postulated so far: 
regulation of Suc22R2 nuclear import, role in RNR architecture and in vivo 
control of RNR activity. The restraint of RNR activity possibly correlates with the 
in vitro inhibition  or the nuclear sequestration of Suc22R2 , or a combination of 
both. 
To further investigate these potential functions and understand in more 
depth the role of Spd1 in regulating RNR, alanine-scanning mutagenesis of 
Spd1 has provided 41 mutants scanning the whole gene. These mutants were 
used in different assays to assess the effect the mutations had on the described 
functions of Spd1: 
- Structure-dependent RNR regulation: FRET of CFP-Suc22R2 
Cdc22R1-YFP  
- Inhibition of RNR: in vivo rescue of Rad3ts Csn1 Δ lethality or rescue 
of spore formation defect in Ddb1 Δ 
- Nuclear import:  Suc22R2 nuclear localization 
- Spd1 mutants protein stability and degradation 
 
Apart from the FRET data, the other assays were done by collaborators but will 
be included here for the full understanding of this project’s results (Nestoras et 
al, 2010) . 
 
The Spd1 mutants stability will first be reviewed (Fig VII.2 part e.). In vitro 
and in vivo degradation was studied in the 41 Spd1 mutants with the aim of 
finding a degron domain, as described in the S. cerevisae’s Sml1. Although in 
vitro degradation was indeed dependent on Cul4-Pcu4-Ddb1 and the 
signalosome (Liu et al, 2003) , no clear domain for degradation was identified. 
 In vivo structure-mediated regulation of Ribonucleotide Reductase in S. pombe – PhD thesis by Ann-Sofie Schreurs 
 
204 
In vivo degradation of the Spd1 mutants was assayed by treatment of the cells 
with HU, leading to Spd1 degradation by a Cul4-Ddb1 pathway. Spd1 protein 
levels before and after HU were observed by SDS-PAGE, and again no domain 
seemed necessary for Spd1 degradation. However, some of the mutations 
seemed to affect the initial protein levels, therefore their stability. 
 
Next the nuclear localization of Suc22R2 in the mutants are shown in 
Figure VII.2 part d. spd1 mutants 2, 14 and 26 have completely lost their role of 
nuclear import, and have the same phenotype as the spd1 Δ. Other mutants, for 
example spd1 mutants 3, 11-16, 33; have an increase sensitivity to HU in terms 
of Suc22R2 nuclear localization, as upon treatment with the drug the small 
subunit is completely pan-cellular (compared to spd1+ wt which retains 20% of 
Suc22R2 in the nucleus). The region corresponding to the spd1 mutants 10-19 
(HUG domain) is proposed to bind to Suc22R2 and promote nuclear import, by 
comparison to the role of the HUG domain in the orthologues Sml1, Dif1 and 
Hug1. In contrast, some spd1 mutants (spd1 mutants 21, 38-41) exhibit the 
opposite phenotype i.e. a strong Suc22R2 nuclear localization after HU. 
 
 The results of the experiments measuring in vivo regulation of RNR 
inhibition by Spd1 are shown in fig. VII.2 part b and c. Two phenotypes were 
tested to evaluate Spd1-dependent restraint of RNR activity. The first one (part 
b.) uses the ability of spd1 deletion to rescue the lethality of the double mutant 
strain Rad3ts Csn1 Δ. The concomitant loss of the Rad3 checkpoint protein and 
the signalosome component Csn1 leads to cell death (Liu et al, 2003) because 
in those cells Spd1 is stable and RNR activity inhibited throughout the cell cycle 
including in S-Phase where dNTPs are necessary. The viability was assessed 
by survival of the strains at restrictive temperature. 
The second in vivo experiment was the use of the Ddb1 Δ spore 
formation defect, which is reverted by deletion of Spd1 (Holmberg et al, 2005) . 
Again, if Ddb1 is not present, Spd1 will not be degraded and meiosis will not be 
completed. This defect of meiosis progression (thus RNR inhibition) was 
measured by spore formation. 
Both assays gave similar results, showing the Spd1 HUG domain (spd1 
mutants 9-19) was important for RNR inhibition. Other spd1 mutants have a 
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spd1 Δ phenotype (loss of inhibition): spd1 mutant 26 as well as spd1 mutants 
34 to 41 seem partially important for the inhibition role of Spd1. 
 
 Taking together the data so far, we can conclude that the role of Spd1 in 
RNR inhibition does not necessarily correlate with the role of nuclear import of 
Suc22R2. A particular example to illustrate this is spd1 mutant 2:  the nuclear 
import role in this mutant is completely abolished whereas it has full capacity to 
inhibit the RNR. In contrast, spd1 mutant 10 and 11 have a normal capacity to 
import Suc22R2 into the nucleus but have lost the inhibition function.  
The data suggest the importance of the HUG domain for Suc22R2 
localization and RNR inhibition. Mutations in the C-terminus of Spd1 (spd1 
mutants 34 to 41) also influences RNR inhibition, and was called the Spd1 
domain (Nestoras et al, 2010) . In contrast, mutations in the R1 region (putative 
R1Cdc22 interaction domain by similarity with the R1 domain of Sml1) do not 
affect either function. 
 
 Finally, the FRET results are represented in Figure VII.2, part a. Of the 
41 spd1 mutants, 29 spd1 mutations did affect the ability of Spd1 to promote 
CFP-Suc22R2 Cdc22R1-YFP FRET. In most of the 12 spd1 mutants with a 
positive FRET signal, the FRET efficiencies were comparable to the spd1+ wt. 
In addition, those FRET efficiencies have the same profile as the spd1+ wt i.e. 
FRET is observed in both compartments of S-phase cells and G2-phase cells. 
spd1 mutants 8 and 36 have slightly lower FRET efficiencies. 
The FRET results do not correlate with the other Spd1 roles: spd1 mutants 4 
and 5 have the same profiles (normal Suc22R2 import and RNR inhibition) but 
have opposite FRET results. Similarly the spd1 mutants 12 and 13, that lost the 
RNR inhibition but have a normal importer role, have opposite FRET results. 
The converse is also observed, as spd1 mutants with different localization 
profiles (spd1 mutant 1 and 2) also have different FRET results, and spd1 
mutants with similar Suc22R2 localization but opposite RNR inhibition (spd1 
mutant 2 and spd1 mutant 14) can have opposite FRET signals. 
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Figure VII. 2 Comparison of the FRET experiments with the other data of experiments 
conducted on the 41 spd1 mutants (Reproduced from Nestoras et al. 2010) 
The spd1+ wt, spd1 Δ and the spd1+ mutants are compared in the different assays. The region 
corresponding to the HUG and RNR interaction domains are indicated above. 
a. Ability to promote FRET between CFP-Suc22R2 and Cdc22R1-YFP. Where the mutant number 
is underlined, FRET data has been verified by reversing the tags (i.e. YFP-Suc22R2 
Cdc22R1-CFP).  
b. Inhibition of RNR in spd1 mutants strains, measured by the rescue of the synthetic 
lethality of the Rad3ts Csn1Δ. 
c. Inhibition of RNR in Spd1 mutants strains, measured by the rescue of the Ddb1Δ spores 
formation defect. 
d. Spd1 nuclear import role assessed by nuclear accumulation of Suc22R2 (without HU -blue- 
and with HU –purple-). 
e. Stability of the Spd1 mutants proteins estimated in vivo.  
 
If one of the roles of Spd1 is to act as a scaffold for the RNR, this could 
occur in some of the spd1 mutants background. The inherent structural flexibility 
of the IDP would be required rather than functional active domains. However 
comparing the FRET results with the secondary structure of Spd1, we can say 
that there is a slight tendency for the secondary structures in Spd1 to be 
important for the FRET of the RNR.  
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IV.  RNR architecture after drugs or perturbed cell cycle 
1.  RNR inhibition: Hydroxyurea  
 HU is a free radical scavenger inhibiting the RNR activity, as the 
essential tyrosyl radical of Suc22R2 is necessary for the enzyme’s activity. In the 
presence of HU, the dNTPs levels drop drastically and cells transit to a slow 
replication mode (Poli et al, 2012).  Also after addition of HU, Suc22R2 
relocalizes to the cytoplasm, due to checkpoint-dependent Spd1 degradation 
(Liu et al, 2003). The long-term transcriptional response of cells to HU and all 
the involved proteins is still under investigation (Dubacq et al, 2006) and we will 
only consider its role as a radical scavenger here. The consequence of the 
inactivation of the RNR will be a loss of the de novo synthesis of dNTPs, but a 
preservation of the pools present (Koc et al, 2004). Consequently replication 
initiation, rate, and length will be affected as they will all be reduced and slowed 
down (Davidson et al, 2012; Poli et al, 2012).  
Upon treatment of the cells with HU, the FRET signal between CFP-
Suc22R2 and Cdc22R1-YFP (and YFP-Suc22R2 Cdc22R1-CFP) is lost. The same 
results are achieved in the 12 spd1 mutants that underwent FRET beforehand. 
The strains that did not FRET before still have a negative FRET signal. 
The loss of the FRET signal is S-phase independent as demonstrated by the 
control with G2-phase blocked cells also loosing the FRET signal after addition 
of HU. Therefore, we can speculate that HU affects the RNR through modifying 
the structure or conformation of the Suc22R2 Cdc22R1 complex. As the free 
tyrosyl radical is embedded inside the small RNR subunit’s structure, it could be 
that during the scavenging process, the RNR complex’s structure is relaxed 
and/or the conformation modified. Another possibility is the modification of 
stoichiometry of the RNR complex as some partial higher order oligomerization 
of the RNR has occurred after HU treatment  as observed by size exclusion 
chromatography. This observation was Spd1-independent. This suggests that 
there are various stiochiometry possibilities for the RNR complexes in S. 
pombe. 
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The FRET observed between the homo-dimers Suc22R2 is also 
abolished after HU treatment. This could indicate that R2 becomes inactivated 
(apoR2) due to loss of the radical. This loss of radical could affect the structure 
of Suc22R2 and have an effect on the general conformation of the complex, as it 
is known that the apoR2 has a different iron center organization to the active 
R2. It has been described that upon loss of the deeply embedded tyrosyl 
radical, the structure is modified with a slightly larger distance between the iron 
centers of each subunit. Although small, these differences in the inner structure 
of the R2 could be translated into the displacement of the fluorophores and loss 
of FRET.  
Other reasons could explain the FRET signal abolishment, for example 
the energy transfer could be quenched. However, some publications have used 
HU and observed FRET on unrelated proteins: CFP-YFP FRET (Tian et al, 
2007), GFP-RFP FRET (Morris et al, 2009) making us confident that this loss of 
FRET is due to biological reasons. In addition, when we added HU to a FRET 
positive DNA hairpin in vitro, preliminary results showed that the positive FRET 
signal remained. 
2.  RNR activation: 4NQO 
The RNR complex is activated after DNA damage, and 4-NitroQuinoline 
1-Oxide is an adequate drug to study DNA damage as it forms DNA base 
adducts through the 4NQO resulting metabolite 4-hydroxyaminoquinoline 
(Bailleul et al, 1981) (Thomas et al, 1991). DNA damage will trigger the cell 
cycle DNA damage checkpoint (Rad3 and Chk1-dependent) followed by an 
induction of the expression of the RNR genes leading to a 2 fold-increase in 
dNTPs in S. pombe (Hankansson et al, 2006b). Note that in S. pombe this 
increase in dNTPS levels is less than the increases observed in E. coli, S. 
cerevisae and mammals. The levels of dNTPs are higher following DNA 
damage than the increase of the dNTPs levels observed during the S-Phase of 
an unperturbed cell cycle (Chabes et al, 2003a).  
Considering these observations, it is reasonable to assume that after addition of 
4NQO, the RNR complexes will be active or even “hyper-active” (or “mature” 
complexes) to provide those higher levels of dNTPs locally for DNA repair. The 
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process of the dNTPs synthesis is not entirely clear, as questions remain on the 
nature of the dNTPs synthesis location and transport. Thus leading to the 
emergence of dNTPs channeling models. Channeling of dNTPs can be defined 
as direct transfer from one enzyme to the other, resulting in small sizes of 
dNTPs pools with a rapid turnover. The dNTPs compartmentalization and 
channeling hypothesizes have been discussed for many years (Mathews & 
Slabaugh, 1986) (Reichard, 1987), in addition recent research regarding dNTPs 
synthesis included as part of the DNA replication complex emphasizes this 
model (Poli et al, 2012) (Salguero et al, 2012).  
Also involving RNR aggregation at a specific localization, recent studies have 
shown the recruitment and importance of RNR complex at the sites of DNA 
damage in form of foci (Niida et al, 2010a) (Moss et al, 2010) . In this context, it 
is interesting to remember the observation of the strong Suc22R2 nuclear 
localization after treatment of 4NQO. dNTPs levels are hard to measure in vivo, 
and the RNR proteins are abundant, thus limiting resources to investigate this 
hypothesis in a direct manner. However the above-mentioned research 
supports the suggestion that active RNR complexes can be in the nucleus of 
the cell. 
The FRET results after DNA damage are interesting:  the spd1+ wt CFP-
Suc22R2 Cdc22R1-YFP strain (as well with swapped tags) retain its positive 
FRET signal after treatment with 4NQO and in the spd1 deleted strains, the 
FRET signal stays negative. However, all of the spd1 mutants have a positive 
FRET signal after treatment with the DNA damaging agent, even the spd1 
mutants that did not have the capacity to FRET between the fluorophores 
beforehand now have the ability for positive FRET between CFP-Suc22R2 and 
Cdc22R1-YFP. Like the spd1+ wt strain, the FRET efficiencies are positive 
throughout the cell and the cell cycle, although some spd1 mutants have lower 
FRET efficiencies. The spd1 mutants have different characteristics of RNR 
inhibition, RNR localization and Spd1 protein levels; but they have in common 
the ability to enable FRET after DNA damage.  
From these observations, we can propose that upon DNA damage, there 
is a specific “mature/active” RNR structure in place, partially dependent on 
Spd1 (as the Spd1 deleted has no FRET signal). Spd1 could act as a scaffold  
(Gunasekaran et al, 2003), binding to both RNR subunit therefore inducing 
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modifications in the RNR complex, and even after degradation of Spd1 after 
DNA damage, the complex could be formed into the correct conformation 
allowing FRET. This mature/active complex could be through a modification of 
stoichiometry or a change in structural conformation.  
We have seen how dNTPs are important for the DNA replication, in 
addition, the right balanced amount of the 4 dNTPs levels is important for 
limiting mutations (Kumar et al, 2010) . dNTPs levels are also important after 
DNA damage, to enable DNA repair, but also higher levels of dNTPs will allow 
DNA polymerases to bypass certain lesions (Sabouri et al, 2008). Some spd1 
mutants (i.e. spd1 mutant 26) have very low protein expression, but it could be 
that very small amounts of the scaffold protein are enough. As mentioned 
earlier, the IDPs proteins have peculiar structural qualities, and we can 
speculate that upon DNA damage, the IDPs will conform their structure to form 
a scaffold for the RNR. It is also possible that some other proteins are involved. 
Other interesting results were the homo-complexes FRET experiments, 
indicating that the small RNR subunits Suc22R2 exhibits close interactions in 
normal cells and in cells after DNA damage. Although the FRET efficiency is not 
entirely quantifiable, the FRET efficiency of CFP-Suc22R2 YFP-Suc22R2 after 
4NQO is reduced. This lower FRET efficiency could result from a fast turnover 
of new Suc22R2 supply, or a modification in conformation, but Suc22R2 remains 
in dimer after DNA damage.  
An interesting observation about the ring structure of six big subunits 
Cdc22R1 and a dimer of Suc22R2 is the ratio of tyrosyl radicals available for the 
number of active sites: two to six. Thus this leads to the proposal of a dynamic 
turnover of Suc22R2, providing new active tyrosyl radicals to the ring of Cdc22R1. 
It could be asked why the RNR complexes are not always in a “hyper-
active” or “mature” form, but it has to be remembered that levels of dNTPs have 
to be kept to an optimum level to avoid an increase in the mutation rate.  
3.  Heat shock  
Transcription of heat-shock proteins (HSPs) occurs in response to heat 
stress but also to other stresses  (Gallo et al, 1991) . In non-stressed cells, 
HSPs function as chaperones, with roles varying to maintaining newly 
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synthesized protein in an unfolded state or assisting proteins to form higher 
order complexes. Upon heat shock, HSPs have various functions: sequestration 
of heat-damaged proteins (preventing protein aggregation) as well as regulating 
unfolded proteins (Morano et al, 2012) . 
Heat shock has been described to affect the transcription of RNR: a 
larger suc22+ transcript of 1.9kb is observed (Harris P, 1996 ). Compared to the 
smaller 1.4kb suc22+ transcript, the larger transcript (1,9kb) has its initiation 
codon 550 bp upstream. The 1,9kb transcript is present at low levels during a 
normal cell cycle, but increased after heat shock in an Rad1-independent but 
Caf1-dependent manner (Harris P, 1996 ) (Takahashi et al, 2007). 
After heat shock in the RNR –tagged strains, the FRET efficiency is 
maintained and even increased in the spd1+ wt CFP-Suc22R2 Cdc22R1-YFP. 
This increase in FRET could have several explanations: increase of FRET 
positive complexes in the population, or the fluorophores are in general closer 
together corresponding to a modification of the conformation of the RNR 
complex. Since, we are observing the interaction between tagged proteins, we 
are not detecting the hypothetical protein resulting of the larger suc22+ 
transcript. 
4.  Live cell imaging observations 
Finally, some very dynamic aggregations of RNR have been observed 
during live cell imaging. Although verifications have first to be made in order to 
confirm that those RNR foci are not laser-damage induced, some hypothesis 
can be made with regards to their origins. These could be the colocalization of 
the RNR with the replisome, or DNA repair factories. RNR could be recruited 
locally to the DNA to facilitate the replication and repair by providing dNTPs 
locally (Niida et al, 2010a). Other possibilities, which may be worth 
investigating, are colocalization with the spindle pole body, PML bodies or other 
vesicle-like formation in the cells. 
The origins of these aggregates remains unexplained, but may be 
potentially interesting to have a clearer view of the dynamics and regulation of 
the enzyme.  
 In vivo structure-mediated regulation of Ribonucleotide Reductase in S. pombe – PhD thesis by Ann-Sofie Schreurs 
 
212 
V.  RNR Oligomerization 
Protein interactions are critical for many cellular processes in cells. Such 
interactions include the stable association of proteins within multi-subunit 
complexes and the transient association of regulatory proteins. Many of these 
multi-subunit complexes have been described in heterocomplexes, but also 
homocomplexes. Sometimes these quaternary structures are shaped in rings, 
for example: MCM complex , Cohesin , ORC complex, PCNA , Ku complexes, 
heat shock proteins… Many of these ring-structured complexes are linked to 
DNA-related mechanisms.  
The simple colocalization of two proteins in the same subcellular 
compartment does not provide evidence that they interact; therefore to supply 
proof of protein-protein interaction we used FRET (Pietraszewska-Bogiel & 
Gadella, 2011). FRET is based on the ability of a donor fluorophore to transfer 
some of the energy from its excited state to a close acceptor fluorophore. 
Because FRET energy transfer is highly distance-dependent, detection of FRET 
requires the two fluorophores to be within 1-10nm, the distance typically found 
for directly interacting proteins. 
Through our FRET data we have observed structural modifications of the 
RNR, which were dependent on Spd1 but also on the different drugs used. 
Conformational change is expected in the RNR as both subunits have various 
flexible domains and it has been suggested that different loops within the 
structure will allow conformational change (Larsson, 2004) (Xu et al, 2006)  to 
adapt to the various effectors as well as substrates. Oligomerization has also 
been described in RNR complexes throughout different species (Hofer et al, 
2012) . Considering the low sequence identity between those different species, 
the superposition of the obtained structures resulted in impressively high 
similarities. In addition, higher order complexes seem present throughout the 
different RNR species. 
In vitro studies have been investigating in more detail the oligomeric 
formation of RNR. In mammals, α2β6 (α2: 2xR2 and β6: 6xR1) is the major RNR 
form present, induced by ATP as well as dATP (Kashlan et al, 2001) 
(Rofougaran et al, 2006). The inhibited dATP RNR form has been demonstrated 
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to be in a ring-shaped homocomplex (Fairman, 2011) and similar observations 
were made for S. cerevisae by the same team (Fairman, 2011). The classical 
α2β2 complexes seems to be only a minor form present. While it has been 
proposed that the RNR complex cycles from the active ATP-induced α2β6 to the 
inactive dATP-induced α2β6, the two forms seem to have different structures. 
Indeed, a point mutation disabling RNR to form dATP-dependent R1 hexamers 
could still form ATP-dependent hexamers (Fairman, 2011) (Hofer et al, 2011). 
This suggests a different structure for the active ATP-induced RNR form, 
although with similar stoichiometry. 
In E. coli, similar larger complexes were depicted with the RNR varying 
from an active α2β2 to an inactive α4β4 (Rofougaran et al, 2008b). The inactive 
RNR form in E. coli has also been recently crystallized (Ando et al, 2011)  and 
is also in a ring structure although a different ring: sequential small and big RNR 
dimers make the α2β2α2β2 ring.  
In addition, other stoichiometries have been described, for example 
another inhibited RNR form was observed in a stable α6β6 stiochiometry after 
addition of gemcitabine to the ATP induced α6. Three β2 were shown to bind to 
the α hexamer  (Wang et al, 2009). Gemcitabine is a cytidine-based substrate 
analogue. The inhibition of RNR activity by gemcitabine is caused by the decay 
of the tyrosyl radical on the small subunit R2 and has been observed to alkylate 
the catalytic cysteine residues of the large subunit R1. A crystal structure of the 
gemcitabine bound-R1 in S. cerevisiae shows that the orientation of 
gemcitabine in the catalytic site is altered from the orientation of the natural 
cytidine-based substrate. 
All these recent findings confirm the model of an αnβn regulation with 
various subunits “n”. The RNR activity regulation is linked to these various 
oligomeric conformations, by abolishing or facilitating the correct electron chain 
transport. 
All these structures take into account the allosteric regulation of the RNR. 
As we wanted to investigate more precisely the stoichiometry of RNR with 
regards of the effects of Spd1 and Spd2, we decided to take the S. pombe RNR 
system in vitro to study the different RNR forms in a controlled environment, 
and observe the direct effect of Spd1 on the RNR complexes in vitro. This 
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would also allow us to estimate more precisely which RNR oligomeric or 
conformational forms have the ability to FRET or not. The aim was to correlate 
in vivo FRET data with the in vitro precision to allow us further interpretation of 
the in vivo data.  
 
VI.  Conclusion 
The results of this project with other observations, allow us to propose a 
model with regards to the role of Spd1 and Spd2 in the structure-dependent 
regulation of RNR. Also, the mechanisms behind the activation and inactivation 
of RNR in vivo, independently of the regulators can be hypothesized.  
We suggest that Spd1 mediates the formation of immature RNR 
complexes, and after Spd1 degradation those complexes are in the optimal 
conformation for catalytic activity. In spd1 deleted cells, the absence of Spd1 
would drive RNR to form an alternative architecture. These alternative RNR 
complexes are abundant and not inhibited by Spd1, thus the RNR activity is not 
limited by this variant architecture. 
In support of this model, another IDP has been described with very similar roles: 
the p27 cyclin-dependent kinase inhibitor. It mediates the formation of immature 
inactive Cdk2-CycA complexes (Sherr & Roberts, 1999) (Borriello et al, 2007; 
Galea et al, 2008a) by binding to CyclinA and Cdk2, independently but 
simultaneously. The protein p27 has two distinct independent binding sites for 
CyclinA and Cdk2, and folds after binding, leaving only a flexible loop unbound. 
Interestingly, p27 binds Cdk2 inside a cleft, mimicking the method used by RNR 
and ATP, thus inhibiting Cdk2. These bindings involve drastic conformational 
changes regulating the complexes. After p27 degradation by phosphoprylation 
(Uranbileg et al, 2012), the complex is actived. This mechanism has since been 
described in other similar protein complexes (Sherr & Roberts, 1999) 
(Krukenberg et al, 2011) and suggested to strongly influence the cell cycle. 
In the RNR complex, the R2 C-terminus is buried in a cleft of R1, and R2 
C-terminal mimicking peptides interfere with this optimal conformation (Cohen, 
1986) (Hamann et al, 1998). It has also been suggested that in S. cereveisae 
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(Zhao et al, 2000)  Sml1 using its C-terminal binds this same R1 cleft, which is 
necessary for full RNR inhibition. 
With regards to the drugs used, we can only speculate about the effect 
they have on the RNR complexes. HU is a radical scavenger and inactivates R2 
thus the RNR activity. Considering the depth of the radical inside the R2, as well 
as the described different iron centre structure upon loss of the radical, we can 
expect a conformational change readable by loss of FRET. In addition, if we 
consider the ultimate effect of gemcitabine (loss of free radical) and the 
observed higher order complex associated with this RNR inactivation we can 
speculate that the same occurs in presence of HU. Partial higher-order 
complexes were observed after addition of HU to our strains. 
The 4NQO result is less straightforward to interpret, but it seems to 
represent the active form of RNR. The complex in which RNR is formed after 
DNA damage is optimal for FRET to occur and seems dependent on Spd1. 
Maybe the inherent qualities of the IDP are required to configure the RNR in an 
optimum complex to provide high supplies of dNTPs. 
  
 
Figure VII. 3 Schematic model based on the hypothesis suggested during this project 
Diagram representing the models for RNR regulation in S. pombe by structure-induced 
modifications. Without Spd1 the RNR complex is not in a specific conformation, but with the 
addition of Spd1 and Spd2, RNR is conformed to a more optimum conformation. After 
degradation of the RNR regulators proteins (Spd1 and Spd2), the RNR complex can still be 
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affected by other effectors. HU will inhibit the complex, resulting in a different conformation or 
oligomerization. DNA damage by 4NQO will keep the RNR complex in an optimum 
conformation for efficient dNTPs production. Activation of RNR activity by ATP will result in an 
efficient conformation for dNTPs production, and it has been described to be in a ring shaped of 
α6 with a dimer of β2 inside the structure. The inhibition of RNR by dATP will lead to a variant 
structure hexameric α6, possibly α6β2-6. 
 
It is now accepted that the allosteric regulation of RNR happens through 
an αnβn mechanism, although this has been mostly studied in vitro and with 
dATP and ATP as effectors. Through this project we can say that the RNR 
regulators in S. pombe (Spd1 and Spd2) could also have structure-dependent 
regulatory functions. 
Understanding the full details of RNR regulation is of great interest for 
basic research, but is also for the interest for drug developments. RNR inhibition 
is widely used and considered for treatments against viruses, cancer and other 
diseases (Cooperman, 2003) (Cerqueira et al, 2006) . 
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CHAPTER VIII Future directions  
I.  FRET assays in vivo 
1.  Complete the Spd2 FRET data 
It would be interesting to obtain the in vivo FRET experiment with spd1 Δ 
and spd2 Δ after treatment with 4NQO to understand if Spd2 has a similar role 
to Spd1. 
In addition, combining some spd1 mutants with spd2 Δ for FRET analysis 
without treatment, but especially after treatment with 4NQO.  
2.  Confirm the inactive RNR FRET data  
As the FRET results after HU treatment was at first unexpected, 
additional experiments in conditions where RNR is inhibited would confirm this 
data. RNR inhibitors are various: nucleoside analogues, iron chelator or free-
radical scavengers.  
3.  Confirm the active FRET (4NQO) data 
Although 4NQO was a good tool to obtain active/“hyper-active” RNR 
complexes, it would be interesting to have a second experiment where upon 
DNA damage the FRET signal is positive in the spd1 wt strains as well as the 
spd1 mutants. 
Therefore, other damaging agents could be used: MMS and/or Bleomycine. 
To ensure of the correct DNA damage occurrence as well as the DNA damage 
response pathways have been activated, controlling Chk1 phosphorylation 
would be an important control. 
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II.  Single-molecule microscopy experiments 
1.  Further RNR purified proteins characterization 
In first instance, Cdc22R1-CFP and Cdc22R1-YFP have to be purified from 
E. coli in order to characterize the proteins with regards to their diffusion time 
and stoichiometry for use in subsequent experiments. 
Addition of dNTPS to the purified Cdc22R1 is an essential part for future 
directions, as the aim is to obtain an ATP-activated RNR as well as dATP-
inhibited RNR. 
2.  Binding assays using RNR and the purified Spd1 proteins (wt and 
mutants) 
This will enable us to observe a shift in the diffusion time, therefore a 
binding. Then the more precise measurements can be done using both tagged 
RNR subunits, adding or not the purified Spd1 proteins 
- YFP-Suc22R2 with Cdc22R1-CFP without Spd1 (and swapped tags) 
- YFP-Suc22R2 with Cdc22R1-CFP with Spd1 (and swapped tags) 
- YFP-Suc22R2 with Cdc22R1-CFP with the Spd1 mutants (and swapped 
tags) 
- YFP-Suc22R2 with Cdc22R1-CFP with Spd1 and Spd2 (and swapped 
tags) 
- YFP-Suc22R2 with Cdc22R1-CFP with Spd2 (and swapped tags) 
In addition, the presence of the tyrosyl radical should be monitored to relate to 
the in vivo data. 
3.  In vitro FRET of the RNR  
Finally, we could then proceed to the FRET measurement in vitro using 
the same samples as mentioned above. The FRET data in vitro should 
correspond to the in vivo data, and the advantage of a more controlled 
environment with a precise knowledge of the stoichiometry of each subunits will 
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help to interpret previous data.  We should be able to draw a conclusion on the 
meaning of positive FRET signal and negative FRET signal in the context of the 
RNR proteins. 
4.  S. pombe purified proteins experiments 
Further investigation could also be done with the endogenous purified 
RNR proteins. The purification process should be repeated in bigger volumes, 
and find methods to purify cross-linked RNR complexes after treatment of the 
cells with HU as well as 4NQO.  
III.  Additional key biochemistry experiments  
1.  Native PAGE gels of the purified proteins 
This could be done to assess the stiochiometry of the purified RNR 
proteins, from E. coli as well as from S. pombe. Not only would these data 
indicate the state of the proteins, but it would confirm the photobleaching step 
assay done on the TIRFM. 
2.  Size exclusion chromatography (SEC) of RNR in S. pombe cells 
Additional SEC data could be carried out in order to understand RNR 
regulation. After HU or 4NQO treatment to the cells, in the various RNR tagged 
strains: spd1 Δ, spd1 mutants, spd2 Δ, and spd1 Δ spd2 Δ. This data could 
maybe help us correlate the FRET data with the oligomerization status of the 
RNR complexes. 
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IV.  Additional Microscopy Experiments 
1.  Suc22R2 dynamics and FRAP 
As mentioned during this thesis, the small subunit Suc22R2 has 
localization dynamics throughout the cell cycle, with mostly nuclear localization 
in G2 but partial cytoplasm relocalization during S-phase. Classical intensity 
measurements could be done on the long time-scale videos, but in addition, 
FRAP (Fluorescence Recovery After Photobleaching) could provide us 
information regarding the diffusion times of Suc22R2 in various conditions and 
strains, but it could also supply protein binding data.  
2.  Determining the nature of the RNR foci 
Confirming the laser power correlation with the number of foci followed 
by observing if the foci colocalize with various other cellular components could 
be of interest (PCNA tagged proteins to follow replication, DNA damage, using 
rad22 foci, degradation vesicles, spindle pole body (SPB) by using the marker 
Sad1 for example). 
3.  PALM 
An important step for this project and future experiments is the use of 
PhotoActivable Light Microscopy (PALM). As mentioned in the introduction, this 
method will improve highly the resolution, achieving single molecule levels in 
vitro, along with other upcoming potentials. 
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CHAPTER IX Annexes and Publication 
I.  Annexe 1: FRET measurement by FACS 
Alternative methods to measure FRET results in a faster and more 
automated way were of interest during this project. Therefore, the idea to use 
FACS for measuring the YFP fluorescence in a same amount of cells did seem 
testable, as in a FRET negative strain, there should be less YFP fluorescence. 
The method had been described before (Banning et al, 2010; You et al, 2006) 
thus the idea to try it with S. pombe cells. 
In first instance, comparison between a FRET positive strain  (CFP-Suc22R2 
Cdc22R1-YFP spd1 wt) and a FRET negative strain (CFP-Suc22R2 Cdc22R1-YFP 
spd1 Δ) provided us with a specific result: distinct profile were observable as the 
FRET negative strain had less YFP fluorescence (shift of the measurements on 
the x axis: “FITC”). 
 
Figure IX. 1 FACS profiles of FRET positive and FRET negative strains 
The FRET positive strain CFP-Suc22R2 Cdc22R1-YFP Spd1 wt and the FRET negative 
strain CFP-Suc22R2 Cdc22R1-YFP Spd1 Δ were compared after measurements on the 
FACS. Set quantities of unsynchronized cells were tested using s. pombe standards. 
The YFP fluorescence was measured using the FITC filters. 
 
 In vivo structure-mediated regulation of Ribonucleotide Reductase in S. pombe – PhD thesis by Ann-Sofie Schreurs 
 
222 
These results were encouraging therefore further controls were done to ensure 
the observable results were genuine. Non-tagged strains (501, 503) as well as 
single tagged strains: YFP-Suc22R2 and Cdc22R1-YFP (positive YFP signal and 
“negative FRET” control), CFP-Suc22R2 and Cdc22R1-CFP (negative YFP signal 
control) were used on the system. The FRET positive and FRET negative 
strains as well, enabling us to verify the controls and the repeatability of the 
system.  All these controls were correct and reproducible. 
 
 
Figure IX. 2 FACS profiles of FRET controls 
FACS measurements of the FRET was controlled using non-tagged strains (501 and 
503) as well as single tagged strains (CFP/YFP-Suc22R2 and Cdc22R1-CFP/YFP). The 
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FRET positive strain CFP-Suc22R2 Cdc22R1-YFP Spd1 wt and the FRET negative strain 
CFP-Suc22R2 Cdc22R1-YFP Spd1 Δ were also used. Set quantities of unsynchronized 
cells were tested using s. pombe standards. The YFP fluorescence was measured 
using the FITC filters. 
 
Finally, various spd1 mutants were measured on the FACS by a blind method to 
ensure a clear read-out would be possible. Unfortunately, the FACS profiles 
were not as straightforward as the FRET positive and FRET negative profiles, 
resulting in unsure interpretation. On the figure below, the FRET results as 
known by confocal measurements are annotated. Unfortunately it was not 
possible to distinct the results and correlate them to the know FRET results.  
 
Figure IX. 3 FACS profiles of spd1 mutant strains 
FACS measurements profiles of some spd1 mutant strains. The FRET status as 
measured by confocal is mentioned above. Set quantities of unsynchronized cells were 
tested using s. pombe standards. The YFP fluorescence was measured using the FITC 
filters. 
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II.  Annexe 2: List of primers 
 
Cloning: 
  
  
pUC19-inserT-
verif-F 5' GAAATACCGCACAGATGCGT 3' 
pUC19-inserT-
verif-R 5' GCTGGCACGACAGGTTTCCCG 3' 
    
XFP-Suc22-F-
1 5' GAATGGTATCAAAGTTAACTTCA 3' 
XFP-Suc22-F-
2 5' GCTCTGAAGTTCAGATCCCTG 3' 
XFP-Suc22-R-
1 5' CCTTAGGTTCACGAATGTATG  3' 
XFP-Suc22-R-
2 5' GACTTCAGCTCTGGTCTTGT  3' 
    
Cdc22-XFP-F-
1 5' GCCGGTACTCCTCGTCCCCAACT  3' 
Cdc22-XFP-F-
2 5' GCCGTAGCAATATGCGC  3' 
Cdc22-XFP-F-
3 5' GTCTTAAGACTGGAATGTACT  3' 
Cdc22-XFP-R-
1 5' GCCTTTCCATTCTTTATAACTG  3' 
Cdc22-XFP-R-
2 5' GCATCGGCAAGACCTTGAACA  3' 
Cdc22-XFP-R-
3 5' GTCGTCTTTCATCGTAACGAGG  3' 
    
T7-Check-f 5' AATTAATACGACTCACTATAGGG  3' 
T7-Check-r 5' TGCTAGTTATTGCTCAGCGG  3' 
    
yfp-A-peT3A-F 5'AAGGAGATATACATATGTCTAAAGGTGAAGAATTATTCA 3' 
yfp-A-peT3A-R 5' GTCATGCTAGCCATATGTTATTTGTACAATTCATCCATACC3' 
    
Cdc22-CDNA-
infusion-F 5' AAGGAGATATACATATGTTTGTATACAAAAGAGACGGACGTC 3' 
Cdc22-CDNA-
infusion-R 5' GACGGAGCTCGAATTCGGCTGAGCACATTTCGCAAGC 3' 
    
New-P-Cdc22-
F 5' AAGGAGATATACATATGTTTGTATACAAAAGAGACGGACGTC 3' 
New-P-Cdc22-
R 5' GTCATGCTAGCCATATGGGCTGAGCACATTTCGCAAGC 3' 
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New-l-xfp-F 5' AGCCCATATGGCTAGCGGTTTAATGTCTAAAGGTGAAGAATTATTC 3' 
New-l-xfp-R 5' CACCAGTCATGCTAGCTTATTTGTACAATTCATCCATACCATGG 3' 
    
InFusion-l-x-F-
fin  5' GCTCAGCCGAATTCGAGCTCGGTTTAATGTCTAAAGGTGAAGAATT 3' 
InFusion-l-x-R-
fin  5' TGCTCGAGTGCGGCCGCTTATTTGTACAATTCATCCATACCATGG 3' 
    
pET3a_L_F  5'TATGTTTGTATACAAAAGAGACGGACGTCGTAGGCGCGCCG 3' 
pET3a_L_R  5'GATCCGGCGCGCCTACGACGTCCGTCTCTTTTGTATACAAACA  3' 
    
cdc22EX2_F  5'GACGGACGTCAAGAGAAAGTGG  3' 
XFP_R  5'AAGTGGCGCGCCTTATTTGTACAATT  3' 
    
suc22XFP_pE
T_F 5'GGGGAAGCTTCATATGTCTAAAGGTGAAGAATTATTCACTGGT  3' 
suc22_pET_R 
5'GGGGGATCCCTAAAAGTCCTCATCGATTGTAAATGTATGATC  3' 
  
  
Strains 
Checking  
  
Cdc22-Check-
F    5’ TTATTGAGATGAACTATTACTC 3’  
Cdc22-Check-
R  5’ AAACATTAAAAGAAACAATAAAATGT 3’  
    
Cdc22 Check-
2 F 5' CCGGTTTCCACTCTTAGCTT 3' 
Cdc22 Check-
2 R 5' CCATTCTGAGCCTGCTCACT 3' 
    
Suc22-Chk-F 5' CAA GAG ATA ATC GCG GTG GAA GA 3' 
Suc22-Chk-R 5' GCA AAA GTG AGT AGG TCT CAG AG 3' 
    
Spd1-Chk2-F 5' GATCCGTGTTCGATAGGCAT 3' 
Spd1-Chk2-R 5' GAGAGACAAATGCCCAAAAG 3' 
    
Spd2-Check- F   5’ CATTGAAAATTAAAAGATTGCTC 3’ 
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Spd2-Check-
R1  5’CAGGCTTGGCAAAAGAATC3’  
    
Spd2-Check-
R2  5’ GAGTAATAGTTCATCTCAATAA 3’  
    
Spd2-Check2- 
F   5' GTAATTGCTAGCATTTGTGATTCACC 3' 
Spd2-Check2-
R2  5' CCAATAGTATCGAAAGCTTTATCTTGC 3' 
    
Ura4-R2 5' CCAACCAGCTTCTCTATATCTCTTG 3' 
    
XFP reverse  5’ TGTGGTCTCTCTTTTCGTTTGGA 3’  
  
Strains Construction and other primers: 
  
n-Term spd1 F 
5’AAACGTCACAAAGCCGAGTAGCAAACGCTCCCACAACCAAACACTACACAAAGGTTCG
TCGACAATTTATTTTGGAAAAAATGTCTAAAGGTGAAGAATT 3’ 
n-Term spd1 R 
5’GCTTTCGGGAAGCTGAGGACGCATTGAAGACTCAGGCTGCTCAACATGAGTCTTTGTG
GTCATAACTCGCTTGCTGCTGTGCATACCACCCCCGCGCCC  3' 
    
n-Term cdc22 
F 
5' 
AGCGTGACGCGTCTGAACGCGTTTTTCATTTACTATAAATATTCCCGGTATTTACCACCTT
ACAAACTAGAACAAACACGATGTCTAAAGGTGAAGAATT 3' 
n-Term cdc22 
R 
5' 
AAACGGCAACGTTGTAACAAAATTTCTACTAATCTTCTAACTGTATTTTATTTCCTGTTTCA
TACCTCTTTTGTATACAAACATACCACCCCCGCCGC C  3' 
    
mEOS2-
subClone-
Cdc22-F  5' AAAA TTA ATT AA CATGAGTGCGATTAAGCCAGACAT 3'  
mEOS2-
subClone-
Cdc22-R 5' AAAAGGCGCGCCTTATCGTCTGGCATTGTCAGGC 3' 
    
mEOS2-
subClone-
suC22-F 5' AAAAGGATCCATGAGTGCGATTAAGCCAGACAT 3' 
mEOS2-
subClone-
suC22-R  5' AAAAGTCGACTCGTCTGGCATTGTCAGGCAAT 3' 
    
pFA6A-verif-F  5' TTATGTATCATACACATACGATTTAG 3' 
pFA6A-verif-R  5' GAGCCGTAATTTTTGCTTCGC 3' 
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pGEM-verif-F  5' CGTTGTAAAACGACGGCCAGT 3' 
pGEM-verif-R  5' CAGCTATGACCATGATTACGCC 3' 
    
GFP-F 5' TAAAGGTGAAGAATTATTCACTGGTG 3' 
GFP-R 5' TATTTGTACAATTCATCCATACCATGG 3' 
    
CFP-F 5' CTTTGACTTGGGGTGTTCAATG 3' 
CFP-R 5' CGAAAGGGCAGATTGTGTGG 3' 
    
YFP-F 5' GGCCAACACTTGTCACTACTTTC 3' 
YFP-R 5' GATCTTTCGAAAGGGCAGATTGATAG 3' 
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Regulation of ribonucleotide reductase
by Spd1 involves multiple mechanisms
Konstantinos Nestoras,1 Asma Hadi Mohammed,2,6 Ann-Sofie Schreurs,1,6 Oliver Fleck,3
Adam T. Watson,1 Marius Poitelea,1 Charlotte O’Shea,4 Charly Chahwan,5 Christian Holmberg,3
Birthe B. Kragelund,4 Olaf Nielsen,3 Mark Osborne,2 Antony M. Carr,1,7 and Cong Liu1
1Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Brighton BN1 9RQ, United Kingdom;
2Department of Chemistry, School of Life Sciences, University of Sussex, Brighton BN1 9RJ, United Kingdom; 3Department
of Biology, University of Copenhagen, DK-2200 Copenhagen, Denmark; 4Structural Biology and NMR Laboratory, Department
of Biology, University of Copenhagen, DK-2200 Copenhagen, Denmark; 5Department of Molecular Genetics, University of
Toronto, Toronto, Ontario M5S 1A8, Canada
The correct levels of deoxyribonucleotide triphosphates and their relative abundance are important to maintain
genomic integrity. Ribonucleotide reductase (RNR) regulation is complex and multifaceted. RNR is regulated
allosterically by two nucleotide-binding sites, by transcriptional control, and by small inhibitory proteins that
associate with the R1 catalytic subunit. In addition, the subcellular localization of the R2 subunit is regulated
through the cell cycle and in response to DNA damage. We show that the fission yeast small RNR inhibitor Spd1
is intrinsically disordered and regulates R2 nuclear import, as predicted by its relationship to Saccharomyces
cerevisiae Dif1. We demonstrate that Spd1 can interact with both R1 and R2, and show that the major restraint of
RNR in vivo by Spd1 is unrelated to R2 subcellular localization. Finally, we identify a new behavior for RNR
complexes that potentially provides yet another mechanism to regulate dNTP synthesis via modulation of RNR
complex architecture.
[Keywords: Ribonucleotide reductase; intrinsically disordered proteins; nuclear import; Cullin 4]
Received October 9, 2009; revised version accepted April 7, 2010.
Faithful DNA replication, a prerequisite for maintaining
genome integrity, requires the maintenance of the correct
concentration and the relative ratios of dNTPs (Chabes
et al. 2003; Holmberg et al. 2005). dNTPs are formed by
ribonucleotide reductase (RNR), which converts ribonu-
cleoside diphosphates into their deoxy forms. Eukaryotes
use type Ia RNR complexes comprised of multimers of two
subunits: the large (R1) catalytic subunit, and the small
(R2) diferric-tyrosyl radical-generating subunit (Stubbe
2003; Nordlund and Reichard 2006). Distinctive for type
Ia RNR complexes are two allosteric nucleotide-binding
sites on R1 (Reichard 2002; Nordlund and Reichard 2006).
The N-terminal ‘‘overall activity’’ site is an ATP cone do-
main that binds either ATP (stimulatory) or dATP (in-
hibitory). The specificity site can bind ATP, dATP, dTTP,
or dGTP and selects the substrate to be reduced, thus
maintaining the appropriate dNTP ratios (Nordlund and
Reichard 2006).
RNR is also regulated by a number of further mecha-
nisms. In all eukaryotes studied, RNR protein levels are
regulated via transcription. This is particularly obvious in
response to genotoxic stress, when DNA repair synthesis
requires dNTPs to be present outside of S phase. Work in
the budding yeast Saccharomyces cerevisiae identified
a further layer of control via the binding of a small RNR
inhibitor protein, Sml1, to the R1 subunit (Zhao et al.
1998, 2000; Chabes et al. 1999). Sml1 is degraded as cells
enter S phase and in response to genotoxic stress outside
of S phase (Zhao et al. 2001). Work in the fission yeast
Schizosaccharomyces pombe (Liu et al. 2003) demon-
strated that the R2 subunit is localized primarily to the
nucleus in non-S-phase cells, and is relocalized to the
cytoplasm in response either to S-phase entry or follow-
ing DNA damage checkpoint activation. Because the
majority of the R1 subunit is constitutively cytoplasmic,
this relocalization was proposed to promote RNR
complex formation and dNTP synthesis. R2 nuclear
localization depends on a small RNR regulator, Spd1. In
S. cerevisiae, an Spd1-related protein, Dif1, was subse-
quently shown to promote R2 nuclear import (Lee et al.
2008; Wu and Huang 2008). In cooperation with a nuclear
anchor, Wtm1 (Lee and Elledge 2006), Dif1-dependent
import results in R2 nuclear accumulation. R2 nuclear
accumulation is regulated by S-phase-dependent or geno-
toxic stress-dependent Dif1 degradation. The reduced
6These authors contributed equally to this work.
7Corresponding author.
E-MAIL a.m.carr@sussex.ac.uk; FAX: 44-1273-678121.
Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.561910.
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Dif1 level decreases nuclear import while nuclear export
remains active, promoting a net increase in cytoplasmic
R2 (Lee et al. 2008).
S. cerevisiae Sml1 and Dif1 proteins share a domain,
the SML box (Fig. 1A; Lee et al. 2008). Synteny analysis
suggests that the SML1 and DIF1 genes are derived from
the same ancestral locus, diverging when S. cerevisiae
underwent genome duplication during its evolution. The
SML1 locus subsequently underwent a further direct
duplication event so that a related gene, HUG1, is imme-
diately adjacent (Lee et al. 2008). Hug1 andDif1 also share
a sequence motif, the HUG box, that is not apparent in
Sml1. Hug1 function is not well defined; its transcript is
induced by DNA damage, and it has been proposed to
regulate RNR feedback inhibition (Basrai et al. 1999;
Benton et al. 2006).
Spd1 in S. pombe and Dif1 in S. cerevisiae regulate R2
nuclear localization. The HUG domain is conserved
between Spd1 and Dif1. Dif1 binds R2 via the HUG
domain (Lee et al. 2008) to facilitate R2 nuclear import,
suggesting that Spd1 may share this function. Spd1 also
shares a region of sequence similarity with Sml1, equat-
ing to the last half of the suggested Sml1 RNR1-binding
domain (Zhao et al. 2000; Lee et al. 2008). This region
resides downstream from the C-terminal a-helix region of
Sml1, a region with a clear role in RNR1 inhibition (Zhao
et al. 2000). Conservation of an R1 interface, albeit
limited, would be consistent with the direct association
between Spd1 and Cdc22R1 reported to mediate vitro
biochemical inhibition of RNR (Hakansson et al. 2006).
The sequence conservation between Spd1, Dif1, Sml1,
and Hug1 indicates that Spd1 may be the sole S. pombe
ortholog of the ancestral gene (summarized in Fig. 1).
Here we provide evidence that Spd1 is an intrinsically
disordered protein (IDP) that acts as an import factor for
the RNR R2 subunit. Using FRET analysis, we demon-
strate that Spd1 controls RNR complex architecture.
However, this does not correlate to the formation of
active complexes. We suggest it reflects an additional
level of RNR regulation beyond formation of canonical
RNR tetramers of 2xR1 and 2xR2 subunits (a2b2 tetra-
mer). By structure–function analysis, we separate three
roles for Spd1: We identify a mutant defective specifically
for Suc22R2 nuclear import (spd1-M2), mutants specifi-
cally defective in their ability to restrain RNR function in
vivo (i.e., spd1-M12 and spd-M35), and mutants that have
specifically lost the ability to promote FRET (i.e., spd1-
M1 and spd1-M6). Thus, each of these three roles can be
separated from each other, underlining the segmental
distribution of function typical of IDPs. Contrary to
expectation, we show that the ability of Spd1 to restrain
RNR activity in vivo (and thus interfere with S phase) is
Figure 1. Spd1 is an intrinsically unfolded protein.
(A, top) Cartoon representation of relationship to S.
cerevisiae Dif1, Sml1, and Hug1 (data adapted from
Lee et al. 2008). (Bottom) Disorder and structure
predictions from the indicated software. (Red boxes)
Coil; (green boxes) helix. (B) Spd1 was purified to
homogeneity and showed a lower electrophoretic
mobility than expected (18 kDa vs. 14 kDa). Lane 2
(fraction 6) and lane 3 (fractions 7 and 8) of the
MonoQ purification after buffer change to PBS (pH
7.4). (Lane 1) Low-molecular-weight markers; mo-
lecular weight is indicated in kilodaltons. (C) A far-
UV CD spectrum of Spd1 recorded from 250 to 190
nm on 10 mM Spd1 and 10 mMNaH2PO4 (pH 7.4). A
large negative ellipticity with a maximum at 199 nm
suggests an unfolded protein with little or no sec-
ondary structure. (D) An 15N,1H-HSQC NMR spec-
trum of 1.0 mM 15N-Spd1 and 10 mM NaH2PO4 (pH
7.4) recorded at 10°C. Very little dispersion of signals
is seen, as well as variable peak intensities.
Nestoras et al.
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not a consequence of its ability to sequester Suc22R2 in
the nucleus. The restraint of RNR activity in vivo likely
reflects the in vitro inhibition of RNR by Spd1 identified
by biochemical analysis, although this remains to be
established formally.
Results
Spd1 is an IDP
Sml1 is a member of a group of proteins that are in-
trinsically disordered (Danielsson et al. 2008). An IDP
lacks a well-structured three-dimensional fold (Tompa
2002). However, nuclear magnetic resonance (NMR)
studies show that IDPs can adopt transient structure in
solution, and that some IDPs fold onto their interaction
partner when they associate. This process, coupled fold-
ing and binding, can result in protein–protein interactions
with relatively low affinity but high specificity (Sugase
et al. 2007). The Spd1 sequence has the typical charac-
teristics of an IDP: a high content of charged residues
(23%), and a low aliphatic index (52.85; for reference,
myoglobin = 95.1). Structural prediction programs such as
DrDOS (Ishida and Kinoshita 2007) predict a high proba-
bility of disorder, with minor regions that can potentially
form intermittent secondary structures. Most consistent
are the two helical regions between residues 27–44 and 66–
76, plus the possibility of shorter, extended structures
between 6–10 and 115–120 (Fig. 1A).
To investigate the disorder characteristics by spectros-
copy, recombinant Spd1 was purified to >98% homoge-
neity (Fig. 1B). Electrophoretic mobility corresponded to
;18 kDa, higher than the expected 14.2 kDa. This is a
general attribute of IDPs (Tompa 2002). A far-UV CD
spectrum showed no distinct signs of pronounced sec-
ondary structure elements, with very little negative
ellipticity in the 210- to 220-nm range (Fig. 1C). Instead,
a large negative signal with maximum at 199 nm was
evident, highly indicative of an unfolded protein. An
15N,1H- HSQC NMR spectrum recorded at 10°C showed
a very narrow distribution of signals in the 1H dimension,
also typical of unfolded proteins (Fig. 1D). Importantly,
a distribution of both high and low intensities of the
NMR signals was observed, which suggests some resi-
dues of Spd1 are in intermediate exchange on the NMR
time scale, possibly due to sampling of several conforma-
tions. Thus, Spd1 possesses all of the hallmarks of an IDP:
low electrophoretic mobility, a lack of secondary struc-
ture in far-UV CD, and a collapsed NMR spectrum
corresponding to an unfolded protein. Similar results
have been established previously for Sml1 (Danielsson
et al. 2008).
Spd1 regulates R2 nuclear import, but does not act
as a nuclear anchor
In S. cerevisiae, two distinct mechanisms contribute to
nuclear accumulation of R2: Dif1-dependent nuclear
import, and R2 retention by the Wtm1 nuclear anchor.
To establish if Spd1 shares the nuclear import function,
we examined if Suc22R2 accumulates in the nucleus in
spd1-d cells by blocking nuclear export with leptomycin
B (LMB), which inhibits Crm1-dependent nuclear export
of Suc22R2 (Liu et al. 2003). Suc22R2 did not accumulate
in the nucleus in response to LMB treatment (Fig. 2A),
indicating that Suc22R2 is no longer transported into the
nucleus in the absence of Spd1 and thus cannot accumu-
late there when export is blocked.
Despite considerable effort, we did not identify a ho-
molog or ortholog of the Wtm1 nuclear anchor mecha-
nism in S. pombe. In addition, spd1 deletion results in
complete Suc22R2 delocalization from the nucleus. In
S. cerevisiae, Dif1 deletion only partially disrupts R2
nuclear accumulation. The remaining accumulation is
Wtm1-dependent (Lee and Elledge 2006). This suggests
there is no nuclear anchor for Suc22R2 in S. pombe, but it
remains formally possible that Spd1 both contributes to
Suc22R2 nuclear import and acts as a canonical Suc22R2
nuclear anchor. If so, forced Spd1 localization to the
nucleolus would be predicted to result in concomitant
nucleolar Suc22R2. We thus modified the spd1+ locus to
express a C-terminal fusion of 13-Myc epitopes followed
by the Fib1 fibrillarin-like protein that is known
to localize to the nucleolus (Gallagher et al. 1993).
The fusion protein (Fig. 2B) expressed by the spd1 pro-
moter retained function, as judged by the correct profile
and dynamics of Suc22R2 localization (Fig. 2C; data
not shown). In a GFP-Suc22R2 background, we observed
that Spd1-13Myc-Fib1 localized to the nucleolus, but
Suc22R2 was not enriched in the nucleolus when com-
pared with spd1+ controls (Fig. 2C). Thus, Spd1 shares
a nuclear import function with Dif1, but does not
contribute to nuclear retention via a nuclear anchor
function.
Spd1 is required for FRET between Cdc22R1
and Suc22R2
The increased colocalization of R1 and R2 subunits in
the cytoplasm during S phase and in response to geno-
toxic stress is proposed to allow active RNR complexes to
form when dNTPs are required (Liu et al. 2003, 2005;
Holmberg et al. 2005; Zhang et al. 2006; Wu and Huang
2008). To explore this possibility, we established a FRET
assay (Fig. 3A,B) to examine the Cdc22R1/Suc22R2 inter-
action. First, we used the fluorescent protein tags to es-
timate the relative abundance of Cdc22R1 and Suc22R2 in
both the nuclear and cytoplasmic compartments in G2-
and S-phase cells. The relative fluorescence between
Cdc22R1 and Suc22R2 is 3:1 (data not shown). In G2 phase,
Suc22R2 fluorescence was approximately threefold more
intense in the nucleus than the cytoplasm, with ;74% of
the signal residing in the nucleus (Fig. 3C). In S phase,
nuclear Suc22R2 fluorescence is partitioned between two
nuclei and comprises ;26.5% of the GFP-Suc22R2 signal.
Individually, each nucleus shows a significant loss of in-
tensity comparedwithG2 phase.We also see a correspond-
ing gain in intensity (from 26% to 63.5%) in the cytoplasm
(Fig. 3C).
In spd1+ cells, FRET could be detected in the cyto-
plasm and the nucleus of cells in both G2 and S phase
Spd1 inhibition of RNR
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(Fig. 3D). In this case, FRET was used simply as an
indicator of the R1–R2 interaction and not as a quantita-
tive measure of association number or structural prox-
imity. Surprisingly, in spd1-d cells, we did not detect
FRET in the cytoplasm or nucleus of either S-phase or G2
cells (Fig. 3E). Treating spd1+ cells with hydroxyurea
(HU), an agent that inhibits RNR and synchronizes cells
in S phase, resulted in the FRET signal disappearing
(Fig. 3E). However, FRET was similarly lost when
cdc25-22 cells synchronized in G2 were held in G2 and
treated with HU (data not shown), indicating an S-phase-
independent effect of HU. Taken together, these data
indicate that Spd1 affects the association of Cdc22R1/
Suc22R2 subunits, but that this does not correlate with
apparent activation of RNR.
Alanine scanning mutagenesis of Spd1
From the available data, we can postulate three possible
in vivo functions for Spd1: regulation of Suc22R2 nuclear
import, an influence on RNR complex architecture that
equates to our FRET analysis, and, finally, an in vivo
restraint of RNR activity that correlates with an in-
creased dNTP concentration in the absence of Spd1 in
csn1-d and ddb1-d cells (Holmberg et al. 2005) and is
possibly equivalent to either the inhibition observed in
vitro (Hakansson et al. 2006), the nuclear sequestration of
Suc22R2, or a combination of both. To understand how
these potential functions relate to each other, and to shed
light on the mechanism by which Spd1 inhibits RNR, we
created 41 independent spd1 mutants in which each
Figure 2. Spd1 regulates Suc22R2 nuclear
import. (A) spd1+ CFP-suc22 and spd1-d
CFP-suc22 cultures were treated with HU
(20 mM) to arrest cells in S phase and/
or leptomycin (100 ng/mL) to block nu-
clear export. After 2 h, cells were formal-
dehyde-fixed, and GFP was visualized by
epifluorescence and DNA was visualized
by DAPI staining. In spd1+ cells treated
with HU, Suc22R2 becomes pan-cellular.
(Bottom left) Concomitant treatment with
leptomycin prevents nuclear export and
Suc22R2 redistribution. (Bottom right) In
the absence of Spd1, GFP-Suc22 is distrib-
uted throughout the cell and does not
accumulate in the nucleus when nuclear
export is blocked. (B) Cartoon representa-
tion of the spd1-Myc and spd1-Myc-Fib1
constructs integrated at the spd1 locus
under control of the spd1 promoter. A
53 glycine linker (5G) separates Spd1 from
the tags. (C) GFP-Suc22 (epifluorescence),
DAPI-stained DNA, and the Myc epitope
(indirect immunofluorescence) visualized
in fixed cells following logarithmic
growth. (D) Merged images of Myc and
GFP-Suc22 localization from the spd1-
Myc-Fib1 culture. White arrows indicate
example Myc staining nucleoli. Bars, 5 mm.
Nestoras et al.
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sequential group of three residues were substituted for
alanine (Fig. 4A), and examined their influence on Spd1
degradation and Spd1-dependent phenotypes.
Analysis of Spd1 degradation in vitro and in vivo
We established an in vitro assay for Spd1 degradation by
incubating 35S methionine-labeled Spd1 in whole-cell
extract. Degradation kinetics were monitored by SDS-
PAGE and autoradiography (Fig. 4B). Degradation was
dependent on the Cullin 4 E3 ubiquitin ligase Pcu4–
Ddb1Cdt2 and the signalosome, as predicted (Liu et al.
2003). Each individual mutant protein (Fig. 4C) was 35S
methionine-labeled and incubated with degradation-
competent extract, and the percentage of protein remain-
ing after 10 and 20 min was quantified. The results did
not identify a domain responsible for degradation, but did
reveal a single stable mutant, Spd1-M14. Deconvolution
of this mutant into the three individual alanine sub-
stitutions revealed that a single lysine residue (K42) was
required for efficient degradation (Fig. 4D).
We were surprised not to define a degron domain, and
were also wary of the observation that a single lysine is
required: Usually, disrupting a single lysine residue in
vivo results in adjacent lysines acting as alternative
ubiquitin acceptor sites. We thus integrated each mutant
into the spd1 locus, where they are expressed under
control of the spd1 promoter. To assay degradation, each
strain was grown to logarithmic phase and treated with
20 mM HU. This induces the Cdt2 targeting subunit of
Cul4–Ddb1Cdt2 ubiquitin ligase and promotes Spd1 deg-
radation (Liu et al. 2005). Samples for Western blot
analysis were prepared immediately before HU addition
and at 1, 2, and 4 h. Again we did not define a specific
domain controlling Spd1 degradation (Fig. 4E). The Spd1-
M14 and Spd1-K42A mutant proteins identified in the in
vitro studies also showed no evidence of stability (Fig. 4E;
data not shown). There were several additional observa-
tions. First, a double mutant encompassing the two
checkpoint kinase consensus sites, Spd1-M(3 + 18), was
not stabilized (Fig. 4F). Second, the initial protein levels of
many mutants varied significantly. This is a reproducible
observation seen with two independent a-Spd1 anti-
bodies, and likely reflects that triple alanine substitution
in an IDP is expected to affect intrinsic stability. Third,
only two mutant proteins, Spd1-M21 and Spd1-M23,
were significantly stabilized.
Separation of Suc22R2 localization and RNR
inhibitory regulation
We crossed each spd1 mutant into the GFP-suc22 back-
ground and observed Suc22R2 localization by direct
fluorescence in untreated cells and cells exposed to 20
mMHU for 4 h (Fig. 5). In spd1+ cells, Suc22R2 was largely
nuclear (most asynchronous S. pombe cells are in G2).
Figure 3. Spd1 is required for FRET between Cdc22R1 and Suc22R2. (A) Cartoon representation of FRET between CFP- and YFP-tagged
RNR subunits. Bleaching the YFP acceptor results in an increased emission signal from the CFP donor. The green circle represents the
nucleus (Suc22R2 accumulates in the nucleus). Squares represent the bleached area; in this instance, a region of cytoplasm. (B)
Equivalent cartoon showing result when fluorophores are not sufficiently aligned for FRET. Notice that, instead of an increase in the
signal from the donor (i.e., evidence of FRET), a moderate decrease is seen (as opposed to no change) due to some overlap in the
absorption spectra for CFP and YFP. (C) Percentage of nuclear and cytoplasmic fluorescent intensity of Cdc22-CFP and CFP-Suc22 in
single tagged cells visualized under the same microscope slide. (D) Representative images from spd1+ and spd1-d cultures without
treatment with HU. (E) Quantification of combined nuclear and cytoplasmic FRET signal. Error bars, SD from mean. Negative FRET
(formally no-FRET) results from nominal photobleaching of the donor along with the acceptor.
Spd1 inhibition of RNR
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Following HU treatment (cells arrested in S phase; Spd1-
degraded), ;20% of cells retained weak nuclear GFP
fluorescence, and Suc22R2 became pan-cellular in the
remaining ;80%. spd1-m2, spd1-m14, and spd1-m26
were fully defective for Suc22R2 nuclear accumulation.
A small but notable effect on nuclear accumulation was
observed for spd1-m34, spd1-m35, and spd1-m36. Four
mutants—spd1-m11, spd1-m12, spd1-m13, and spd1-
m33—showed more dramatic loss of Suc22R2 nuclear
accumulation upon HU treatment compared with spd1+
cells. Finally, four mutants—spd1-m21, spd1m-38, spd1-
m40, and spd1-m41—displayed robust Suc22R2 nuclear
accumulation poorly reversed by HU treatment. No
mutant showed a complete inability to delocalize
Suc22R2 to the cytoplasm (the phenotype seen when
Spd1 is completely stable; i.e., in pcu4-d, cdt2-d, and
csn1-d mutants). Notably, the region that corresponds to
the conserved HUG domain (spd1-m10 through spd1-
m20) was particularly sensitive to mutation in the assay
for nuclear localization. In Dif1, this domain is proposed
to bind the R2 subunit and promote its nuclear import.
If the mechanisms by which Spd1 restrains RNR
function in vivo depend on its ability to localize Suc22R2
in the nucleus, then RNR activation would be at least
partially dependent on the loss of nuclear Suc22R2 accumu-
lation in S phase, and spd1 mutants unable to accumulate
Figure 4. Stability of Spd1 mutant pro-
teins. (A) The 41 mutants of spd1 created.
These are designated as spd1-M1, spd1-
M2, etc. Each mutant results in the three
indicated amino acids being changed to
alanine. Bold indicates conserved HUG
and R1 domains (see Fig. 1A). (B) In vitro
degradation of 35S-labeled Spd1. In vitro
translated Spd1 is incubated for the in-
dicated number of minutes with whole-
cell extract derived from either wild type
(Wt) or the indicated mutants.mts3-ts and
mts2-1 are mutations in genes encoding
subunits of the proteasome and show
compromised degradation in this assay.
As is seen in vivo, Spd1 degradation is
dependent on the signalosome subunits
Csn1 and Csn2, and on the Cullin 4
homolog Pcu4. (C) Quantification of in
vitro degradation assay for the individual
mutants. (Blue symbols and dashed line)
10-min incubation; (red symbols and solid
line) 20-min incubation. (D) The three
amino acids mutated in spd1-M14 were
changed individually to alanine and tested
for stability in wild-type cell extract. Both
bands are Spd1-specific. (E) In vivo stabil-
ity of Spd1 mutant proteins. Each mutant
was integrated separately at the spd1 ge-
nomic locus under control of the spd1
promoter. Logarithmically growing cells
were incubated with HU (20 mM) for 1,
2, and 4 h; extract was prepared and sub-
jected to SDS-PAGE; and Spd1 was de-
tected by Western analysis with polyclonal
a-Spd1 antisera. A white star marks the
Spd1-specific bands. Before each mutant, a
control lane contains extract from spd1-d
cells. Blots were probed in parallel for
Cdc2 as a loading control. (F) Identical
analysis of spd1-M3, spd1-M18, and the
combined spd1-M3-18 mutations that
cover the two conserved Cds1Chk2 kinase
consensus sites.
Nestoras et al.
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Suc22R2 in the nucleus should phenocopy the spd1-d
null. We thus tested two robust phenotypes for Spd1-
dependent restraint of RNR activity. The first is the
ability of spd1-null mutants to suppress the synthetic
inviability associated with concomitant loss of the csn1
signalosome component and the rad3 checkpoint gene
(Liu et al. 2003). Essentially, in csn1-d mutants, Spd1 is
stable, and thus RNR activity is restrained in S phase—a
situation reminiscent of the inviability ofMEC1 deletion
and the ability of SML1 deletion to suppress this (Zhao
et al. 1998). Mutants in the HUG domain—plus spd1-
m26, spd1-M34, spd1-M35, and spd1-M41—rescued rad3-
d csn1-d synthetic lethality with significant efficiency, in
many cases approaching that of the spd1-d null (Fig. 6A).
The second assay we chose is the ability of spd1
deletion to rescue the spore formation defect evident in
the ddb1-d background (Liu et al. 2003; Holmberg et al.
2005). Ddb1 is a component of the Pcu4–Ddb1Cdt2 ubiq-
uitin ligase required for Spd1 degradation, so Spd1 re-
strains RNR activity in S phase and lowers dNTP pools in
ddb1-d mutants, and thus they cannot progress through
meiosis and form spores. This phenotype and the low
dNTP pools are reversed by deleting spd1. We combined
each of the 41 spd1 mutants with h90 ddb1-d and scored
the percentage of asci with either zero, one, two, three, or
four spores (Fig. 6B). Spore formation was restored (>70%
four-spored asci, close to that of ddb1-d spd1-d double-
null cells: >90%) in mutants spd1-m11 through spd1-
m16, spd1-m18, spd1-m19, spd1-m26, spd1-m34 through
spd1-m38, and spd1-m41.
Both of these assays are robust and semiquantitative
(Liu et al. 2003; Holmberg et al. 2005). Taking them
together, we conclude that the defect in Suc22R2 nuclear
import does not correlate with the biological evidence for
restraint of RNR activity. Of particular interest are
mutants spd1-m2 (import-defective, no defect in restrain-
ing RNR) and spd1-m10 plus spd1-m11 (little or no
import defect, but significantly unable to restrain RNR
activity). The broader trends in the data make clear that
HUG domain mutations (spd1-m10 through spd1-m20)
influence both import and restraint. Mutations in the
C-terminal region (spd1-m34 through spd1-m41) also
influence both import and restraint, and likely define
a new segment of Spd1.We suggest this is named the Spd1
domain, in keeping with the nomenclature of Lee et al.
(2008). Finally, mutations within the putative R1-binding
region (of which only three residues are identical between
Sml1 and Spd1) do not appear to dramatically influence
Figure 5. Subcellular localization of Suc22R2 in the individual spd1mutants. (A) GFP-Suc22 was visualized by epifluorescence in fixed
untreated cells and cells treated for 4 h with HU (20 mM) before fixation to arrest S phase. Controls were spd1+ (+) and spd1-d (!). These
are shown on the left. The majority of spd1+ cells show nuclear GFP-Suc22. Following incubation in HU, no evidence of nuclear
accumulation of GFP-Suc22 is seen in >80% of cells, the signal being pan-cellular. In the absence of Spd1, nuclear accumulation is not
seen in either untreated or treated cells. (B) A representative image: spd1-M14 behaves like a null mutant of spd1 in this assay. GFP-
Suc22 was visualized in spd1-M14 cells without HU treatment. DNA was visualized by DAPI staining. Error bars, SD from mean.
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Figure 6. Ability of individual spd1 mutants to restrain RNR function in vivo. Two in vivo assays for RNR function are shown. (A)
The ability of spd1 mutants to rescue the synthetic lethality of a rad3-ts csn1-d double mutant at 34°C. A dilution series for each
mutant was spotted, and plates were incubated at 34°C (partial loss of checkpoint). Viability is a semiquantitative measure of the loss of
the in vivo inhibitory function of Spd1 (Liu et al. 2003). (B) The ability of spd1 mutants to rescue the spore formation defect of
homothalic/h90 ddb1-d mutants. The number of spores formed gives a semiquantitative measure of the loss of the in vivo inhibitory
function (Holmberg et al. 2005). The in vivo dATP concentration relative to ddb1-d cells were measured in selected mutants and are
given above. Loss of inhibitory function correlates with increased dNTP pools. Wild-type (Wt) ddb1-d and ddb1-d spd1-d controls are
shown on the left.
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either import or restraint of RNR activity (spd1-m28
through spd1-m32).
The ability to promote R1–R2 FRET does not correlate
with RNR inhibition or nuclear import
Each of the 41 spd1mutants was crossed into the cdc22R1-
CFP YFP-Suc22R2 strain and tested for their ability to
promote Cdc22R1–Suc22R2 FRET. Only 12 of the 41
mutants could promote R1–R2 FRET (Fig. 7A). In most
of these 12 cases, the FRET signal was comparable with
that seen in spd1+ cells, and was seen in G2 and S phase in
both the nuclear and the cytoplasmic compartments
(Fig. 7B). The ability to promote R1–R2 FRET did not
correlate with either the Suc22R2 nuclear import function
of Spd1 or its ability to restrain RNR activity. For example,
spd1-M2 keeps the R1–R2 FRET signal but lacks the R2
nuclear localization function. Mutant spd1-M12 similarly
promotes R1–R2 FRET but has lost the ability to restrain
RNR activity. Mutants demonstrating the converse are
also apparent; i.e., spd1-M1 kept both the Suc22R2 nuclear
import function and the ability to restrain RNR activity,
but has lost the ability to promote FRET.
Spd1 can interact with both Cdc22R1 and Suc22R2
Active RNR in vitro consists of an a2b2 tetramer consist-
ing of 2xR1 and 2xR2 subunits (Nordlund and Reichard
2006). Since RNR is active in spd1-d cells, R1–R2 FRET
cannot simply reflect active tetramers. Furthermore,
R1–R2 FRET does not decrease when cells enter S phase,
so it is unlikely that the FRET signal reflects inactive
R1–R2 complexes. Both Escherichia coli (Rofougaran
et al. 2008) and mouse (Rofougaran et al. 2006) R1 sub-
units can be induced to form hexamers (a6) in vitro by
either dATP or ATP binding. These subsequently form
a6b2 octamers by association with a 2xR2 dimer (b2). a6b2
complexes have been suggested to represent the primary
active RNR form because sufficient ATP is available in
cells to occupy the majority of activity sites, and a corre-
lation has been observed between a6 hexamer formation
and ATP activation (Rofougaran et al. 2008). We used size
fractionation to establish whether the presence of Spd1
correlated with the presence of higher-order RNR com-
plexes (Fig. 8A). No evidence for multimer formation
was observed in either exponential spd1+ or spd1-d cells.
Limited higher-mass complexes were observed following
HU treatment, but these were not spd1-dependent. Thus,
we believe it unlikely that R1–R2 FRET reflects different
higher-order complex formation.
Despite extensive efforts, we were not able to identify
conditionswhere Spd1 can be coprecipitatedwithCdc22R1
or Suc22R2 from cell extracts. IDPs can bind multiple
substrates with high specificity but low affinity, which is
consistent with the low-affinity Spd1–Cdc22R2 interaction
Figure 7. Ability of the individual spd1 mutants to
promote Cdc22R1-Suc22R2 FRET. Each of the 41 in-
dividual mutants was crossed to the cdc22-YFP CFP-
suc22 background and tested for FRET signal. (A)
Summary of FRET intensities. FRET was examined in
both the nucleus and the cytoplasm of both mono-
nuclear (G2) and septating binucleate (S-phase) cells.
(Left) Controls are spd1+ and spd1-d. (B) The data for
each circumstance for the mutants able to promote
FRET. Error bars, SD from mean.
Spd1 inhibition of RNR
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reported (Hakansson et al. 2006). We thus used fluores-
cence quenching to establish if Spd1 could bind either R1
or R2 subunits (Fig. 8B). Recombinant Spd1 can interact
with both Cdc22R1 and Suc22R2 in vitro, as predicted by
Hakansson et al. (2006) and supported by our identification
of a role for Spd1 in Suc22R2 nuclear import.
Discussion
RNR dysregulation results in inappropriate total dNTP
levels and/or unbalanced dNTP ratios, which are changes
detrimental to genome stability (Chabes et al. 2003). RNR
subunit availability is regulated in most organisms via
transcriptional control (Elledge et al. 1993; Nordlund and
Reichard 2006). In the fission yeast, cdc22R1 and suc22R2
are induced transcriptionally at the transition between
G1 and S phase by the Cdc10, Res1, and Res2-containing
transcription factor MBF (Fernandez Sarabia et al. 1993).
In addition, DNA structure checkpoint activation results
in inhibition of the Nrm1 MBF corepressor and sub-
sequent MBF-dependent transcription (de Bruin et al.
2006). However, in cycling cells, the levels of Cdc22R1
Figure 8. Spd1 interacts with both Cdc22R1 and Suc22R2. (A) Gel filtration of extracts prepared from cdc22-CFP GFP-suc22 double-
tagged spd1+ and spd1-d cells after cross-linking with (right) and without (left) 4-h HU treatment. The a2b2 complex is predicted to be
274.6 kDa. Size markers are given above. (B) Fluorescence quenching assay for interaction between individual RNR subunits and Spd1.
(Far left) Fluorescence emission spectra of individual proteins. (Middle left) Suc22R2 + Spd1. Predicted additive fluorescence emission
(thin line) and experimental results (thick line) differ, demonstrating an interaction. (Middle right) Equivalent assay for Cdc22R1 + Spd1.
(Far right) Aliquots of purified proteins assessed by SDS-PAGE. (C) Summary of data. (From the top) Ability to promote FRET. The
region corresponding to the HUG and RNR interaction domains (see Fig. 1) are indicated. Where the mutant number is underlined,
FRET data have been verified by reversing the tags (i.e., cdc22-CFP YFP-suc22). The ability of spd1mutant cells to grow at 34°C in the
rad3-ts csn1-dmutant background. Growth is scored semiquantitatively from the data in Figure 6A and several repeats. Spore viability
data are reproduced from Figure 6B. Nuclear accumulation of Suc22R2 is reproduced from Figure 5A. The degradation of Spd1 in vivo is
semiquantitatively estimated (by eye) from the data in Figure 4E and several repeats for all mutants. Asterisks indicate those mutants
with partial (*) or complete (**) resistance to the in vitro degradation assay.
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and Suc22R2 protein do not change dramatically during
the cell cycle or after checkpoint activation (Watson et al.
2004). Most likely, transcriptional regulation ensures that
cells entering the cell cycle from stationary phase, or
those damaged during stationary phase, have a supply of
RNR subunits. A significant proportion of RNR regula-
tion in cycling cells thus occurs post-translationally.
The in vivo inhibitory function(s) of Spd1
In S. cerevisiae, the Sml1 inhibitor binds to the R1
subunit (Zhao et al. 2000; Zhang et al. 2007) and prevents
dNTP synthesis by inserting its C-terminal aromatic
residue into a cleft usually occupied by the C-terminal
residue of R2. Each S phase, Mec1 kinase activates the
downstream Dun1 kinase to promote Sml1 degradation
(Zhao and Rothstein 2002), likely by phosphorylating
serine residues within the Sml1 phospho-degron (SML
box) (see Fig. 1). When Mec1 is absent, Sml1 is not
degraded, and dNTP synthesis is inhibited during S phase.
Sincemec1mutants are also checkpoint-defective,MEC1
is an essential gene: A combination of low dNTP pools
and a checkpoint defect results in cell death. Concomi-
tant deletion of SML1 and MEC1 restores cell viability
because S phase is no longer inhibited and the checkpoint
thus is not required (Zhao et al. 2001).
Like S. cerevisiae Sml1, S. pombe Spd1 inhibits RNR in
vitro (Hakansson et al. 2006) and restrains RNR activity
in vivo when present in S phase (Liu et al. 2003).
Importantly, restraint of RNR activity did not correlate
with Suc22R2 relocalization. Both of the previously char-
acterized biological assays for in vivo RNR activity gave
consistent results and identified several mutants that
clearly separate the nuclear import role of Spd1 from its
ability to restrain RNR activity in vivo. Specifically, spd1-
M12 is unable to restrain RNR activity but is competent
for Suc22R2 nuclear import, while mutant spd1-M2 keeps
the ability to restrain RNR activity but is, as far as the
assay allows us to judge, fully defective for the nuclear
import function. The complementary specific loss of
function between these two mutants strongly suggests
that the major regulatory role of Spd1 on RNR activity is
not directly dependent on subcellular distribution of
RNR subunits. Most likely, the restraint of RNR activity
in vivo correlates with the in vitro inhibition via binding
to Cdc22R1 (Hakansson et al. 2006).
We can identify two specific regions of Spd1 that, when
mutated, result in decreased restraint of RNR. These two
regions are the HUG domain and an additional region, the
Spd1 domain, defined by mutants spd1-M34 through
spd1-M41. The HUG domain is required for both the
nuclear import function and the ability to restrain RNR
activity in vivo. This raises the possibility that Spd1
interacts with both R1 and R2 subunits in S. pombe
minimally through its HUG domain. We demonstrated
that Spd1 can indeed bind both Cdc22R1 and Suc22R2 in
vitro, but defining the mechanism of association awaits
further biophysical characterization, as the dual specific-
ity of Spd1 likely reflect the potential for low-affinity
interactions between IDPs and several substrates.
Spd1 functions to promote nuclear import but is not
a nuclear anchor
To establish if Spd1 shares the Dif1 function in nuclear
import, we explored whether blocking nuclear export in
spd1-deleted cells resulted in nuclear Suc22R2 accumula-
tion: The absence of nuclear export will result in Suc22R2
nuclear accumulation if import is active. In LMB-treated
spd1-d cells, Suc22R2 did not accumulate in the nucleus,
demonstrating that Spd1 is required for active Suc22R2
nuclear import. A cluster of the mutants analyzed (spd1-
M11 through spd1-M16) were either partially or com-
pletely defective for Suc22R2 import (data summarized in
Fig. 8C). This cluster largely encompasses the conserved
HUG domain, suggesting that, like for Dif1, the HUG
domain is important for nuclear import and likely defines
an R2 interaction surface, a prediction consistent with
our identification of a direct association between Suc22R2
and Spd1 in vitro. Two additional mutants, spd1-M2
and spd1-M26, also lost Suc22R2 nuclear accumulation
function.
In S. cerevisiae, loss of active import (DIF1 deletion)
results in decreased but not absent R2 nuclear accumu-
lation because the Wtm1-dependent nuclear anchor re-
tains R2 subunits (Lee and Elledge 2006). Loss of both
Dif1 (active import) and Wtm1 (anchoring) is required for
complete loss of R2 nuclear accumulation. In S. pombe,
loss of Spd1 alone results in complete loss of Suc22R2
nuclear accumulation. Either there is no R2 nuclear
anchor in S. pombe, or Spd1 itself fulfils both import
and anchoring roles. However, when Spd1 is localized
artificially to the nucleolus, we did not detect additional
Suc22R2 in the nucleolus, implying that there is no
nuclear anchor for Suc22R2.
Alanine scanning mutagenesis did not define
a degron domain
In S. cerevisiae, the SML box of the Sml1 and Dif1
proteins is thought to define a phospho-degron targeted
by Mec1ATR-dependent Dun1 kinase activity. In
S. pombe, Spd1 degradation is independent of Rad3ATR
and the downstream kinase Cds1Chk2 during S phase.
While Spd1 degradation becomes dependent on both
kinases in response to checkpoint activation, this de-
pendency is known, at least in part, to reflect the
checkpoint dependence of cdt2 transcript induction.
cdt2 encodes the adaptor for the ubiquitin ligase Pcu4–
Ddb1Cdt2 that targets Spd1 for degradation. We did not
define a distinct domain required for Spd1 degradation.
This is consistent with the lack of evidence for regulation
of Spd1 degradation by phosphorylation (Liu et al. 2005).
Furthermore, no single serine or threonine mutation
prevented degradation. There are no consensus Rad3ATR
sites on Spd1, but two potential Cds1Chk2 sites are
evident. Mutating both of these sites individually (spd1-
M3 and spd1-M18) or together (spd1-M3–18) did not affect
Spd1 stability.
Four mutants—spd1-M21, spd1-M23, spd1-M40, and
spd1-M41—were partially resistant to degradation. Cells
expressing these partially stable proteins were less
Spd1 inhibition of RNR
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responsive to loss of nuclear accumulation of Suc22R2
following HU, but none were synthetically lethal with
rad3-ts (data not shown). This indicates that, unlike
indirect stabilization of Spd1 via deletion of E3 ligase
components, these mutant proteins did not keep their
ability to fully restrain RNR activity. Intriguingly, the in
vitro degradation assay identified a single lysine required
for Cul4–Ddb1Cdt2 and signalosome-dependent E3 ubiq-
uitin ligase degradation of Spd1. However, mutating this
residue made no difference to in vivo Spd1 stability. One
possibility is that K42 is the sole Ub acceptor in vitro, but
is likely substituted by other lysines in vivo.
A novel Spd1-dependent level of RNR regulation?
Since we and others have speculated previously that
active RNR complexes are formed in the cytoplasm after
colocalization of Cdc22R1 and Suc22R2 following Spd1
degradation, we established a FRETassay to examine R1–
R2 association in different cellular compartments. Our
assumption was that 2xR1–2xR2 tetramer formation
(a2b2 complex) would be enhanced in the cytoplasm
following Spd1 degradation. While we could clearly
visualize FRET between Cdc22-YFP and CFP-Suc22
(and similarly when the tags were reversed) (data not
shown), R1–R2 FRETwas not enhanced upon loss of Spd1,
but was instead completely Spd1-dependent and did not
correlate with RNR activity: It was neither increased nor
decreased in the cytoplasm of S-phase cells compared
with G2 cells. R1–R2 FRET also disappeared when spd1+
cells were treated with HU. However, spd1+ cells held in
G2 and treated with HU lost the FRET signal within 30
min (data not shown), despite not progressing into
S phase, indicating that HU, a free-radical scavenger,
may independently quench the FRET signal.
Of the 41 spd1mutants tested for R1–R2 FRET, 12 were
positive. While there was some variation in the intensity
of the FRET signal in these mutants, this was modest,
relatively evenly distributed between the nuclear and
cytoplasmic compartments, and not specifically different
for either G2- or S-phase cells. Interestingly, the distribu-
tion of the mutants able to FRET did not correlate with
either the nuclear import role or the in vivo restraint of
RNR activity. For example, spd1-M2 cells were FRET-
competent and had lost nuclear import completely, while
spd1-M12 cells were FRET-competent but were unable to
restrain RNR activity.
What does the FRET signal represent? In vitro, active
RNR complexes consist of 2xR1 and 2xR2 subunits
(a2b2). Both ATP (activating) and dATP (inhibitory) bind-
ing to the allosteric overall activity site stimulate a2b2
formation, despite their opposite effects on activation.
Our gel filtration data indicate the presence of R1–R2
complexes at the size expected for a2b2 complexes and
show that these were not dependent on spd1+. Combined
with the observation that Spd1 loss leads to RNR activa-
tion, we can conclude that the presence of active a2b2
tetramers cannot be the cause of the FRET signal. Recent
work using both E. coli (Rofougaran et al. 2008) andmouse
(Rofougaran et al. 2006) RNR proteins has suggested that
both dATP and ATP induce the formation of R1 hexamers
(a6) that can form an a6b2 octamer by association with
a dimer (b2) of R2 subunits. However, by gel filtration
analysis, we did not observe evidence for Spd1-dependent
higher-order RNR complexes. A subfraction of Cdc22R1
and Suc22R2 were seen to migrate at higher molecular
weight, but this occurred after treatmentwith HU andwas
independent of spd1 status.
Our data suggest that Spd1-dependent FRET between
R1 and R2 subunits reflects a changed conformation of the
RNR a2b2 complex. We hypothesize that Spd1 mediates
formation of immature inactive RNR complexes. In these
inactive complexes, the fluorophores are appropriately
aligned to allow FRET between Cdc22R1 and Suc22R1,
reflecting an optimal complex architecture for subsequent
activation when Spd1 is degraded. In support of this
proposal, the p27 cyclin-dependent kinase inhibitor is an
IDP that mediates formation of immature inactive Cdk2–
CycA complexes (Russo et al. 1996). p27 folds onto the
Cdk2 and CycA subunits, both individually and at the
same time. Intriguingly, p27 directly inhibits Cdk2 by
altering the conformation of the catalytic cleft and insert-
ing a tyrosine residue as anATP-mimicking residue. In this
context, we note that, in active a2b2 tetramers, the R2
C-terminal residue is buried in a deep cleft of R1, and that
interference with optimal RNR complex architecture has
been observed using R2 C-terminal-mimicking peptides
(Cohen et al. 1986). It has also been suggested that the
C-terminal Phe of Sml1 (F104), which is mandatory for full
inhibition in S. cerevisiae (Zhao et al. 2000), may also
insert into the same deep cleft of R1 that is the binding
pocket for the C-terminal aromatic residue of the R2
subunit. The change in fluorescence emission also sup-
ports the involvement of tyrosines and/or tryptophans in
the interactions.
Once Spd1-dependent inactive complexes are formed,
we propose that Spd1 degradation would leave them in the
optimal conformation for catalytic activity by removing
the direct inhibition and allowing activation via ATP
binding to the allosteric ‘‘overall activity’’ site. To explain
why spd1-d cells never exhibit FRET butmaintain RNR in
an active form, we postulate that, in the absence of Spd1,
RNR complexes do still form, but with an alternative
suboptimal architecture. The fact that these are abundant
and not inhibited by Spd1 compensates for the loss of the
Spd1-dependent forms.
Conclusion
We showed that Spd1 acts as an import factor for Suc22R2,
as predicted from its relationship to Dif1 in S. cerevisiae.
Since it also functions to restrain RNR activity in vivo,
we asked if these two phenomena were related. Contrary
to our expectation, the assaysmeasuring restraint of RNR
activity in vivo did not correlate with Suc22R2 import,
demonstrating that the major function of Spd1 in regu-
lating dNTP synthesis is unrelated to its role in nuclear
sequestration of Suc22R2. We also established a FRET
assay that revealed a novel aspect of RNR behavior that
has the potential to provide yet another mechanism to
Nestoras et al.
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regulate RNR, possibly through alterations of tetramer
architecture. The precise role for this new effect of Spd1
on RNR and how it relates to the regulation of RNR
awaits further analysis. The segmental distribution of
Spd1 functionality uncovered here is reminiscent of the
hallmarks of IDPs, including the association with multi-
ple partners. Thus, the IDP nature of Spd1 likely explains
how this small protein is able to regulate R1–R2 com-
plexes in multiple ways.
Materials and methods
Cloning, expression, stability, purification, and interactions
of recombinant proteins
The spd1, suc22, and cdc22 ORFs were PCR-amplified, cloned
into appropriate vectors, and verified by sequencing. Individual
spd1mutations were constructed using oligonucleotide-directed
mutagenesis, and each was verified by sequencing. Coupled in
vitro transcription–translation (Promega) was performed using
the manufacturer’s instructions to produce 35S-labeled protein.
Cell extracts were prepared by resuspending cell pellets in an
equal volume of HB buffer (25 mM Tris-HCl at pH 7.5, 15 mM
EGTA, 15 mM MgCl2 0.1% NP-40, 1 mM DTT, 0.1 mM NaF)
and grinding by mortar and pestle under liquid nitrogen, and
were clarified by 10-min centrifugation in a microfuge at 4°C. In
vitro degradation reactions were started by adding 35S-labeled
protein and were stopped after 10- or 20-min incubation at room
temperature by adding SDS sample buffer. Labeled protein was
visualized by SDS-PAGE and was quantified using a Storm
PhosphorImager. Expression and purification of Cdc22 and
Suc22 was as reported previously (Hakansson et al. 2006). For
expression of recombinant protein spd1+, ORF was ligated into
pET11a and expressed in BL21(DE3) (0.1 M IPTG). For pro-
duction of 15N-labeled protein, cells were grown in 1 L LB media
(100 mg/mL ampicillin) to OD600 0.7–0.8, harvested by centrifu-
gation (25 min at 2000g), resuspended in M9 media (100 mg/mL
ampicillin) with (15NH4)2SO4 (1.5 g/L) as the sole nitrogen
source, and grown for 1 h before induction. Induction was for 3
h at 37°C. Induced cells were harvested (15 min at 5000g);
resuspended in 25 mL of 13 PBS (140 mM NaCl, 2.7 mM KCl,
10 mM Na2HPO4, 1.8 mM KH2PO4), 25% (w/v) sucrose, 5 mM
EDTA, and 1% (w/v) Triton X-100; and sonicated three times
with intermediate washes in the same buffer. Spd1 was found in
the pellets, and this was dissolved in 50mL of 20mMTris (pH 8),
4.5 M urea, and 0.1% (v/v) Triton X-100, and spun 15 min at
20,000g. Supernatant was applied to a Mono Q column equili-
brated in buffer A (20 mM Tris at pH 8, 4.5 M urea, 0.1% [v/v]
Triton X-100) and eluted in a linear gradient of buffer B (20 mM
Tris at pH 8, 4.5M urea, 0.1% [v/v] Triton X-100, 1MNaCl). The
relevant fractions were identified and dialyzed extensively
against 13 PBS (pH 7.4) using a cut-off of 3000 g/mol. Protein
was concentrated and stored at !20°C until further use. Gel
filtration was performed by loading 2 mg total cross-linked
protein on a Superose 6 column following extraction of proteins
by grinding in liquid nitrogen. Cells were first incubated with 2
mM homobifunctional cross-linker SDP (Thermo Scientific) for
30 min. Log-phase cells were either treated or not with 20 mM
HU for 4 h. Interactions between Cdc22 or Suc22 with Spd1 were
assayed by fluorescence quenching spectroscopy using a Perkin-
Elmer LS50B and 1 mM protein concentrations alone or in
mixture in 10 mM sodium phosphate (pH 7.4). Excitation was
at 280 nm at room temperature, averaging five scans and
subtracting buffer backgrounds. Theoretical emission spectra
for the case of noninteracting proteins were generated by
addition of spectra recorded on individual proteins. To assay
dATP concentration, small molecule extracts were prepared
from 50-mL cultures growing in minimal medium and harvested
at 5.0 3 106 cells per milliliter on a 0.45-mm filter, washed once
in ice cold water, and resuspended in ice-cold 500-mL 20%TCA/
15 mM MgCl2. After three freeze–thaw cycles and final centri-
fugation, the supernatant was ether-extracted seven times to
remove TCA. ATP was measured indirectly using a luciferase-
based ATP determination kit from Biaffin GmbH and Co., KG,
according to instructions. dATP was determined by a primer
extension assay on a dA-specific template as described in Roy
et al. (1999). Extended products were quantified on a Storm
PhosphorImager.
Spectroscopy
A sample of 10 mM Spd1 was prepared in 10 mM NaH2PO4
adjusted to pH 7.4 using NaOH. A far-UV CD spectrum was
recorded at room temperature on a Jasco 810 spectropolarimeter
using a light path length of 1 mm. A total of five scans were
accumulated from 250 to 190 nm, and buffer background was
subtracted. Scanning speed was 20 nm/min, and data pitch was
0.1 nm. The resulting spectrum was smoothed using an FFT
filter supplied by the Jasco software. A 15N,1H-HSQC NMR
spectrum was recorded at 10°C on a Varian INOVA 750-MHz
(1H) spectrometer with 48 transients in the direct dimension and
400 increments in t1. The spectrum was transformed and
visualized using NMRPipe (Delaglio et al. 1995). The NMR
sample was 1mM 15N-Spd1 and 10mMNaH2PO4 (pH 7.4) in 300
mL, which was centrifuged for 5 min at 5000g and transferred to
a 5-mm Shigemi NMR tube.
Cell biology and genetics
Yeast strains were constructed using standard methods. spd1
mutants and genomic tagged constructs were created by PCR-
amplifying the desired ORF using primers with ;80-base-pair
(bp) homology with the sequences flanking the genomic ORF.
The resulting fragment was purified and transformed into an
spd1Tura4 strain where ura4+ had replaced the spd1 ORF.
Replacements were selected by growth on 5-FOA, tested by
PCR, and verified as correct by sequencing. To assay spore
formation, strains were incubated on malt extract agar plates
and incubated for 3 d at 25°C, and 200 U were assessed for
zygotes/asci with zero to four spores. dATP measurements were
performed on purified nucleotides by assessing ability to support
primer extension against dNTP standard controls. The dATP
level is calculated relative to ATP in the extract; i.e., the primer
extension assay was performed on extract volume equal to 75
nmol ATP, as determined by a luciferase-based assay.
For epifluorescence and indirect immunofluorescence, cells
were grown in log culture at 30°C (unless otherwise specified) in
supplemented yeast extract (YE) media with or without drug as
specified. For FRET analysis, cells were harvested, washed with
PBS, and air dried on the slide; a drop of mounting medium (50%
glycerol, 50%water) and a cover slip were added; and fluorescent
proteins were visualized using a laser scanning confocal micro-
scope (LSM 510, Zeiss). Photobleaching of the acceptor was
performed by scanning the 514-nm Argon laser across a specific
region of interest (ROI) within a cell (cytoplasm or nucleus).
Images were processed in ImageJ (NIH). To calculate FRET,
images were normalized and intensities were measured for the
ROI. IDA indicates intensity of the donor in the presence of
acceptor (prebleach), ID indicates intensity of the donor in the
absence of acceptor (post-bleach), and IAUTO indicates back-
ground intensity (autofluorescence of an untagged control). The
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FRET efficiency is expressed as a percentage: 1 ! [(IDA !
IAUTO.)/(ID ! IAUTO.)] 3 100. We also verified FRET efficien-
cies using a dedicated ImageJ macro. Levels of complexed and
dissociated R1–R2 were unresolved in the present assay: Donor
intensities were not corrected for noninteracting R1–R2, render-
ing FRET efficiencies as a marker of subunit association a quan-
titative measure of R1–R2 complex concentration or donor–
acceptor proximity. Concomitant photobleaching of donor with
the acceptor is similarly not accounted for, resulting in negative
FRETefficiencies in the absence of R1–R2 interaction and a lower
estimate of FRET in cases of positive association.
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